Appearance of epitopes in bovine milk protein variants, their allergenicity and potential use in human nutrition by Lisson, Maria
VVB LAUFERSWEILER VERLAG
édition scientifique
Photo cover: 
MARIA LISSON 
Appearance of Epitopes in Bovine Milk Protein 
Variants, Their Allergenicity and Potential Use 
in Human Nutrition
A dissertation submitted to the Faculty of 
Agricultural Sciences, Nutritional Sciences 
and Environmental Management, 
Justus-Liebig-University, Gießen, for the 
doctoral degree of Dr. oec. troph.
VVB
M
A
R
I
A
 
L
I
S
S
O
N
 
 
 
 
A
L
L
E
R
G
E
N
I
C
I
T
Y
 
O
F
 
B
O
V
I
N
E
 
C
A
S
E
I
N
 
V
A
R
I
A
N
T
S
 
VVB LAUFERSWEILER VERLAG
STAUFENBERGRING 15
D-35396 GIESSEN
Tel: 0641-5599888 Fax: -5599890
redaktion@doktorverlag.de
www.doktorverlag.de
VVB LAUFERSWEILER VERLAG
édition scientifique
9 7 8 3 8 3 5 9 6 2 2 4 8
ISBN: 978-3-8359-6224-8
Das Werk ist in allen seinen Teilen urheberrechtlich geschützt.
Die rechtliche Verantwortung für den gesamten Inhalt dieses 
Buches liegt ausschließlich bei dem Autor dieses Werkes.
Jede Verwertung ist ohne schriftliche Zustimmung des Autors 
oder des Verlages unzulässig. Das gilt insbesondere für 
Vervielfältigungen, Übersetzungen, Mikroverfilmungen
 und die Einspeicherung in und Verarbeitung durch 
elektronische Systeme.
1. Auflage 2014
All rights reserved. No part of this publication may be
 reproduced, stored in a retrieval system, or transmitted, 
in any form or by any means, electronic, mechanical, 
photocopying, recording, or otherwise, without the prior 
written permission of the Author or the Publishers.
st1  Edition 2014
©  2014 by VVB LAUFERSWEILER VERLAG, Giessen
Printed in Germany 
VVB LAUFERSWEILER VERLAG
STAUFENBERGRING 15, D-35396 GIESSEN
Tel: 0641-5599888 Fax: 0641-5599890 
email: redaktion@doktorverlag.de
www.doktorverlag.de
édition  scientifique
 
Department of Animal Breeding and Genetics, Justus‐Liebig‐University Gießen 
  
Supervisor: Prof. Dr. G. Erhardt 
 
  
 
  
Appearance of Epitopes in Bovine Milk Protein Variants,  
Their Allergenicity and Potential Use in Human Nutrition 
 
 
  
A dissertation submitted to the Faculty of Agricultural Sciences, Nutritional Sciences  
and Environmental Management, Justus‐Liebig‐University, Gießen,                                                  
for the doctoral degree of Dr. oec. troph.  
 
 
 
 
Presented by  
 
Maria Lisson (M. Sc.)  
born in Rosenheim 
  
   
Gießen, 2014 
 
 
 
With the consent of the Faculty of Agricultural Sciences, Nutritional Sciences and 
Environmental Management, Justus‐Liebig‐University Gießen 
 
 
 
Dean:  
Prof. Dr. Dr. Peter Kämpfer 
 
 
 
 
 
 
 
1. Referee:  Prof. Dr. G. Erhardt 
 
2. Referee: Prof. Dr. C. Kunz 
 
 
 
 
 
 
 
 
 
 
Date of disputation: 
15.09.2014
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Meinen Eltern für ihre beispiellose Unterstützung  
in all meinen Lebenslagen 
 
 
 
 
 
 
Table of contents 
 
Table of contents 
 
List of abbreviations ....................................................................................................... I 
1.  General introduction .................................................................................................. 1 
 1.1. Importance of cow milk  ...................................................................................... 1 
  1.1.1. Economic importance of cow milk  .................................................................... 1 
  1.1.2. Dietary importance of cow milk  ........................................................................ 2 
 1.2. Cow milk allergy .................................................................................................. 4 
  1.2.1. Definition, epidemiology, and etiology .............................................................. 4 
  1.2.2. Pathogenesis and manifestation of cow milk allergy  ........................................ 5 
   1.2.2.1. IgE-mediated cow milk allergy  .............................................................. 6 
   1.2.2.2. Non-IgE-mediated cow milk allergy  ...................................................... 8 
   1.2.2.3 Mixed IgE-/non-IgE-mediated cow milk allergy  ..................................... 9 
  1.2.3. Diagnosis of cow milk allergy  ............................................................................ 9 
  1.2.4. Management and treatment of cow milk allergy  ............................................. 10 
   1.2.4.1. Avoidance of cow milk  .......................................................................... 10 
   1.2.4.2. Prevention  ............................................................................................. 11 
   1.2.4.3. Immunotherapy  .................................................................................... 12 
 1.3. Cow milk allergens  .............................................................................................. 12 
  1.3.1. Caseins  ............................................................................................................... 13 
  1.3.2. Whey proteins  ................................................................................................... 14 
  1.3.3. Genetic polymorphisms of milk proteins  .......................................................... 15 
   1.3.3.1. Casein polymorphisms  .......................................................................... 16 
     1.3.3.1.1. αS1-casein  ............................................................................... 16 
     1.3.3.1.2. αS2-casein  ............................................................................... 17 
     1.3.3.1.3. β-casein  ................................................................................. 17 
     1.3.3.1.4. κ-casein  .................................................................................. 19 
   1.3.3.2. Whey protein polymorphisms  .............................................................. 20 
     1.3.3.2.1. α-lactalbumin  ........................................................................ 20 
     1.3.3.2.2. β-lactoglobulin ....................................................................... 21 
   1.3.3.3. Importance of milk protein polymorphisms  ......................................... 22 
  1.3.4. Allergenic structures in milk proteins  ................................................................ 23 
 
Table of contents 
  1.3.5. Allergy to other mammalian milk  ...................................................................... 25
 1.4. Aims and design of the study  .............................................................................. 28 
2.  In vitro gastrointestinal digestion of bovine αS1- and αS2-casein variants gives rise to 
different IgE-binding epitopes  .................................................................................... 30 
3.  Genetic variants of bovine β- and κ-casein result in different immunoglobulin E-binding 
epitopes after in vitro gastrointestinal digestion  ........................................................ 56 
4.  Immunoglobulin E epitope mapping by microarray immunoassay reveals differences in 
immune response to genetic variants of caseins from different ruminant species ....... 82 
5.  General discussion of the results  ............................................................................. 114 
 5.1. In vitro gastrointestinal digestion analyses of casein variants  ................................. 114 
 5.2. Influence of genetic polymorphisms on the allergenicity of milk protein variants .. 120 
 5.3. Concluding remarks and future approaches  ............................................................ 124 
6.  Summary  ................................................................................................................. 126 
7.  Zusammenfassung  ................................................................................................... 128 
8.  References of the general parts  ............................................................................... 130 
Acknowledgement   ...................................................................................................... 148 
Danksagung  ................................................................................................................. 149 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
List of abbreviations 
I 
List of abbreviations 
 
AA    Amino acid 
AAF   Amino acid-based formula 
ACE    Angiotensin I converting enzyme  
αS1-CN   αs1-casein 
αS2-CN   αs2-casein 
α-LA   α-lactalbumin 
BSA   Bovine serum albumin 
β-CN   β-casein 
β-LG   β-lactoglobulin 
κ-CN   κ-casein 
CMA   Cow milk allergy 
CMI    Cow milk intolerance 
EHF   Extensively hydrolyzed formula 
ESFA    European food safety authority 
IEF   Isoelectric focusing 
IgE   Immunoglobulin E 
Igs   Immunoglobulins 
LF   Lactoferrin 
MALDI-TOF-MS Matrix assisted laser desorption/ionization-time of flight-mass 
spectrometry 
OIT   Oral immunotherapy 
PC   Phosphatidylcholine 
PCR   Polymerase chain reaction  
RAST   Radio allergo sorbent test 
SLIT   Sublingual immunotherapy 
SPT   Skin prick test 
 
1. General introduction 
 1 
1. General introduction 
1.1. Importance of cow milk  
1.1.1. Economic importance of cow milk 
The use of milk for nutritional purposes took place in the seventh millennium BC, early in the 
evolution of animal domestication (Evershed et al., 2008). Today, it is not only a substantial 
food within human nutrition but also one of the most important agricultural products in the 
world. The demand for milk contributes to rise, which is due to an increasing population and 
income, economic growth, changed dietary habits, as well as the growing popularity of dairy 
products, particularly in developing countries (OECD/FAO, 2012). Worldwide cow milk 
production in 2011, representing 83% of total milk (the rest coming from buffalo, goat, 
sheep, and camel), amounted to 605,644,740 tonnes with the top 5 producing countries 
(USA: 14.69%, India: 8.66%, China: 6.09%, Brazil: 5.29%, and Russia: 5.18%) accounting for 
39.9% of production (FAOstat, 2013). The worldwide average milk consumption (liquid milk 
and processed products) increased to 107.3 kg per capita per year in 2011. Asia represents 
the largest consuming region with 39% of global milk consumption, followed by Europe at 
28% and North America at 13% (IDF, 2012). However, milk consumption per capita varies 
widely among and even within regions from highs in Europe (277 kg) to lows in Asia (67 kg). 
The countries Estonia, Ireland, and Finland in Northern Europe show the highest 
consumption per capita of liquid milk, all in excess of 130 kg, whereas per capita butter and 
cheese consumption dominate in Western Europe with France (butter: 7.5 kg, cheese: > 25 
kg) and Luxembourg (cheese: > 25 kg) at the top (IDF, 2012).  
Germany is the sixth largest producer in the world generating 30,685,200 tonnes milk in 
2012 and accounting for 5% of world production (BLE, 2013a,b; FAOstat, 2013). In 2012, 
4,190,485 dairy cows were kept by 82,865 German dairy cow farmers, with a milk yield of 
7,323 kg per cow per year (4.13% fat and 3.41% protein) and with Holstein Friesian and 
Simmental as the most important cattle breeds (BLE, 2013a,b; DeStatis, 2013). Within the 
last 12 years, per capita milk consumption in Germany has varied only slightly and has 
strongly depended on both product and price. Thus, per capita consumption of fresh milk 
products decreased from 92.88 kg in 2000 to 90.42 kg in 2012, whereas for cheese a 
continuous increase from 21.6 kg to 23.7 kg was recorded. The per capita consumption of 
milk products in 2012 amounted to 54.64 kg for drinking milk, 18.1 kg for yogurt, 5.64 kg for 
cream products, and 6.18 kg for butter (BLE, 2013a,b).  
 
1. General introduction 
 2 
1.1.2. Dietary importance of cow milk 
Cow milk and dairy products are food staples in most Western societies and their 
consumption is recommended by many nutrition organizations. Cow milk can be described 
as one of the most nutritionally complete foods being rich in essential nutrients such as 
protein, fat, vitamins, and minerals (Table 1). The main constituent of milk is water at ca. 
87-88%, with the remainder being ca. 3-6% fat, 4.7-4.8% carbohydrate (lactose), 3.2-3.6% 
protein, and 0.7-0.8% ash representing minerals and vitamins (Töpel, 2004). 
The protein of milk is characterized by a high biological value as it comprises all essential 
amino acids (AA) in beneficial combination (Buttriss, 2003). Due to the high content of the 
essential AA lysine, milk can be used as valuable supplement for plant proteins that are 
limited in this AA (Tomé et al., 2004). Cow milk is also rich in the branched chain AA valine, 
leucine, and isoleucine, which promote protein synthesis, suppress protein catabolism, serve 
as substrates for gluconeogenesis, and trigger muscle protein synthesis (Etzel, 2004; Haug et 
al., 2007). Furthermore, cow milk contains a wide range of proteins acting as enzymes and 
enzymes inhibitors, metal and vitamin binding proteins, growth factors, hormones, as well as 
antibodies (Claeys et al., 2013). It is also an important source of biologically active peptides 
that have beneficial effects on human health (Korhonen & Pihlanto, 2006).  
Cow milk possesses small amounts of essential omega-6- (linoleic acid, 18:2) and omega-3- 
(α-linolenic acid, 18:3) fatty acids as well as conjugated linoleic acid (CLA). The later one has 
been shown to have anticarcinogenic properties with an average content in milk varying 
between 0.3 and 0.6% of total fatty acids (Dhiman et al., 2000; Haug et al., 2007). The 
content of these fatty acids is greatly influenced by farming of animals and feeding regime 
(grain, fiber and energy intake, dietary fats, seasonal and regional effects) (Claeys et al., 
2013).   
Cow milk makes a contribution for the provision of nearly all minerals, trace elements, and 
vitamins needed for human health. The greatest amount of calcium is obtained from milk 
and dairy products and, therefore, it is difficult to achieve dietary calcium recommendations 
without consuming these foods. Further relevant minerals in milk are phosphor, potassium, 
and magnesium, which are essential for bone metabolism (Caroli et al., 2011). Together with 
zinc, they are present in a highly bioavailable form being well absorbed and utilized by the 
body.   
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Table 1. Composition of some important nutrients (per 100 g) in whole milk with a standardized fat content of 
3.5% (Dhiman et al., 2000; DEBInet, 2013). 
Milk component Concentration in 100 g whole milk 
Energy (kcal) 
            (kJ) 
Fat (g) 
65 
272 
3.569 
Saturates (g)  
Monounsaturates (g) 
Polyunsaturates (g) 
α-linolenic acid 18:3 (g) 
Linoleic acid, 18:2 (g) 
2.401 
0.882 
0.074 
0.025 
0.046 
Protein (g) 
Casein (g) 
Whey proteins (g) 
3.382 
2.706 
0.676  
Carbohydrates 
Lactose (g) 
Glucose (g) 
Galactose (g) 
Oligosaccharides (g) 
4.7 
4.685 
0.006 
0.009 
< 0.1 
Water-soluble vitamins 
Thiamin (vit B1) (mg) 
Riboflavin (vit B2) (mg) 
Pyridoxine (vit B6) (mg)  
Cobalamin (vit B12) (μg) 
Pantothenic acid (mg) 
Folate (μg) 
Fat-soluble vitamins 
Retinol (vit A) (μg) 
Cholecalciferol (vit D)  (μg) 
Tocopherol (vit E) ( mg) 
 
0.037 
0.18 
0.039 
0.4 
0.35 
9 
 
28 
0.09 
0.07 
Minerals  
Calcium (mg) 
Potassium (mg) 
Magnesium (mg) 
Zinc (mg) 
Phosphor (mg) 
Sodium (mg) 
Chloride (mg) 
 
120 
140 
12 
0.4 
92 
45 
102 
Essential amino acids 
Lysine (mg) 
Valine (mg) 
Leucine (mg) 
Isoleucine (mg) 
Proline (mg) 
 
283 
194 
328 
147  
322 
 
Concerning vitamins, all known vitamins are available in whole milk, although with varying 
quantities and with vitamin B12, vitamin B2, and vitamin A as the most important ones. Milk 
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content of several vitamins and minerals such as vitamin A and E, as well as selenium and 
iodine are influenced by the cows’ diet (Haug et al., 2007; Claeys et al., 2013). 
 
1.2. Cow milk allergy 
1.2.1. Definition, epidemiology, and etiology 
Despite the numerous health benefits of cow milk, its consumption can lead to nutritional 
and immunological problems such as cow milk allergy (CMA) or cow milk intolerance (CMI). 
CMA has to be differentiated from CMI as they are distinct disorders that need separate 
methods of diagnosis and different strategies for treatment and management (Crittenden & 
Bennett, 2005). CMA is clinically an immunologically mediated adverse reaction to single or 
multiple proteins found in cow milk (Figure 1).  
 
Figure 1. Classification of adverse reactions of cow milk (adapted from Bahna, 2002; Crittenden & Bennett, 
2005; Hochwallner et al., 2011). 
 
In contrast, CMI refers to non immunologic reactions to cow milk such as disorders of 
digestion, absorption, or metabolism of certain cow milk components, mainly lactose 
(Bahna, 2002; Monaci et al., 2006).  
Cow milk protein is often the first foreign food antigen infants are orally exposed to. That is 
why CMA is the most common food allergy in infants and young children with an incidence 
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of 2-3% in the general population (Skripak et al., 2007). CMA in adults is rare and affects 0.1-
0.5% of the grown persons (Lam et al., 2008; Osterballe et al., 2009). Usually, CMA occurs 
during the first year of life after introduction of cow milk or cow milk based-formula in the 
infant´s diet (Benhamou et al., 2009). It may also appear via breast milk, when the maternal 
diet contains cow milk (Huang & Kim, 2012). The majority of children outgrow their allergy at 
school age, but tolerance can even develop later (Savilahti & Savilahti, 2013). Skripak et al. 
(2007) found rates of tolerances of 19% at the age of 4 years, 42% at the age of 8 years, 64% 
at the age of 12 years, and 79% at the age of 16 years.  
The etiology of CMA seems to be multifactorial and has not been clearly defined. It is 
probably based on the interaction between genetic predisposition of the individual and 
environmental factors (Cochrane et al., 2009; Savilahti & Savilahti, 2013). 
 
1.2.2. Pathogenesis and manifestation of cow milk allergy 
Although the exact site of food absorption and allergy induction remains unclear, most of 
the food allergens are thought to sensitize an individual via the gastrointestinal tract 
(Moreno, 2007; Schnell & Herman, 2009). However, also the skin has been shown to be an 
important route of sensitization to food allergens (Dunkin et al., 2011; Berin & Sampson, 
2013). The gastrointestinal tract represents the largest surface area in the human body with 
the main function being the digestion and absorption of food, as well as the prevention of 
pathogen, toxin, and food antigen penetration. It is comprised of a single layer of epithelial 
cells that establish a selective barrier separating the external environment from the internal 
milieu and allowing the transport of nutrients, while retaining larger molecules and harmful 
pathogens within the lumen (Perrier & Corhésy, 2011). This mucosal barrier is armed with 
complex physiological and immunological protective mechanisms. The physiologic part is 
composed of the single layer of epithelial cells that are joined together by tight junctions and 
covered with a thick mucus layer secreting a number of factors such as mucins, antimicrobial 
peptides, and trefoil factors into the mucosal lumen. Moreover, luminal and brush border 
enzymes, bile salts, and extremes of pH contribute to the protection against the invasion of 
pathogens and antigens. The immunologic barrier includes the innate immune cells and 
factors, represented by polymorphonuclear neutrophils, macrophages, dendritic cells, 
natural killer cells, and Toll-like receptors, as well as the adaptive immune cells and factors, 
comprising intraepithelial and lamina propria lymphocytes, Peyer patches, secretory IgA, and 
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cytokines that play a key role in defending and elimination of invading pathogenic bacteria 
and foreign antigens (Sicherer & Sampson, 2010; Berin & Sampson, 2013). Consequently, an 
abrogation or alteration of this mucosal barrier through e.g. stomach pH neutralization, 
immaturity of the infants gut barrier and immune system, low stomach pepsin activity at 
birth, raised intragastric pH in infants or patients taking antacids, as well as malfunction of 
pancreatic and intestinal enzymes might promote CMA in infants and adults (Cochrane et al., 
2009; Sicherer & Sampson, 2010). In addition, an enhanced intestinal permeability can 
probably contribute to CMA by increasing the exposure and passage of intact allergens 
(Sicherer & Sampson, 2010; Perrier & Corhésy, 2011). In most people, the intestinal immune 
system recognizes milk proteins as harmless and suppresses immunoreactivity leading to 
oral tolerance. The development of oral tolerance is supposed to be obtained through the 
production of regulatory T-cells or by anergy and deletion of allergen specific T-cells. It is 
believed that in CMA the process of oral tolerance is abrogated or broken down (Fiocchi et 
al., 2010; Sicherer & Sampson, 2010; Perrier & Corhésy, 2011). Also, several factors such as 
genetic predisposition, infections, intestinal microflora modification, age at fist exposure, 
maternal diet, antigen transfer through breast milk, as well as the nature, timing, dose, 
quantity, and frequency of antigen load, influence oral tolerance induction or sensitization to 
cow milk (Cochrane et al., 2009; Fiocchi et al., 2010; Savilahti & Savilahti, 2013). The immune 
mechanisms involved in CMA are classified in Immunoglobulin E (IgE)-mediated and non-IgE-
mediated, as well as mixed IgE-/non-IgE-mediated forms (Figure 1) (Fiocchi et al., 2010).  
 
1.2.2.1. IgE-mediated cow milk allergy 
IgE-mediated CMA is considered to be the most common form in infants and children (Vanto 
et al., 2004). The mechanisms of IgE-mediated CMA are well understood and consist of 2 
phases: First sensitization followed by memory induction and second immediate reaction 
(Figure 2a and b).  
 
a) Sensitization and memory induction 
After primary exposure, cow milk protein is absorbed by the gut mucosa and presented to 
the immune cells (Figure 2a). The allergen is taken up by antigen presenting cells, especially 
dendritic cells, and degraded to peptide fragments, which are presented via major 
histocompatibility compelx class-II (MHC-II) to the T-cell receptor of naïve CD4+ T cells. 
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These CD4+ T cells differentiate into helper 2 (Th2) cells that secrete cytokines IL-4 and IL-13. 
Both cytokines induce the B cell activation signal and class switching of B cells to IgE. The 
specific IgE antibodies circulate in the organism and attach with the high affinity IgE-receptor 
FcεR1 of mast cells or basophiles (Kumar et al., 2012).  
 
 
 
 
 
 
Figure 2. a) Sensitization and memory induction of IgE-mediated allergic reaction and b) Immediate phase of 
IgE-mediated allergic reaction (Valenta, 2002).  
 
Sensitization leads to the establishment of allergen-specific memory T cells and of IgE+ 
memory B cells, which produce increased levels of allergen-specific IgE antibodies after 
repeated contact with the allergen (Valenta, 2002). 
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b) Immediate reaction 
After a subsequent contact with cow milk protein, the allergen binds via the immunoreactive 
structures (epitopes) to the specific IgE antibodies on mast cells and basophiles. Cross-linking 
of high affinity IgE-receptor FcεR1 by allergen-bound IgE results in the degranulation of mast 
cells and basophiles as well as the release of inflammatory mediators such as histamine, 
prostaglandins, leuktotriens, and chemokines (Figure 2b). These mediators are able to cause 
smooth muscle contraction, vasodilatation, mucous secretion, local swelling, and other 
allergic symptoms (Valenta, 2002; Kumar et al., 2012).  
IgE-mediated CMA is characterized by acute onset, with symptoms arising within a few 
minutes to hours. Clinical manifestation can involve one or more body systems such as the 
skin, the respiratory system, and the gastrointestinal tract (Figure 3). The majority of CMA 
patients show more than 2 symptoms and the severity varies from mild (e.g. angioedema) to 
severe and life-threatening anaphylaxis (cardiovascular collapse or syncope) (Du Toit et al., 
2010; Fiocchi et al., 2010). The patients typically show high levels of cow milk protein-
specific IgE antibodies in serum or have a positive skin prick test (SPT), or both (Savilahti & 
Savilahti, 2013).  
 
1.2.2.2. Non-IgE-mediated cow milk allergy 
Non-IgE-mediated CMA appears in a significant proportion of infants but it is more common 
in adults (Crittenden & Bennett, 2005). In contrast to IgE-mediated CMA, the immunological 
mechanisms of non-IgE-mediated CMA are poorly understood. However, reactions are 
probably due to a cellular immune response and primarily mediated through T cells (Ho et 
al., 2012; Savilahti & Savilahti, 2013). It is thought that T cells, activated by the allergen, 
proliferate and produce different cytokines (e.g. IL-5, IFN-γ), which lead to the activation of 
e.g. eosinophils or macrophages and, hence, to the release of various inflammatory 
mediators (Shek et al., 2005;  Benhamou et al., 2009; Ho et al., 2012). Non-IgE-mediated 
mechanisms may also involve antibody-dependent cell-mediated cytotoxicity or formation of 
immune complexes and complement activation (Hochwallner et al., 2011). The reactions of 
non-IgE-mediated CMA are of delayed onset and of subacute or chronic nature. Symptoms 
usually occur from 1 hour to several days after ingestion of cow milk protein and mainly 
affect the gastrointestinal tract or the skin (Figure 3). The diagnosis of non-IgE-mediated 
CMA is more difficult than IgE-mediated CMA because the patients do not have circulating 
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milk protein-specific IgE antibodies in serum and their SPT result is negative (Crittenden & 
Bennett, 2005; Fiocchi et al., 2010). 
 
1.2.2.3. Mixed IgE-/non-IgE-mediated cow milk allergy 
The mixed IgE-/non-IgE-mediated CMA is a combined form of both humoral and/or cell-
mediated mechanisms and is usually characterized by a delayed or chronic onset (Figure 3). 
The symptoms may appear as atopic dermatitis and eosinophilic gastroenteropathies 
(Fiocchi et al., 2010). 
 
 
Figure 3. Clinical manifestations of cow milk allergy (Benhamou et al., 2009; Fiocchi et al., 2010; Waserman & 
Watson, 2011). 
 
1.2.3. Diagnosis of cow milk allergy  
The diagnosis of CMA is based on a comprehensive history and careful physical examination 
to gain information about the nature and course of symptoms, the feeding history, and the 
relationship of symptoms to milk ingestion or to other factors such as exercise or drugs 
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(Bahna, 2002). In a next step, SPT and/or serum-specific IgE tests, such as Radio allegro 
sorbent test (RAST) or ImmunoCAP® (Phadia, Uppsala, Sweden), can be performed. For SPT, 
fresh cow milk or whole cow milk protein extracts are applied to the skin and pricked. The 
test is considered positive if the diameter of wheal reaction is at least 3 mm larger than in 
the negative control (Savilahti & Savilahti, 2013). RAST or ImmunoCAP® are quantitative 
immunoassays for the measurement of milk protein-specific IgE antibodies in serum. Patient 
sera are incubated with a solid phase matrix carrying the immobilized allergen, which 
captures specific IgE antibodies of the patients’ serum. The detection of allergen-specific IgE 
antibodies takes place with a labeled antibody specific for the Fc portion of human IgE 
(Asero et al., 2007; Benhamou et al., 2009). In clinical practice, 0.35 kUA/L is commonly used 
as the cut-off value for cow milk-specific IgE levels (Fiocchi et al., 2010). However, these 
diagnostic tests alone do not provide sufficient evidence for food allergy as they only 
indicate sensitization to the food and, thus, a supportive clinical history is needed. 
If diagnosis of CMA remains uncertain, elimination diet and oral food challenges (open or 
double-blind) with cow milk are an important tool. After avoidance for usually 2-4 weeks, 
gradual increasing amounts of cow milk or formula are given to the patient at time intervals. 
The challenge is stopped when clinical symptoms are observed or after a specified quantity 
has been ingested without positive reactions. The double-blind, placebo-controlled oral food 
challenge (DBPCFC) is considered as the gold standard for diagnosis of CMA (Asero et al., 
2007; Benhamou et al., 2009). Nevertheless, oral challenges are expensive, time-consuming, 
difficult to perform, and accompanied by the risk of anaphylaxis (Fiocchi et al., 2010).  
 
1.2.4. Management and treatment of cow milk allergy  
1.2.4.1. Avoidance of cow milk 
Currently, the only effective treatment for CMA is a consequent avoidance of cow milk and 
cow milk based products. In breast-fed infants with CMA, a maternal cow milk elimination 
diet with calcium supplements is recommended as long as breastfeeding persists. 
Afterwards, the infant should receive a hypoallergenic formula. If infants with CMA are not 
breastfed or the mother cannot or no longer whishes to breastfeed, the use of safe, 
affordable, and nutritionally adequate formulas are required. A hypoallergenic formula 
contains < 1% of immunoreactive proteins and is tolerated by at least 90% of infants with 
CMA (Dupont et al., 2011). These criteria are met by extensively hydrolyzed cow milk whey 
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and/or casein formulas (EHF) and by amino acid-based formulas (AAF). In EHF, the allergenic 
epitopes of cow milk proteins are destroyed by extensive hydrolysis, which mainly generates 
peptides of < 1500 Da as well as free AA (Dupont et al., 2011). The main drawbacks are the 
bitter taste of the peptides and the loss of physical and biologic functionality of the milk 
proteins (Lee, 1992). EHF are tolerated by the majority of infants with CMA but they can 
induce adverse reactions in some allergic patients (Boissieu et al., 1997). Residual 
allergenicity of EHF may be due to short peptides still containing IgE-binding epitopes or 
allergenic higher-molecular-weight particles that arise through aggregation of smaller 
peptides during production (Beyer, 2007). In case of allergic reactions to EHF or for infants 
with severe CMA or multiple food allergies, AAF are required. AAF are regarded as non-
allergenic, since they are pure chemically made formulas, which are free of intact proteins 
and peptides consisting of isolated AA only (Greef et al., 2012).  
The use of a soya-based formula in CMA is not recommended before the age of 6 month, 
because of the high levels of phytates, aluminum, and phyto-oestrogens present in soya 
protein. Moreover, soya is a potent allergen itself and 10-14% of infants with CMA have 
concomitant soya allergy (Dupont et al., 2011). Milk of other animal source such as goat, 
sheep, buffalo, horse, or donkey are not suitable as general substitute in CMA because these 
milks are not nutritionally adequate to meet the infants’ needs. Furthermore, a high degree 
of cross-reactivity exists between milk proteins from cow, goat, sheep, as well as buffalo, 
which is based on the close homology between these proteins (Du Toit et al., 2010; Dupont 
et al., 2011).  
 
1.2.4.2. Prevention  
Exclusive breastfeeding for 4-6 months is regarded as the best preventative for CMA. Human 
milk is low in allergens by nature, provides antigens for the neonatal intestinal immune 
system, and contains bioactive factors (e.g. IgA, growth factors, cytokines, lactoferrin, 
lysozyme, and oligosaccharides) that modulate immune development, defense against 
pathogens, as well as promote beneficial colonization by commensal bacteria (Tooley et al., 
2009; Ballard & Morrow, 2013).  
There is some evidence that probiotics (e. g. lactobacillus GG) and prebiotics 
(oligosaccharides) have protective effect against allergic manifestation and infections 
(Arslanoglu et al., 2008). It has also been demonstrated that probiotics accelerate the 
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development of tolerance in infants (Berni Canani et al., 2012). Pro and prebiotics are 
frequently added to infant formulas, as they can induce the development of an intestinal 
microbiota similar to that found in breastfed infants (Arslanoglu et al., 2008). However, 
further research is needed before routine use of prebiotics as data from several studies 
yielded contradictory results (Osborn & Sinn, 2013). 
 
1.2.4.3. Immunotherapy 
Oral immunotherapy (OIT) is a promising approach for treatment of CMA but yet it is not 
considered to be ready for use in clinical practice due to the relatively high frequency and 
unpredictability of adverse reactions (Huang & Kim, 2012). OIT aims to induce 
desensitization and optimally tolerance to the implicated food. During an induction phase, 
small increasing amounts of cow milk are administrated to the patient. Afterwards, 
maintenance of desensitization is based on regular consumption of a maximum tolerated 
dose of cow milk (Dupont et al., 2011; Savilahti & Savilahti, 2013). Several studies on cow 
milk OIT have been published and recently reviewed (Brożek et al., 2012; Savilahti & 
Savilahti, 2013). The majority of patients with CMA were successfully desensitized to cow 
milk by OIT. Yet, to date there is no evidence whether permanent tolerance can be achieved 
by OIT. 
Another possibility for treatment of CMA is called sublingual immunotherapy (SLIT). SLIT also 
involves small increasing amounts of cow milk but they are placed under the tongue. In SLIT, 
the typical dosage amounts are low but there is less potential to provoke adverse effects 
(Huang & Kim, 2012). It has been demonstrated that SLIT is able to desensitize CMA patients 
to varying degrees (Boissieu & Dupont, 2006; Keet et al., 2012). More research is needed to 
ascertain which form of immunotherapy is more effective in inducing longterm tolerance 
with the lowest risk of severe adverse reactions (Narisety & Keet, 2012). 
 
1.3. Cow milk allergens 
Cow milk contains 30-35 g of protein per liter comprising more than 25 different proteins. 
However, only some of them are known to be potential allergens (Hochwallner et al., 2013). 
Based on the behavior by acidification of milk at pH 4.6, 20 °C, milk proteins are divided into 
2 main groups. These are the insoluble casein and the soluble whey protein fraction (Table 
2). Caseins (designation: Bos d 8 according to the WHO-IUIS allergen nomenclature sub-
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committee) and the whey proteins α-lactalbumin (α-LA, Bos d 4) and β-lactoglobulin (β-LG, 
Bos d 5) are the most important allergens in cow milk, whereas the whey proteins bovine 
serum albumin (BSA, Bos d 6), immunoglobulins (Igs, Bos d 7) and lactoferrin (Lf, Bos d 
lactoferrin) are defined as minor milk allergens (Järvinen & Chatchatee, 2009). Most patients 
with CMA are sensitized to several cow milk proteins with a great variability of the IgE 
response in specificity and intensity (Wal, 2002; Hochwallner et al., 2010a). Thus, no single 
protein can be held responsible for the major part of allergenicity in milk. There are 
controversial reports about the prevalence of IgE reactivity to certain cow milk proteins. The 
majority of studies found the caseins being more allergenic than the whey proteins (Docena 
et al., 1996; Shek et al., 2005; Gaudin et al., 2008; D'Urbano et al., 2010) but Hochwallner et 
al. (2010a) detected the whey proteins β-LG and α-LA as the most frequently recognized milk 
allergens.   
 
1.3.1. Caseins  
The casein fraction accounts for 80% of total milk protein and comprises the 4 different 
proteins αS1-casein (αS1-CN), αS2-casein (αS2-CN), β-casein (β-CN), and κ-casein (κ-CN) (Table 
2) (Wal, 2002; Farrell et al., 2004). They are coded by members of a multigene family and 
tightly linked within a 250-kb cluster on chromosome 6 in the order αS1-, β-, αS2-, κ-CN 
(Threadgill & Womack, 1990; Hayes et al., 1993). 
The caseins show little sequence homology but they share some common features such as 
heat stability, high susceptibility to all proteases and exopeptidases, dipolar structure with 
amphiphatic properties, and calcium sensitivity of αS1-, αS2- and β-CN (Wal, 2002). The 
caseins are phosphoproteins with a varying degree of phosphorylation occurring at serine or 
threonine residues. The calcium-sensitive αS1-, αS2-, and β-CN contain cluster of 
phosphoseryl residues with the motif SerP-SerP-SerP-Glu-Glu in their polar domains. These 
polyanionic phosphate groups bind metal ions, including calcium, zinc, and magnesium with 
high affinity, which influence the physical-chemically, functional, and alimentary 
characteristics of the caseins (Fox, 2003). In addition, caseins own a high proportion of the 
structure breaking AA proline, which contributes to their open, flexible, and mobile 
conformation. This is why the caseins lack on stable secondary and tertiary structures and 
have been referred to as rheomorphic (Swaisgood, 1993; Fox & McSweeney, 1998). 
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Table 2. Characterization of major and minor allergenic proteins in cow milk (Wal, 2002; Farrell et al., 2004). 
  Caseins (80%) ~30 g/L Whey proteins (20%) ~5 g/L
 
 αS1-CN αS2-CN β-CN κ-CN α-LA β-LG Igs BSA Lf 
Allergen name
1
 
 
Bos d  
9 
Bos d  
10 
Bos d 
11 
Bos d 
12 
Bos d 
4 
Bos d 
5 
Bos d 
7 
Bos d 
6 
Bos d 
Lf 
Concentration % 32 10 28 10 5 10 3 1 traces 
Concentration g/L 12-15 3-4 9-11 3-4 1-1.5 3-4 0.6-1.0 0.1-0.4 0.009 
Size (kD) 23.6 25.2 24.0 19.0 14.2 18.3 150 66.3 80 
Residues/molecule 
Amino acids (AA) 
Proline 
Cysteine 
Disulphide bridges 
Phosphate 
Isoionic point (pI) 
 
199 
17 
0 
0 
8 
4.9-5 
 
207 
10 
2 
1 
11 
5.2-5.4 
 
209 
35 
0 
0 
5 
5.1-5.4 
 
169 
20 
2 
1 
1 
5.4-5.6 
 
123 
2 
8 
4 
0 
4.8 
 
162 
8 
5 
2 
0 
5.3 
 
- 
- 
- 
- 
- 
- 
 
583 
28 
35 
17 
0 
4.9-5 
 
689 
30 
34 
17 
0 
8.7 
1
 according to the WHO-IUIS allergen nomenclature sub-committee. 
 
The different caseins associate with each other in solution to form aggregates termed 
micelles, where the calcium-sensitive αS1-, αS2- and β-CN are stabilized within the micelle by 
κ-CN, which is located on the surface. These complexes bind essential minerals such as 
calcium phosphate (Fox & McSweeney, 1998; Wal, 2002).  
Among the 4 caseins, αS1-CN has been identified as the most immunogenic protein inducing 
strong immediate or delayed allergic reactions, and many subjects with CMA show a high 
titer of IgE specific for this protein (Shek et al., 2005; Ruiter et al., 2006, Gaudin et al., 2008; 
Schulmeister et al., 2009). 
 
1.3.2. Whey proteins 
Whey proteins represent 20% of total milk protein with β-LG and α-LA as the main 
components followed by the minor constituents BSA, Igs, LF, and the proteose-peptone 
fraction (Table 2) (Farrell et al., 2004). 
The 2 major whey proteins and allergens, β-LG and α-LA, are well characterized and localized 
on chromosome 11 and 5, respectively (Hayes et al., 1993; Hayes & Petit, 1993). In contrast 
to the caseins, typical features are solubility at pH 4.6 and heat instability, as well as a 
hydrophilic surface with a homogeneous distribution of hydrophobic and hydrophilic side 
chains. Because of the low content of proline, β-LG and α-LA are highly structured proteins 
and show stable secondary, tertiary, and in most cases, quaternary structures. They have no 
phosphorylated AA but are rich in sulfur, which mainly occurs in form of cysteine and 
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methonine. The high content in cysteine allows the formation of disulfide bridges that 
contribute to the compact and stable structure of these proteins and enable the 
intermolecular formation of complexes (Fox & McSweeney, 1998; Fox, 2003).  
Due to the fact that β-LG is not found in human milk and is relatively stable to digestion, it 
has long been considered as the major allergen in cow milk. A high degree of homology 
between the AA sequences of α-LA from cow and human exists being 74% identical and 
another 6% similar (Wal, 2002). Nevertheless, frequencies in IgE recognition of up to 75.8% 
are found for this protein and recent data suggest that α-LA is more important in 
allergenicity than β-LG (Hochwallner et al., 2010a). 
  
1.3.3. Genetic polymorphisms of milk proteins  
Within the 6 main milk proteins a marked heterogeneity exists, which arises from genetic 
polymorphisms or other factors such as the variability in the degree of phosphorylation and 
glycosylation and the presence of disulfide bonds (Fox & McSweeney, 1998). Based on these 
heterogeneities, differences in the molecular weight, electrical charges, and hydrophobicity 
of the proteins occur (Farrell et al., 2004). The genetic polymorphism of milk proteins is a 
consequence of either substitutions of AA or deletions of a certain AA sequence along the 
peptide chain and result in several variants for each protein. These protein variants are 
controlled by autosomal codominant genes and are inherited in a mendelian manner leading 
to different genotypes in milk (Ng-Kwai-Hang et al., 1984). Over the last years, a total of 54 
genetic variants could be demonstrated in the 6 main milk proteins in Bos genus at protein 
and DNA level by different electrophoretic [Isoelectric focusing (IEF), Polyacrylamide gel 
electrophoresis] and DNA based [Polymerase chain reaction-Restriction fragment length 
polymorphism (PCR-RFLP), sequencing, allele-specific PCR, single strand conformation 
polymporphism] techniques (Prinzenberg et al., 1996, 1999; Barroso et al., 1999; Caroli et 
al., 2009). Recently, 5 new casein DNA sequence variants with a predicted effect on the 
protein sequence and with the designations αS1-CN J, αS2-CN E, and β-CN J, K, and L were 
discovered especially in Bos indicus breeds by direct sequencing on DNA-level (Gallinat et al., 
2013). However, investigations on the expression of these 5 new variants on protein level 
still remain to be carried out. By using DNA based techniques, protein variants can be 
identified, which are not detectable at protein level with IEF because the AA exchange does 
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not alter the isoelectric point (silent protein variant) or the nucleotide substitutions within 
the codon do not modify the correspondent AA (synonymous variants) (Caroli et al., 2009). 
 
1.3.3.1. Casein polymorphisms 
1.3.3.1.1. αS1-casein 
αS1-CN represents up to 40% of the casein fraction in bovine milk. It exists as one major and 
one minor form, which share the same AA sequence but differ in their degree of 
phosphorylation (8-9). The reference protein αS1-CN B is a single-chain protein consisting of 
199 AA with 8 phosphorylated serine residues and no cysteine (Table 2). Four of the 8 
phosphorylated serine residues are arranged with glutamyl residues as an anionic cluster at 
position AA 63-70 (Farrell et al., 2004).  
So far, 10 genetic variants have been identified on protein and DNA level (Table 3) (Caroli et 
al., 2009; Gallinat et al., 2013). 
 
Table 3. Characterization and distribution of the αS1-CN variants
1
 (adapted from Caroli et al., 2009; Gallinat et 
al., 2013).  
αS1-CN 
variant 
Variation with 
respect to  
αS1-CN B 
Diffusion Species
2
 Breed 
A Deletion  AA 
14-26  
Rather common T Holstein-Friesian, Red Danish, German Red, 
Kostroma, other Friesian 
B Reference protein Most common T, I, G All breeds 
C 192 Glu  Gly Common All All breeds, very common in Bos indicus 
breeds 
D 53 Ala  ThrP Rather common T Flamande, Red Danish, Red Polish, Jersey, 
Italian Brown, German Holstein, etc. 
E 59 Gln  Lys 
192 Glu  Gly 
Common G  
F 66 SerP  Leu  Rare T German Black and White, Italian Brown, 
Ayrshire, etc. 
G Lower protein 
expression   
Rather common T Italian Brown, Podolian, other Italian breeds, 
Carora 
H Deletion 51-58  Rare T Kuri 
I 84 Glu  Asp Rather common T, I Carora, Turkish Red Steppe, Banyo Gudali 
J  167 Val  Phe3 Rather common T, I Sarabi, Gir 
1
The reference protein is shown in bold. 
2
T = Bos taurus; I = Bos indicus; G = Bos grunniens 
3
Predicted effect on protein sequence.  
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The reference protein αS1-CN B is the most common variant in Bos taurus cattle. The αS1-CN 
variants C, D, E, F, I, and J are characterized by single AA substitutions, whereas in αS1-CN A 
and H deletions occur. A special case is given with αS1-CN G as the mature protein is not 
different from the B variant but it is synthesized with a lower amount due to an insertion of 
371 bp in the 19th exon (Rando et al., 1998). 
 
1.3.3.1.2. αS2-casein 
αS2-CN accounts for 10% of the casein fraction in bovine milk and consists of 2 major and 
several minor forms. These components show varying levels of post-translational 
phosphorylations (10-13) and minor degrees of intermolecular disulfide bonding. The 
reference protein αS2-CN A is comprised of 207 AA and contains 11 phosphorylated serine 
residues as well as 2 cysteins (Table 2) at positions AA 36 and 40, which form an 
intramolecular disulfide bond. Due to 3 anionic clusters of phosphoseryl and glutamyl 
residues at positions AA 8-12, AA 56-61, and AA 129-133, αS2-CN is the most hydrophilic 
protein among the caseins (Farrell et al., 2004).  
Within αS2-CN, the 5 genetic variants A, B, C, D, and E have been described on protein and 
DNA level. Variants A, B, C, and E differ from each other by single AA substitutions and 
variant D by a deletion of 9 AA (Table 4) (Caroli et al., 2009; Gallinat et al., 2013). 
 
Table 4. Characterization and distribution of the αS2-CN variants
1
 (adapted from Caroli et al., 2009; Gallinat et 
al., 2013).  
αS2-CN 
variant 
Variation with 
respect to            
αS2-CN A 
Diffusion Species
2
 Breed 
A Reference protein Most common All All breeds  
B 8 SerP  Phe Common I, T, G All Bos indicus breeds, Turkish Gray Steppe, 
Namchi, Anatolian Black, Pinzgauer, etc. 
C 33 Glu  Gly 
47 Ala  Thr 
130 Thr  Ile 
Rare G Mongolia breeds 
D Deletion  AA  
51-59 
Rather common T Montbéliarde, Vosgienne, German Yellow and 
Simmental, Menorquina, Ayrshire 
E 7 Val  Ile3 Rare I Sarabi 
1
The reference protein is shown in bold. 
2
T = Bos taurus; I = Bos indicus; G = Bos grunniens 
3
Predicted effect on protein sequence. 
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1.3.3.1.3. β-casein 
Up to 45% of the casein fraction in bovine milk is assigned to β-CN (Farrell et al., 2004). The 
most common variant used as reference protein is β-CN A2. It is composed of 207 AA with no 
cysteine and 5 phosphoseryl residues (Table 2), of which 4 are clustered with glutamyl 
residues at position AA 14-21. Due to the large hydrophobic C-terminal sequence, β-CN is 
the most hydrophobic of the caseins. The action of the native milk protease plasmin at 3 
different positions gives rise to the formation of γ1-, γ2-, and γ3-CN, as well as the 
complementary proteose peptones (Farrell et al., 2004). 
 
Table 5. Characterization and distribution of the β-CN variants
1
 (adapted from Caroli et al., 2009; Gallinat et al., 
2013).  
β-CN 
variant 
Variation with 
respect to β-CN A
2
 
Diffusion Species
2
 Breed 
A
1
 67 Pro  His Common T, I Most breeds 
A
2
 Reference protein Most common All All breeds 
A
3
 106 His  Gln Rather 
common 
T, I Holstein Friesian, Jersey, Simmental, 
Sahiwal, German Red Pied, etc. 
B 67 Pro  His 
122 Ser  Arg 
Common T, I Most taurus breeds, Hariana, Choa 
C 35 SerP  Ser 
37 Glu  Lys 
67 Pro  His 
Rather 
common 
T Guernsey, Reggiana, Pinzgauer, Italian 
Brown, Piemontese, etc. 
D 18 SerP  Lys Rare I Indian Deshi, East African Boran 
E 36 Glu  Lys Rare T Piemontese 
F 67 Pro  His 
152 Pro  Leu 
Rare T Meuse-Rhine-Yssel 
G 67 Pro  His 
137-138
3
 Pro  Leu 
Rare T Holstein-Friesian 
H
1
 25 Arg  Cys 
67 Pro  His 
88 Leu  Ile 
Rare T Korean cattle 
H
2
 72 Gln  Glu 
93 Met  Leu 
Rare T Normande 
I 93 Met  Leu Rather 
common 
T Italian Red Pied, Italian Holstein, German 
Holstein, Belgian Blue, Jersey, etc. 
J 20 Glu  Lys4 Rare I Golpayegani, Sistani 
K 179 Pro  Ala4 Rather 
common 
I Gir 
L 197 Val  Ala4 Rare I Gir 
1
The reference protein is shown in bold. 
2
T = Bos taurus; I = Bos indicus; G = Bos grunniens 
3
Depending on the sequences, the Pro-Leu inversion at position 137 or 138 is controversial.  
4
Predicted effect on the protein sequence. 
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For β-CN, the 15 genetic variants A1, A2, A3, B, C, D, E, F, G, H1, H2, I, J, K, and L have been 
reported, which are all based on AA substitutions (Table 5) (Caroli et al., 2009; Gallinat et al., 
2013). Variant I represents a silent protein variant because the exchanged AA are both 
neutral and do not modify the electric charge or the isoelectric point. In consequence, it is 
not identifiable at protein level by IEF (Jann et al., 2002).   
 
1.3.3.1.4. κ-casein 
κ-CN accounts for 10% of the casein fraction in bovine milk and comprise a major 
carbohydrate-free component and a minimum of 6 minor components showing varying 
degrees of phosphorylation and glycosylation. The major carbohydrate-free component κ-CN 
A is considered as the reference protein. It is characterized by 169 AA, 1 phosphorylated 
serine residue, and 2 cysteins (Table 2) at positions AA 11 and 88, which enable the 
formation of inter- and intramolecular disulfide bonds leading to several polymeric forms 
(Farrell et al., 2004). On the basis of these disulfide bonds, κ-CN can participate in thiol-
disulfid bond interchange reactions with the heat-denaturable whey proteins upon heat 
treatment (Lowe et al., 2004). κ-CN is the only casein that possesses solely 1 phosphat group 
(Table 2) and, thus, no anionic cluster of phosphoseryl residues occurs in this protein. 
Therefore, it is soluble in the presence of calcium and in contrast to the other caseins not 
calcium sensitive (Swaisgood, 1993; Farrell et al., 2004). κ-CN is the specific substrate of 
chymosin, which cleavages the peptide bound between Phe (105) and Met (106) leading to 
the hydrophobic para-κ-CN (AA 1-105) and the highly charged and glycosylated 
caseinomacropeptide (AA 106-171). This cleavage initiates the clotting of milk, the first step 
of cheesemaking (Fox & McSweeney, 1998; Caroli et al., 2009). 
A total of 14 genetic variants of κ-CN (A, A1, B, B2, C, D, E, F1, F2, G1, G2, H, I, and J) are known 
(Table 6) (Caroli et al., 2009). A silent protein variant is given with κ-CN H. The AA 
substitution has no influence on the isoelectric point of the protein as the involved AA are 
both neutral. κ-CN A1 is a synonymous variant meaning that the nucleotide substitution 
within the codon does not alter the corresponding AA. Thus, κ-CN A1 share the same protein 
sequence as the reference protein κ-CN A. κ-CN A1 and H cannot be demonstrated at protein 
level by IEF and, therefore, typing at DNA level is required for their detection (Prinzenberg et 
al., 1999; Caroli et al. 2009). 
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Table 6. Characterization and distribution of the κ-CN variants
1
 (adapted from Caroli et al., 2009).  
κ-CN 
variant 
Variation with 
respect to κ-CN A 
Diffusion Species
2
 Breed 
A Reference protein Most common  T, I All breeds 
A
1
 Codon CCA  CCG 
150 Pro  Pro 
Synonymous variant 
Rather 
common
3
 
I, T  
T x I
4
 
Boran, Brahman, Nelore, Santa Gertrudis, 
etc. 
B 136 Thr  Ile 
148 Asp  Ala 
Most common I, T All breeds 
B
2
 136 Thr  Ile 
148 Asp  Ala 
153 Ile  Thr 
Rare T Russian cattle 
C 97 Arg  His 
136 Thr  Ile 
148 Asp  Ala 
 
Rather 
common 
T Grey Alpine, Italian Brown, German 
Simmental, Menorquina, etc. 
D 97 Arg  His Rare T Italian Brown 
E 155 Ser  Gly Rather 
common 
T Angler, German Black and White, Holstein-
Friesian, Ayrshire 
F
1
 148 Asp  Val Rare T Yakut 
F
2
 10 Arg  His 
136 Thr  Ile 
148 Asp  Ala 
Rare T Finnish Ayrshire 
G
1
 97 Arg  Cys 
136 Thr  Ile 
148 Asp  Ala 
Rare T Pinzgauer 
G
2
 148 Asp  Ala Common G  
H 135 Thr  Ile Common3 I, T 
T x I
4
 
Madagascar zebu, White Fulani, Wadara, 
Red Bororo, N´Dama, Pinzgauer 
I 104 Ser  Ala Rare T x I4 Namibia 
J 136 Thr  Ile 
148 Asp  Ala 
155 Ser  Arg 
Rare T Ivory Coast, Burkina Faso 
1
The reference protein is shown in bold. 
2
T = Bos taurus; I = Bos indicus; G = Bos grunniens 
3
Mainly in Bos indicus breeds. 
4
T x I = Bos taurus and Bos indicus crossings. 
 
1.3.3.2. Whey protein polymorphisms 
1.3.3.2.1. α-lactalbumin 
α-LA is a monomeric globular calcium binding protein and represents 20% of total whey 
protein in bovine milk. It plays an important role in the biosynthesis of lactose as it is a 
regulatory component of the lactose-synthetase complex. α-LA modifies the substrate 
specificity of galactosyltransferase to form lactose from glucose and UDP-galactose (Fox, 
2003).  
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The reference protein α-LA B is made of 123 AA with a very high content of essential AA 
accounting for 63.2% of total AA in this protein (Farrell et al., 2004). α-LA possesses 8 
cysteine residues allowing the formation of 4 disulfide bonds (Table 2) at positions AA 6 and 
120, AA 61 and 77, AA 73 and 91, as well as AA 28 and 111, which stabilize the structure of 
the protein. Native α-LA consists of a large α-helical domain and a small β-sheet domain. 
Both domains are connected by a calcium binding loop that contains a single strong calcium 
binding site to which also magnesium, manganese, sodium or potassium attaches. The 
binding of these cations increases the stability of α-LA against heat or several denaturing 
agents (Permyakov & Berliner, 2000).  
As shown in Table 7, 4 α-LA variants (A, B, C, and D) have been demonstrated (Caroli et al., 
2009; Visker et al., 2012). 
 
Table 7. Characterization and distribution of the α-LA variants
1 
(adapted from Caroli et al., 2009; Visker et al., 
2012).  
α-LA 
variant 
Variation with 
respect to α-LA B 
Diffusion Species
2
 Breed 
A 10 Arg  Gln Rather 
common 
I, T All indicus and some taurus breeds 
B Reference protein Most common  All breeds 
C Asp  Asn  
Position unknown 
Rare J Australia breeds 
D 65 Gln  His Rare T Holstein-Friesian 
1
The reference protein is shown in bold. 
2
T = Bos taurus; I = Bos indicus; G = Bos grunniens; J = Bos javanicus 
 
1.3.3.2.2. β-lactoglobulin 
β-LG is a dimeric protein and amounts for 65% of total whey protein in bovine milk. The 
reference protein β-LG B is composed of 162 AA and contains 5 cysteine residues (Table 2). 
Two disulfide bonds at positions AA 66 and 160 and AA 106 and 119, as well as 1 free thiol 
group at position AA 121 are present in this protein. Due to the reactive free thiol group, 
interactions and complex formation with k-CN during heat treatment occur (Sawyer, 1969; 
Lowe et al., 2004). β-LG belongs to the lipocalin family that bind and carry a variety of 
hydrophobic ligands such as retinol. All members of this family show a common tertiary 
structure characterized by a single 8-stranded antiparallel β-barrel with an internal ligand-
binding site (Zsila et al., 2002). The structure of β-LG consist of 9 β-strands (A-I) and 1 major 
 
1. General introduction 
 22 
α-helix at the C-terminal end of the molecule. The 8 β-strands A-H form a β-barrel, which 
encloses a hydrophobic cavity where retinol or fatty acids bind (Sakai et al., 2000).  
Several AA substitutions give rise to the existence of the 11 genetic variants A, B, C, D, E, F, 
G, H, I, J, and W (Table 8) (Caroli et al., 2009). 
 
Table 8. Characterization and distribution of the β-LG variants
1
 (adapted from Caroli et al., 2009).  
β-LG 
variant 
Variation with 
respect to β-LG 
Diffusion Species
2
 Breed 
A 64 Gly  Asp 
118 Ala  Val 
Most common  T, I, G All breeds 
B Reference protein Most common T, I, G All breeds 
C 59 Gln  His Rather 
common 
T Jersey 
D 45 Glu  Gln 
 
Rather 
common 
T Montbéliarde, German Holstein, German 
Simmental, etc. 
E 158 Glu  Gly Most common G, J Nepal grunniens, Australia javanicus 
F 50 Pro  Ser 
129 Asp  Tyr 
158 Glu  Gly 
Rare J Australia javanicus 
G 78 Ile  Met 
158 Glu  Gly 
Rare J Australia javanicus 
H 64 Gly  Asp 
70 Lys  Asn 
118 Ala  Val 
Rare T Italian Friesian 
I 108 Glu  Gly Rare T Polish Red 
J 126 Pro  Leu Rare T Hungarian Grey 
W 56 Ile  Leu Rare T Murnau-Werdenfelser, Jersey, Red 
Holstein x Simmental 
1
The reference protein is shown in bold. 
2
T = Bos taurus; I = Bos indicus; G = Bos grunniens; J = Bos javanicus  
 
1.3.3.3. Importance of milk protein polymorphisms 
The importance of genetic polymorphisms in animal breeding is due to their associations to 
milk composition, productions traits, and technological properties of milk (Bovenhuis et al., 
1992; Martin et al., 2002; Heck et al., 2009). A greater concentration of β-LG is given in milk 
with the AA genotype than with AB or BB but associated with lower casein content (Lundén 
et al., 1997; Heck et al., 2009). Milk containing the κ-CN genotype BB shows a higher 
concentration of κ-CN, improved milk clotting properties, and a higher cheese yield, whereas 
unfavorable effects on cheese making have been reported for the variants E and G of κ-CN 
(Wedholm et al., 2006; Caroli et al., 2009). Genetic polymorphisms of milk proteins are used 
in phylogenetic studies by investigating the evolution of animal resources and milk protein 
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genes (Jann et al., 2004; Ibeagha-Awemu et al., 2007). In addition, milk protein 
polymorphisms enable the species identification in milk and dairy products. Thus, 
admixtures of milk from different species in products of protected designation of origin such 
as mozzarella cheese from buffalo and feta cheese from sheep can be detected (Otaviano et 
al., 2008; Reale et al., 2008). Furthermore, milk protein polymorphisms play a notable role in 
human nutrition because they influence the nutritional value of milk and milk products 
determined by bioactive peptides that manifest a wide range of effects including 
antihypertensive, opioid, dipeptidyl peptidase-4 inhibitory, and mineral-binding activities. 
Therefore, they are considered as ingredients of functional foods, dietary supplements or 
nutraceuticals (Kamiński et al., 2007; Weimann et al., 2009; Tulipano et al., 2010, 2011). 
 
1.3.4. Allergenic structures in milk proteins 
Milk allergy is caused by an accumulation of potential antigenic sites or specific areas 
(molecular sections) within the protein, against which the immune system forms antibodies. 
These AA sequences within the allergenic proteins that are bound by IgE antibodies are 
termed IgE-binding epitopes. There are 2 general categories of IgE-binding epitopes, linear 
(sequential) and conformational (Figure 4). Linear epitopes are formed by a sequence of 
contiguous AA on the peptide chain of the protein. They refer to the primary structure of the 
protein. In contrast, in conformational epitopes, the AA are from different regions of the 
protein and must be brought together by folding of the polypeptide chain. This is the reason 
why their allergenicity is associated with the secondary and tertiary structure of the protein 
(Lin & Sampson, 2009; Nowak-Wegrzyn & Fiocchi, 2009).  
Linear epitopes are prevalent and more important in food allergens as food proteins usually 
undergo several processes such as cooking and digestion. Linear epitopes are mainly located 
in the hydrophobic parts of the protein, buried within the tertiary structure and, therefore, 
not accessible for the IgE antibodies in the native form of the protein. During food 
processing and cooking, leading to heat denaturation and alteration of the native structure, 
as well as during digestion in the gastrointestinal tract, resulting in further modification and 
breakup of the tertiary structure, the conformational epitopes are destroyed and the linear 
epitopes are exposed and presented to the immune system (Figure 4) (Hartmann et al., 
2007; Lin & Sampson, 2009).  
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The IgE-binding epitopes in the caseins are generally suggested to be linear. This is due to 
the fact that caseins are not significantly affected by heating, lack on stable and defined 
secondary and tertiary structures, and are rapidly and extensively degraded by proteolytic 
enzymes during digestion (Figure 4) (Vila et al., 2001; Wal, 2002).  Nevertheless, αS1-CN was 
found to contain both linear and conformational epitopes (Schulmeister et al., 2009). In the 
whey proteins β-LG and α-LA, mainly conformational but also linear epitopes are relevant for 
their allergenicity as they are characterized by stabile secondary and tertiary structures, a 
higher resistance to proteolytic enzymes, and instability against heat (Figure 4) (Järvinen et 
al., 2001, 2002; Wal, 2002; Hochwallner et al., 2010b).  
 
 
Figure  4. Conformational and linear (sequential) epitopes in milk proteins. Conformational epitopes are altered 
or destroyed by food processing such as heat treatment, enzymatic digestion, or low pH, while linear epitopes 
are generally not affected. ALAC, α-lactalbumin; BETALAC, β-lactoglobulin (adapted from Nowak-Wegrzyn & 
Fiocchi, 2009). 
 
Linear eptiopes have some prognostic value in the natural history of CMA as associations 
between linear epitopes and persistent CMA have been demonstrated. Patients with 
persistent CMA were found to have higher levels of IgE antibodies against linear epitopes as 
opposed to conformational epitopes of milk proteins (Vila et al., 2001). In addition, IgE 
recognition of certain linear epitopes of caseins dominated in patients with persistent CMA 
(Vila et al., 2001; Järvinen et al., 2002). Furthermore, patients with persistent CMA show an 
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increased epitope diversity and higher affinity of IgE binding than those with transient CMA 
(Wang et al., 2010).  
The linear IgE-binding epitopes of the caseins and whey proteins have been identified by 
several studies using SPOT membrane and microarray immunoassays (Chatchatee et al.,  
2001a,b;  Järvinen et al., 2001; Busse et al., 2002; Cerecedo et al., 2008; Lin et al., 2009; 
Hochwallner et al., 2010b). The results obtained from these 2 systems are mostly quite 
consistent (Table 9). 
 
Table 9. Linear IgE-binding epitopes of the caseins and whey proteins identified by SPOT membrane or 
microarray immunoassay. 
Protein IgE-binding epitopes  
(AA position) 
Technique Reference 
αS1-CN 17-36, 39-48, 69-78, 83-102, 109-120, 123-132, 
139-154, 159-174, 173-194* 
28-50 
49-62   
1-31, 65-100, 134-167 
SPOT membrane 
and Microarray  
Microarray 
Microarray 
Microarray 
Chatchatee et al. (2001a) 
 
Cerecedo et al. (2008) 
Lin et al. (2009) 
Schulmeister et al. (2009) 
αS2-CN 31-44, 43-56, 83-100, 93-108, 105-114,        
117-128, 143-158, 157-172, 165-188, 191-200* 
1-20, 13-32, 67-86, 181-207 
69-77 
SPOT membrane 
and Microarray  
Microarray 
Microarray 
Busse et al. (2002) 
 
Cerecedo et al. (2008) 
Lin et al. (2009) 
β-CN 1-16, 45-54, 55-70, 83-92, 107-120, 135-144, 
149-164, 167-184, 185-208* 
25-50, 52-74, 154-173 
16-39 
SPOT membrane 
and Microarray  
Microarray  
Microarray 
Chatchatee et al. (2001b) 
 
Cerecedo et al. (2008) 
Lin et al. (2009) 
κ-CN 9-26, 21-44, 47-68, 67-78, 95-116, 111-126, 
137-148, 149-166* 
34-53 
SPOT membrane 
and Microarray  
Microarray 
Chatchatee et al. (2001a) 
 
Cerecedo et al. (2008) 
α-LA 1-16, 13-26, 47-58, 93-102 
1-19, 15-34, 105-123, 45-64, 60-79, 90-109 
SPOT membrane 
Microarray  
Järvinen et al. (2001) 
Hochwallner et al. (2010b) 
β-LG 1-16, 31-48, 47-60, 67-78, 75-86, 127-144,   
141-152* 
58-77 
106-119 
SPOT membrane 
and Microarray  
Microarray 
Microarray 
Järvinen et al. (2001) 
 
Cerecedo et al. (2008) 
Lin et al. (2009) 
*Peptides with AA sequences of at least 90% overlapped with the epitopes identified by Lin et al. (2009) using 
microarray immunoassay. 
 
The microarray technology provides many advantages (e.g. assay thousands of target 
peptides in parallel, low volume of serum, robust replication, statistical analysis, and 
simultaneously testing of several immunoglobulin subclasses) and is nowadays mainly 
applied in epitope profiling of food allergens (Lin et al., 2009; Lin & Sampson, 2009).  
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1.3.5. Allergy to other mammalian milk 
In the recent years, there has been an increasing interest in the search for an alternative 
protein source for CMA patients with the focus on the use of proteins from non-bovine milk.  
The mammals cow, water buffalo, goat, sheep, pig, camel, horse, donkey, and human are 
phylogenetically either close or far related (Figure 5).  
 
 
Figure 5. Phylogenetic relationship and clinical cross-reactivity between milk from cow and other mammalian 
species. DBPCFC, double-blind, placebo-controlled food challenge; SPT, skin prick test. *clinical cross-reactivity 
suggested; **no clinical studies available (adapted from Järvinen & Chatchatee, 2009). 
 
Thus, they are characterized by a quite similar milk protein expression, although with some 
differences in the protein composition and distribution (Table 10). Based on the high 
homology of the milk proteins, cross-reactivity between the proteins from different 
mammals occurs. The milk proteins of cow and buffalo represent the highest homologies 
with 96.1 %, followed by cow and sheep with 91.1%, as well as cow and goat with 87.6%. 
Lower sequence similarities are found between the proteins of cow and pig (64.2%), horse 
(62.4%), donkey (62.8%), dromedary (60%), as well as humans (58.4%) (Järvinen & 
Chatchatee, 2009; Restani et al., 2009).  
Goat milk has been proposed as an alternative to cow milk because of the lower quantity of 
α-CN. However, several studies demonstrated that most patients with CMA are also 
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sensitized to goat milk (Bellioni-Businco et al., 1999; Restani, 2004; Vita et al., 2007). Clinical 
studies on the allergenicity to sheep and buffalo milk in patients with CMA are lacking, 
probably due to the high homology with goat, respectively, cow milk making a better 
tolerance to sheep or buffalo milk unlikely. Moreover, a number of case reports indicated 
selective allergies to goat, sheep, buffalo, or ewe milk or to all but without any reactivity to 
cow milk (Restani et al., 1999; Ah-Leung et al., 2006; Broekaert et al., 2008; Mori et al., 
2013). 
Table 10. Mammalian taxonomy and homolgoy between each cow milk protein and the milk proteins from 
other animal species (adapted from Restani et al., 2009). 
 Cow Water 
buffalo 
Sheep Goat Pig Dromedary Horse Donkey Human 
Family  Bovidae Bovidae Bovidae Bovidae Suidae Camelidae Equidae Equidae Primates 
Genus Bos Bubalus Ovis Capra Sus Camelus Equus Equus  Homo 
Species B. 
domesticus 
B. 
bubalis 
O. aries C. 
aegagrus 
S. 
domestica 
C. 
dromedarius 
E. f. 
caballus 
E. asinus H. 
sapiens 
Protein (g%) 3.3 4.5 4.9 4.3 4.8 3.6 2.14 2.2 1.25 
Caseins (%) 80 82 84 84 58 74 56 58 40 
Whey proteins 
(%) 
20 18 16 16 42 26 44 42 60 
Homology          
αS1-casein 100 95.3 88.3 87.9 47.2 44.2 43.3 -
1 31.9 
αS2-casein 100 95.0 89.2 88.3 62.8 58.3 -
1 60.0 -1 
β-casein 100 97.8 92.0 91.1 67.0 69.2 60.5 -1 56.5 
κ-casein 100 92.6 84.9 84.9 54.3 58.4 57.4 -1 53.2 
α-lactalbumin 100 99.3 97.2 95.1 74.6 69.7 72.4 (A) 
69.1 (B/C) 
71.5 73.9 
β-lactoglobulin 100 96.7 93.9 94.4 63.9 absent 59.4 (1) 56.9 (1) 
51.6 (2)  
absent 
Serum albumin 100 -1 92.4 71.2 79.9 -1 74.5 74.1 76.6 
Average 100 96.1 91.1 87.6 64.2 60.0 62.4 62.8 58.4 
1 - Not known 
The protein variants of α-LA and β-LG are shown in parentheses 
 
The greater phylogenetical distance from Bovidae and, in consequence, the lower level of 
homology between the proteins of cow and horse (62.4%), cow and donkey (62.8%), as well 
as especially cow and dromedary (60%) offer these milks as a more suitable protein source 
for CMA subjects. Similar to human milk, the protein content and the ratio of casein to whey 
protein in milk from Equidae (horse and donkey) is lower than from milk of Bovidae. It has 
been shown that donkey’s milk featured a high clinical tolerability, palatability, and 
nutritional adequacy in subjects with CMA (Vita et al., 2007; Monti et al., 2012). 
Furthermore, a high tolerability was also found for mare’s milk (Businco et al., 2000). Finally, 
in common with human milk, camel/dromedary milk is characterized by the absence of β-LG 
leading to a good tolerance in patients with CMA (Shabo et al., 2005; Restani et al., 2009; 
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Ehlayel et al., 2011a,b). Nevertheless, due to the more or less similarity in the AA sequence 
between the proteins of the different ruminants, all these milks may exhibit a certain rate of 
clinical cross-reactivity and, thus, in general, milk of other animal source cannot be 
recommended as substitute for cow milk. Instead, the best alternative diet for patients with 
CMA remains to be defined individually (Restani et al., 2009). In fact, a significant sequence 
homology between the known IgE-binding epitopes of cow and the corresponding AA 
sequences of human milk proteins exist. That is why cross-reactivity between conserved 
regions of bovine and human milk proteins could be identified explaining why exclusively 
breastfed infants with CMA occasionally continued to manifest symptoms despite strict 
maternal milk avoidance (Järvinen et al., 2012). 
 
1.4. Aims and design of the study 
The current treatment for CMA is the elimination of cow milk proteins and dairy products 
from the daily nutrition. This is often hardly to achieve because milk proteins play a very 
important role not only in the production of infant formula but also as processing aids. 
Therefore, they are widely used in many dairy and food products. Within the caseins and 
whey proteins, a wide range of genetic variants has been described for cow but also for 
other species such as sheep, goat, or camel. Nevertheless, their importance regarding 
human nutrition and in particular the allergenic potential has not yet been adequately 
exploited. 
Epitope mapping studies of αS1-, αS2-, β-, and κ-CN as well as α-LA and β-LG identified a large 
number of linear IgE-binding epitopes within these proteins. Some of the AA substitutions 
and deletions characterizing the genetic variants are located within the epitope sequence 
but the effects on their immunoreactivity are still unknown. Before milk proteins induce an 
allergenic reaction, several processes such as digestion, absorption, and interaction with the 
mucosal immune system occur. Despite the caseins are readily and easily digestible proteins, 
it has been proven that the digestion products of β-CN and β-LG still contain IgE-binding 
epitopes and, thus, retain an allergenic potential (Dupont et al., 2010a,b; Picariello et al., 
2010; Benedé et al., 2014). However, the effect of the genetic polymorphisms on the 
digestion of casein variants in association with their IgE-binding epitopes has not yet been 
considered. Therefore, the main focus of this study was the investigation of the influence of 
the genetic polymorphisms on the digestibility and allergenicity of casein variants, in order 
 
1. General introduction 
 29 
to assess if they should be considered in the search for a safe and alternative protein source 
for CMA patients.  
For analysis of the digestibility, in vitro hydrolysis of several αS1-, αS2-, β-, and κ-CN variants 
detected after a screening of productive and endangered cattle breeds was compared using 
a gastrointestinal digestion model system, mimicking the passage of the milk proteins from 
the stomach into the duodenum, and mass spectrometry to identify differences in the 
peptide profile between individual casein variants and to determine resistant fragments 
containing IgE-binding epitopes. In vitro gastrointestinal digestion of the genetic variants αS1-
CN B and C as well as αS2-CN A and B is described in publication 1 and of β-CN A
1, A2, and B, 
as well as κ-CN A, B, and E in publication 2. 
To study the allergenicity of milk protein variants, the influence of the AA substitutions and 
deletions occurring within IgE-binding epitopes of all known casein variants were analyzed 
by microarray immunoassays with sera from patients with CMA. Moreover, the IgE-binding 
properties of the variant-specific peptide products resulting from digestion of the αS1-, αS2-, 
β-, and κ-CN variants were evaluated. As there is an increasing interest in the use of milk 
from other species, caseins from goat and water buffalo were also included in the 
microarray immunoassays to determine variations in the allergenicity between these 
species. Publication 3 mainly focuses on the differences in IgE-binding between epitopes of 
αS1-, αS2-, β-, and κ-CN variants and delineates the allergenic potential of corresponding 
epitopes in caseins from goat and water buffalo. 
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ABSTRACT 
The occurrence and differences of resistant regions containing IgE-binding epitopes of 
αS1-casein (αS1-CN) variants B and C, as well as αS2-CN A and B, after in vitro gastrointestinal 
digestion was investigated using mass spectrometry. The amino acid substitutions 
characterising the genetic variants affected the peptide pattern arising from the caseins and 
thus modifications in their allergenic epitopes occurred. Peptides f174-193 in αS1-CN B and 
f179-198 in αS1-CN C correspond to the IgE-binding epitope f173-194, which has been 
reported as one of the major epitopes in αS1-CN B. Within αS2-CN, the two variant-specific 
peptides, f7-29 from variant A and f1-22 from variant B, contain the previously identified IgE-
binding epitope f1-20. These peptides, and in consequence the protein variants, may exhibit 
different immunoreactions, which could be significant in the production of milk with 
improved nutritional properties, such as hypoallergenic quality, by selection and breeding of 
cows with particular milk protein genotypes. 
 
1. Introduction 
Milk is one of the most commonly consumed foods worldwide primarily because of its high 
nutritional value and health benefits (Hilpert et al., 2009; Pereira et al., 2002). Nevertheless, 
cows’ milk allergy (CMA) is one of the most common causes of food allergy in early 
childhood, affecting around 2-3% of infants (Saarinen, Pelkonen, Mäkelä, & Savilahti, 2005). 
In adults, a prevalence of less than 0.5% is reported (Osterballe, Mortz, Hansen, Andersen, & 
Bindslev-Jensen, 2009). Usually, the majority of children outgrow their allergy by the age of 3 
years, but recent studies have found an increasing number of patients remaining allergic to 
cows’ milk for a longer period (Saarinen et al., 2005; Skripak, Matsui, Mudd, & Wood, 2007). 
Symptoms of CMA range from mild to severe reactions and involve an inflammation of the 
skin and respiratory tract, as well as the gastrointestinal tract. CMA is defined as an adverse 
immunological reaction to one or more milk proteins, which is mainly mediated by milk-
protein-specific immunoglobulin E (IgE) antibodies.  
Whole casein (CN), which comprises the 4 proteins αS1-, αS2-, β- and κ-casein, belongs to the 
major allergenic protein in bovine milk (Bernard, Créminon, Yvon, & Wal, 1998; Docena, 
Fernandez, Chirdo, & Fossati, 1996). Of these, αS1-CN, the most abundant protein, and αS2-
CN constitute 40% and 10% of the whole casein, respectively. Both are phosphoproteins 
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with a varying degree of phosphorylation and a high content of proline residues distributed 
throughout the molecule (Farrell et al., 2004). Due to this high proportion of proline 
residues, the two proteins exhibit no defined tertiary structure but an open flexible structure 
with significant amounts of secondary structure (α-helices or β-sheets) (Farrell et al., 2004; 
Swaisgood, 1993). Therefore, they are very susceptible to proteases and peptidases and 
undergo rapid breakdown during digestion (Astwood, Leach, & Fuchs, 1996; Swaisgood, 
2003).  
Within these milk proteins, a wide range of genetic variants have been described resulting 
from substitutions and deletions of amino acids and leading to different genotypes in milk 
(Caroli, Chessa, & Erhardt, 2009; Erhardt, 1993a, 1993b). A total of 9 αS1-CN variants (A, B, C, 
D, E, F, G, H, I) and 4 αS2-CN variants (A, B, C, D) could be demonstrated for Bos genus with 
important differences in occurrence and frequency of the single variants between species 
and breeds (Caroli et al., 2009).  
Milk protein variants are important in animal breeding due to their influence on milk 
performance traits (Heck et al., 2009; Martin, Szymanowska, Zwierzchowski, & Leroux, 
2002). They have also potential significance for human nutrition, which has not yet been 
adequately exploited. Effects on the functional quality of milk and of dairy products 
concerning bioactive peptides, which are considered as ingredients for so-called functional 
foods, have been described; it has been demonstrated that biologically active peptides 
resulting from various casein variants show differences in their antihypertensive, opioid, 
dipeptidyl peptidase-4 inhibitory and osteoblast mineralisation activities (Jinsmaa & 
Yoshikawa, 1999; Tulipano et al., 2010; Tulipano, Sibilia, Caroli, & Cocchi, 2011; Weimann, 
Meisel, & Erhardt, 2009).  
Until now, the knowledge about the influence of the genetic polymorphism on the 
allergenicity is low. However, it can be assumed that the milk protein variants differ in their 
allergenic properties, which has already been shown for caprine milk (Ballabio et al., 2011). 
It is believed that one prerequisite for a food allergen is its resistance to digestion during the 
passage through the different stages of the digestive tract (Bredehorst & David, 2001; 
Breiteneder & Mills, 2005). Indeed, despite the excellent digestibility of the caseins, they act 
as potent allergens (Bernard et al., 1998; Docena et al., 1996). A possible explanation can be 
that sufficient immunologically active protein fragments, which retain IgE-binding or T-cell 
stimulation capacities, survive the degradative environment of the gastrointestinal tract, are 
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taken up by the gut, and are then presented to the mucosal immune system to sensitise an 
individual or elicit an allergic response in a sensitised individual (Eiwegger et al., 2006; 
Moreno, Mellon, Wickham, Bottrill, & Mills, 2005).  
The immunoreactive structures, known as IgE-binding epitopes, are responsible for the 
allergenicity of a protein. They comprise groups of amino acids within the protein sequence 
that are bound by specific IgE antibodies. Several IgE-binding epitopes of bovine αS1- and αS2-
CN with a length of 9-24 amino acids have been identified by SPOT membrane- and 
microarray immunoassay with sera from CMA patients (Busse, Järvinen, Vila, Beyer, & 
Sampson, 2002; Cerecedo et al., 2008; Chatchatee, Järvinen, Bardina, Beyer, & Sampson, 
2001; Lin et al., 2009). Previous studies have reported the persistence of some of these IgE-
binding epitopes after simulated gastrointestinal digestion, suggesting that digested low 
molecular mass peptides can retain an allergenic potential (Dupont et al., 2010a, 2010b; 
Picariello et al., 2010). However, these studies didn’t take into account the influence of the 
genetic polymorphism of milk proteins on the IgE-binding epitope structure.  
Therefore, the objective of this study was the characterisation of peptides resulting from in 
vitro gastrointestinal digestion of different bovine αS1- and αS2-CN variants using mass 
spectrometry, with the aim of identifying resistant regions containing IgE-binding epitopes 
and to determine possible differences between the casein variants. 
 
2. Materials and methods 
2.1. Milk samples  
A total of 979 individual milk samples were collected from the 3 bovine breeds, German 
Holstein Friesian (n = 421), Pinzgauer (n = 362) and German Gelbvieh (n = 196), derived from 
associations and private dairy farms in Germany and Austria.  
  
2.2. Screening of different bovine breeds by isoelectric focusing of milk samples   
Milk protein variants of skimmed milk samples and isolated casein fractions from 
anion-exchange chromatography were determined by isoelectric focusing (IEF) according to 
Erhardt (1989) carried out on 0.3-mm thin polyacrylamide gels using carrier ampholytes. The 
gels (T = 5.01; C = 3.75; 7.09 M urea) contained 0.644 mL of the following mixture of carrier 
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ampholytes: 15.5% (v/v) Pharmalyte pH 2.5-5.0 (GE Healthcare Europe GmbH, Freiburg, 
Germany), 37.9% (v/v) Pharmalyte pH 4.2-4.9 (GE Healthcare Europe GmbH) and 46.6% (v/v) 
Servalyte pH 5.0-7.0 (Serva Electrophoresis, Heidelberg, Germany). After prefocusing for 14 
min (20 mA, 3000 V), milk samples were separated for 67 min (40 mA, 3000 V). The gels 
were fixed in 20% (w/v) trichloroacetic acid and stained with a solution of 0.1% (w/v) 
Coomassie brilliant blue R 250 (Serva Electrophoresis), 45% (v/v) ethanol and 10% acetic acid 
(v/v). Analysis and identification of the genetic variants were done manually using cow milk 
samples with known αs1-, αs2-, β- and κ-CN variants as reference samples. Allele and 
genotype frequencies were calculated with the program PopGene V 1.32 (Yeh, Yang, & 
Boyle, 1999). 
 
2.3. Preparation of caseins from milk 
Whole casein was obtained by acid precipitation at pH 4.6 after skimming of milk samples 
from cows with defined casein phenotypes (αS1-CN B, C and αS2-CN A, B). Briefly, milk 
samples were acidified with 50% (v/v) acetic acid to pH 4.6 and centrifuged at 1620 x g for 
10 min at 4 °C. The casein precipitate was dissolved in distilled water with 1.0 M NaOH. 
Steps of precipitation and washing were repeated three times. Whole casein was finally 
lyophilised and stored at -20 °C until analysis.  
 
2.4. Purification of caseins by anion-exchange chromatography  
Separation of αS1- and αS2-CN variants from the whole casein fraction was performed by 
anion-exchange chromatography according to a modified method of Andrews and 
Alichanidis (1983). A column (46.5 x 2.5 cm) was packed with diethylaminoethyl (DEAE) 52-
cellulose resin (Serva Electrophoresis) to reach a column volume of 50 mL and equilibrated 
with 0.01 M Tris/imidazol, pH 7.0, 3.3 M urea, 0.01 M 2-β-mercaptoethanol and 3.1 mM 
sodium azide as equilibration (EQ) buffer. An amount of 1.0-1.5 mg lyophilized whole casein 
was dissolved in 30-40 mL EQ buffer and applied onto the DEAE-cellulose column. Stepwise 
elution of the caseins was performed with a NaCl gradient (0.075-0.17 M) using a peristaltic 
pump (Ismatec Ip-4, Zürich, Switzerland). The absorbance of the column effluents were 
monitored at 280 nm (Uvicord SII, LKB, Bromma, Sweden) and fractions (7 mL) collected. The 
main peak fractions of the resulting chromatogram corresponding to the different purified 
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caseins were analysed by IEF as described above, then separately pooled and dialysed 
against 3 x 5 L distilled water for 24 h. After lyophilisation, the purity and identity of the 
isolated casein fractions were assessed by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) and matrix assisted laser desorption ionisation-time of flight-
mass spectrometry (MALDI-TOF-MS). Samples were frozen (-20 °C) for storage until used. 
 
2.5. Sodium dodecyl sulfate polyacrylamide gel electrophoresis  
SDS-PAGE was carried out according to Laemmli (1970) with 1.5-mm thin polyacrylamide 
gels (16 x 14 cm) consisting of a 2.5% stacking gel and a 12% separating gel using the Dual 
Gel Electrophoresis System, Emperor PenguinTM (P9DS OWL, Thermo Fisher Scientific, 
Rochester, New York, USA). Sample preparations were made for electrophoresis containing 
11.5% (v/v) casein fraction, 0.069 M Tris-HCl, pH 6.8, 2.2% SDS, 11.1% glycerol, 5.5% 2-β-
mercaptoethanol and traces of bromophenol blue. The electrophoretic run was done in 
running buffer comprising 25 mM Tris, 192 mM glycine, 0.1% (w/v) SDS, pH 8.3, at 400 V and 
25 mA for the stacking gel and at 400 V and 40 mA for the running gel. The gels were fixed 
with 50% trichloroacetic acid, stained with 0.1% (w/v) Coomassie brilliant blue R 250 and 
destained with a solution of 30% ethanol (v/v) and 10% (v/v) acetic acid. A molecular marker 
(Protein Test Mixture 6, Serva Electrophoresis) added to each gel was used to estimate the 
molecular weight of the casein fractions. 
 
2.6. In vitro gastrointestinal digestion of casein variants 
The casein variants (αS1-CN B, C and αS2-CN A, B) were digested in duplicate by the procedure 
described by Moreno et al. (2005). Each digestion was performed at least twice and control 
incubations in the absence of proteases were done. 
 
2.6.1. In vitro gastric digestion (phase 1) 
A sample of 10-15 mg purified casein was dissolved in 1 mL of simulated gastric fluid (SGF; 
0.15 M NaCl, pH 2.5) and adjusted to pH 2.5 with 1.0 M HCl. After incubation at 37 °C for 15 
min, a solution of 0.32% (w/v) porcine pepsin (activity: 3300 U mg-1 of protein using 
haemoglobin as substrate, Sigma-Aldrich, Steinheim, Germany) in SGF, pH 2.5, was added at 
an approximately physiological ratio of enzyme:casein (1:20 w/w), giving 165 U of pepsin 
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mg-1 protein. Samples and a control with no enzyme addition were incubated at 37 °C, 150 
rpm for 60 min. The digestion was stopped by raising the pH to 7.5 using 1.0 M NaOH. 
Aliquots (40 µL) in triplicate were removed for MALDI-TOF-MS analysis.  
 
2.6.2. In vitro duodenal digestion (phase 2) 
The in vitro duodenal digestion took place with the 60 min gastric digests (phase 1) as 
starting material. Before duodenal proteolysis, the pH of the digests was adjusted to 6.5 with 
0.1 M NaOH and then following solutions were added to simulate a duodenal environment: 
a bile salt mixture containing equimolar quantities (0.125 M) of sodium taurocholate and 
sodium glycodeoxycholic acid, 1.0 M CaCl2 and 0.25 M bis-Tris, pH 6.5. Then, solutions of 
0.1% (w/v) porcine trypsin (activity: 13,800 U mg-1 of protein using benzoylarginine ethyl 
ester as substrate, Sigma-Aldrich) and 0.4% (w/v) bovine α-chymotrypsin (activity: 40 U mg-1 
of protein using benzoyltyrosine ethyl ether as substrate, Sigma-Aldrich) in water were 
added in approximately physiological enzyme:protein ratios of 1:400 (w/w) for trypsin and 
1:100 (w/w) for chymotrypsin, to give 34.5 U of trypsin mg-1 of protein, as well as 0.40 U of 
chymotrypsin mg-1 of protein. The duodenal digestion was carried out in a shaking incubator 
(37 °C, 150 rpm) for 60 min and stopped by addition of a solution of soybean Bowmann-Birk 
trypsin-chymotrypsin inhibitor (Sigma-Aldrich) at a concentration calculated to inhibit twice 
the amount of trypsin and chymotrypsin present in the digestion mix. At the end aliquots (40 
µL) in triplicate were taken for MALDI-TOF-MS analysis. 
 
2.7. Matrix assisted laser desorption ionisation-time of flight-mass spectrometry  
To identify the peptides remaining after gastric (phase 1) and duodenal (phase 2) digestion, 
samples collected at the end of both phases of digestion, as well as isolated casein fractions 
from anion-exchange chromatography, were analysed by MALDI-TOF-MS. Prior to analysis, 
casein digests were desalted using ZipTip C18 columns (Millipore, Eschborn, Germany). The 
samples were crystallised by the dried droplet method using 2.5-dihydroxy benzoic acid as 
matrix. The matrix solution was prepared by dissolving 2.5-dihydroxy benzoic acid and 
methylene-diphosphonic acid (Fluka, Neu-Ulm, Germany) at concentrations of 5 mg mL-1 in 
water, respectively. MALDI-TOF-MS analyses were performed using an Ultraflex TOF/TOF I 
mass spectrometer (Bruker Daltonics, Bremen, Germany) equipped with a UV nitrogen laser 
(λ = 337 nm, 3 ns pulse width) to desorb/ionise the matrix/analyte material. Mass spectra 
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were obtained in positive reflectron ion mode over the m/z range 400-4000. Approximately 
250 spectra were accumulated. For external calibration, a peptide standard mixture (Bruker 
Daltonics) was used.  
 
2.8. Data analysis 
MALDI-TOF-MS data analysis was performed with the Compass 1.2 software (Bruker 
Daltonics). An assignment of observed ions to the corresponding amino acid sequences was 
done, which was based on the known sequences of the different caseins by using the protein 
database Swiss-Prot and TrEMBL, as well as the tools FindPept and Peptide Mass 
(www.expasy.org). For identification of the peptides, the following search parameters were 
chosen: (a) peptide masses were indicated as monoisotopic and [M + H]+; (b) with cysteines 
treated with nothing and methionines oxidised; (c) mass tolerance set to 50 ppm, with a 
maximum of 75 ppm; (d) pepsin, trypsin and chymotrypsin selected as enzymes.  
 
3. Results and discussion  
3.1. Screening of different bovine breeds  
With the screening of the 3 bovine breeds by IEF, the known genetic variants αS1-CN B and C, 
as well as αS2-CN A, B and D, could be demonstrated with different frequencies (Fig. 1 and 
Table 1). In agreement with previous studies (Caroli, Rizzi, Lühken, & Erhardt, 2010; Erhardt, 
1993b, 1996) αS1-CN B showed the highest frequency in all breeds analysed. According to 
Caroli et al. (2010) and Erhardt (1996), αS1-CN C is a common variant in Pinzgauer, whereas it 
could not be found in Gelbvieh, which is in contrast to the finding of Erhardt (1993b).  
 
Table 1  
Allele frequencies of αS1- and αS2-casein in different cattle breeds identified by isoelectric focusing. 
Breed n  αS1-casein αS2-casein 
  B C A B D 
German Holstein Friesian 421 0.994 0.006 1.0 - - 
Pinzgauer 362 0.778 0.222 0.899 0.101 - 
German Gelbvieh 196 1.0 - 0.906 - 0.094 
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As reported by others (Caroli et al., 2010; Erhardt, 1993b, 1996), αS2-CN A was the 
predominant variant in the 3 bovine breeds investigated. A relatively high frequency of 
variant B could be detected in Pinzgauer. αS2-CN B is usually present in Bos indicus breeds, 
and the occurrence of this variant in Pinzgauer can be explained by an introgression of B. 
indicus, as already discussed by Caroli et al. (2010). The rare variant αS2-CN D was present in 
Gelbvieh with low frequencies and in the heterozygous genotype AD. Only the homozygous 
forms αS1-CN BB and CC, as well as αS2-CN AA and BB were included in further analyses.  
 
 
 
Fig. 1. Isoelectric focusing pattern of milk samples from cows with different αS1- and αS2-casein (CN) genotypes, 
which are indicated in capitals at the bottom of the illustration. Reference samples (STD) were used for 
identification of the casein variants. The major bands of the homozygous and heterozygous forms of αS1-CN 
(BB, BC, CC) are marked by a cross, while the αS2-CN genotypes (AA, AB, AD, BB) are denoted with a dot. Milk 
samples used for isolation and digestion of casein variants are underlined. 
 
3.2. Purification of αS1- and αS2-casein variants 
After precipitation and anion-exchange chromatography, αS1-CN B and C, as well as one 
sample of αS2-CN, were recovered in pure forms from the other caseins, as shown by SDS-
PAGE and MALDI-TOF-MS. A significant contamination with αS1-CN could only be detected in 
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samples of αS2-CN A and B. On SDS-PAGE (Fig. 2), the αS1-CN variants (lanes 1-3) displayed 
one band at molecular mass of around 32,000 Da, whereas the position of αS1-CN C (lane 3) 
was slightly below αS1-CN B. The αS2-CN variants (lanes 4-6) showed one main band and had 
almost the same electrophoretic mobility on SDS-PAGE as αS1-CN (Fig. 2). However, αS2-CN A 
(lane 5) migrated slightly faster. On SDS-PAGE gels, the molecular masses for αS1- and αS2-CN 
exceeded the theoretically calculated masses of 23,614 Da and 25,229 Da, respectively 
(Farrell et al., 2004). This is accordance with other studies, where molecular masses of 
approximately 30,000-32,400 Da were observed for α-CN (Almaas et al., 2006; Docena et al., 
1996; Pardo & Natalucci, 2002). 
In addition, mass spectrometry analyses were performed to confirm the purity of the 
isolated casein fractions. For this purpose, the samples were digested with trypsin and 
subjected to MALDI-TOF-MS. Then, the purity of the samples was determined on the basis of 
the intensity coverage (%) of the matched tryptic peptides. According to SDS-PAGE, no 
contamination with other caseins could be demonstrated in the three αS1-CN samples.  
 
 
 
Fig. 2. SDS-PAGE patterns of isolated αS1- and αS2-casein (CN) fractions obtained after anion exchange 
chromatography: lanes 1 and 2, αS1-CN B; lane 3, αS1-CN C; lane 4, αS2-CN B; lanes 5 and 6, αS2-CN A. 
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Two of the 3 αS2-CN samples contained some traces of αS1-CN, which confirms the 
observations from other studies that it is difficult to get a pure separation of αS2-CN with ion- 
exchange chromatography (Holland, Rahimi Yazdi, Ion Titapiccolo, & Corredig, 2010; Hollar, 
Law, Dalgleish, & Brown, 1991; Turhan, Barbano, & Etzel, 2003). The αS2-CN B fraction (lane 
4 in Fig. 2) exhibited the highest content of αS1-CN. The signal intensity of αS1-CN peptides in 
αS2-CN B accounted for 20.6%, whereas in αS2-CN A (lane 6 in Fig. 2) this was 5.5%, as 
calculated by BioTools (Bruker Daltonics).  
 
3.3. In vitro gastrointestinal digestion of αS1- and αS2-casein variants  
As reported for the caseins (Astwood et al., 1996; Dupont et al., 2010a; Fu, Abbott, & Hatzos, 
2002), the genetic variants αS1-CN B and C, as well as αS2-CN A and B, were rapidly 
hydrolysed by pepsin during gastric digestion, and no measurable amount of intact protein 
could be found at the end of this phase. By continuing the digestion with duodenal enzymes, 
the casein peptides were further broken down, leading to a more complex peptide mixture 
than in phase 1. This is expected as αS1- and αS2-CN are poorly structured proteins with no 
defined tertiary structure, which are therefore very susceptible to proteases such as pepsin, 
trypsin and chymotrypsin (Astwood et al., 1996; Swaisgood, 2003).  
Using MALDI-TOF-MS, it was possible to identify the remaining peptides after 
gastrointestinal digestion. This method enables the mapping of the complex peptide mixture 
occurring in the digests of several casein variants. Nevertheless, in both phases of the 
digestion, for some masses, more than one peptide was assigned during the FindPept 
database search, not allowing unambiguous determination of these peptides. In 
consequence, these were not considered in further evaluations. 
 
3.3.1. Gastric digestion (phase 1) of αS1-casein 
After gastric digestion, a total of 37 common peptides were found for αS1-CN B and C with 
molecular masses between 415 and 3017 Da. Among these, 29 peptides were 
unambiguously identified (Fig. 3a). As indicated in Fig. 3a, almost no breakdown could be 
observed in region 54-89 of αS1-CN, while more pepsin-generated peptides were detected in 
the rest of the protein sequence.  
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Fig. 3. Peptides identified by MALDI-TOF-MS after (a) gastric and (b) duodenal digestion of αS1-casein (CN) 
variants B and C. Peptides that were unambiguously identified are represented by black continuous lines. 
Peptides containing the amino acid substitutions and occurring in all αS1- CN variants are indicated with short 
dashed lines (------), peptides found only in αS1-CN B are shown with very short dashed lines (……) and peptides 
detected solely in αS1-CN C are marked by long dashed lines (
_ _ _ _
). The positions of the amino acid 
substitutions and IgE-binding epitopes are highlighted in bold. 
 
The region 54-89 is a highly phosphorylated area with phosphoserine residues in positions 
64, 66, 67, 68 and 75. Post-translational modifications such as phosphorylations are one 
reason why parts of a sequence cannot be identified by MS, because they lead to low 
abundance and suppression effects of peptides (Boersema, Mohammed, & Heck, 2009). 
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Furthermore, phosphopeptides have a poor ionisation and fragmentation efficiency, and 
therefore limit the analysis with MS (Asara & Allison, 1999). Moreover, a comparison with 
the theoretical cleavage sites of pepsin (pH > 2) in the region 54-89 confirmed that no typical 
and specific enzyme cleavage occurs in this part of αS1-CN sequence.  
In addition to the peptides found together in both αS1-CN variants, MALDI-TOF analysis also 
revealed that the digestion gave rise to peptides differing from each other due to the amino 
acid substitution at position 192, which distinguishes variant B (glutamic acid, E) from C 
(glycine, G) (Table 2). Thus, peptides f177-192 and f193-199 occurred only in the digests of 
variant B, because the glutamic acid at position 192 is a preferential cleavage site for pepsin 
(Sweeney & Walker, 1993). 
 
Table 2 
Identification of peptides with amino acid substitutions after gastric (phase 1) and duodenal (phase 2) digestion 
of αS1-casein variants B and C by MALDI-TOF-MS.  
Experimental mass 
[M + H]
a
 
Theoretical mass 
[M + H]
a
 
Position Sequence
b
 
αS1-casein 
variant 
Gastric digestion 
876.48 
1689.79 
 
876.47 
1689.76 
 
193-199 
177-192 
 
(E)/
193
KTTMPLW
199
 
177
PSFSDIPNPIGSENSE
192
 
 
B 
B 
1688.78 1688.78 176-192 
176
APSFSDIPNPIGSENSG
192
 C 
1819.83  
1747.79 
1819.84 
1747.83 
180-196 
180-196 
180
SDIPNPIGSENSEKTTM
196 
180
SDIPNPIGSENSGKTTM
196
 
B 
C 
2216.06 2216.05 180-199 
180
SDIPNPIGSENSEKTTMPLW
199
 B 
 
Duodenal digestion 
876.48 
1358.62 
1407.63 
1407.61 
1495.75 
1486.71 
1414.67 
2105.01 
2105.04 
 
876.47 
1358.61 
1407.64 
1407.66 
1495.63 
1486.70 
1414.68 
2104.97 
2105.02 
 
193-199 
180-192 
184-196 
187-199 
187-199 
180-193 
180-193 
174-193 
179-198 
 
(E)/
193
KTTMPLW
199 
180
SDIPNPIGSENSE
192 
184
NPIGSENSEKTTM
196
 
187
GSENSGKTTMPLW
199 
187
GSENSEKTTMPLW
199 
180
SDIPNPIGSENSEK
193 
180
SDIPNPIGSENSGK
193 
174
TDAPSFSDIPNPIGSENSEK
193 
179
FSDIPNPIGSENSGKTTMPL
198
 
 
B 
B 
B 
C 
B 
B 
C 
B 
C 
a 
Monoisotopic mass values. 
b 
Bold letters represent the position of the amino acid substitution differentiating αS1-casein variants B and C.
 
 
However, a corresponding peptide (f176-192) was found in samples of αS1-CN C despite a 
glycine being at position 192, which can be explained by the decreasing substrate specificity 
of pepsin at pH > 2. It can be assumed that the rate of hydrolysis for this peptide is low, since 
the related peptide f193-199 could not be identified in the digests of αS1-CN C, presumably 
2. In vitro gastrointestinal digestion of bovine αS1- and αS2-casein variants gives rise to different IgE-binding 
epitopes 
 43 
because of its low concentration, not allowing detection by MALDI-TOF-MS. Peptide f180-
196 was identical in both variants, with a mass difference of about 72 Da, resulting from the 
varying molecular weights of glutamic acid (147.13 Da) and glycine (75.07 Da). Furthermore, 
the larger fragment f180-199 was solely observed in variant B (Table 2). 
 
3.3.2. Duodenal digestion (phase 2) of αS1-casein 
Overall, 58 identical peptides could be identified in the digests of αS1-CN B and C by MALDI-
TOF-MS, with molecular masses between 414 and 2998 Da. Of these, 43 peptides were 
exactly assigned (Fig. 3b). The higher number of shorter fragments, as well as the cleavage of 
larger peptides from the gastric digest in areas 1-16, 25-45 and 73-96, indicated a further 
breakdown of the αS1-CN variants. Moreover, 17 peptides observed in phase 1 digestion 
were also found in phase 2, suggesting that these peptides did not undergo a progressive 
degradation by trypsin and chymotrypsin. Similar to gastric digestion, different peptides 
could be demonstrated after duodenal digestion, and these contained the variant specific 
amino acid substitutions (Table 2). Peptide f180-193 was identical in both variants and 
probably displays a breakdown product of peptide f180-196 arising from gastric digestion. 
Peptides f180-192 and f193-199 occurred exclusively in αS1-CN B, because glutamic acid is 
not only a specific cleavage site of pepsin but also of chymotrypsin, even if it is cleaved with 
a low hydrolysis rate (Kellermann, 2006). Together with peptide f184-196, they might 
originate from peptide f180-199, which was solely present in the gastric digest of variant B 
(Table 2).  
The mass difference of 88 Da instead of 72 Da between the peptide f187-199 found common 
in αS1-CN B and C is due to the oxidation of a methionine residue to methionine sulphoxide 
(+16 Da) in the peptide of variant B. Oxidation of methionine residues in peptide sequences 
often takes place in mass spectrometry and arises from light or oxygen exposure of the 
sample rather than from biological oxidation during digestion (Gobom et al., 2001). Peptide 
f174-193 in αS1-CN B and the similar peptide f179-198 in αS1-CN C had identical masses, 
explaining the divergence in their sequences (Table 2). However, peptide f179-198 of αS1-CN 
C resulted from unspecific chymotrypsin cleavage at position 179(F)-180(S) and contained 1 
missed trypsin cleavage at position 193(K)-194(T), whereas peptide f174-193 of αS1-CN B was 
a specific cleavage product of both enzymes with no missed cleavage. One explanation for 
the distinct peptides occurring between the individual variants might be that the amino acid 
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substitution changing the peptide sequence contributes to steric hindrance, which limits the 
access to this region for the enzymes (Dupont et al., 2010a). 
It is interesting to note that, with the exception of peptide f180-199, such large fragments 
were not observed after gastric digestion. Conceivably, the gastric phase gave fragments 
larger than 4000 Da, which were not detectable with MALDI-TOF-MS in this study. Dupont et 
al. (2010b) reported the existence of peptides f179-198, f173-198 and f180-199 derived from 
αS1-CN after gastrointestinal digestion of yoghurt and sterilised milk. In contrast to the 
results of this study, Dupont et al. (2010b) identified no corresponding peptides in raw milk, 
and the authors attributed this to a higher degree of proteolysis as compared with heat-
treated milk, which seemed to be more resistant to digestion. Nevertheless, a comparison of 
those results with the present study is difficult, because Dupont et al. (2010b) used a 
modified form of in vitro digestion adapted to infants. Furthermore, whole milk samples 
were digested instead of isolated casein fractions as studied here.  
 
3.3.3. Gastric digestion (phase 1) of αS2-casein  
The gastric digestion of αS2-CN A and B generated 44 identical peptides with molecular 
masses between 402 and 3130 Da; among these, 32 peptides were unambiguously identified 
(Fig. 4a). With the exception of regions 34-59 and 198-207, which barely provided any 
fragments, the peptides were distributed along the whole protein sequence. It can be 
suggested that some of the intact sequences were extensively hydrolysed and therefore too 
small for detection by MALDI-TOF-MS. In addition, several peptides may have a low 
ionisation efficiency, be of low intensity, or be completely suppressed, and thus not 
measurable by MALDI-TOF-MS (Lochnit & Geyer, 2004). Due to a substitution of the 
phosphorylated serine (S) in variant A by phenylalanine (F) in variant B at position 8, the 3 
peptides f7-12, f8-14 and f5-20 could only be found in αS2-CN A and peptide f9-18 solely in 
αS2-CN B, as phenylalanine is a specific cleavage site for pepsin (Table 3) (Sweeney & Walker, 
1993). However, a similar peptide to the αS2-CN A fragment f5-20 could be demonstrated in 
αS2-CN B in form of peptide f4-21. 
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Fig. 4. Peptides identified by MALDI-TOF-MS after (a) gastric and (b) duodenal digestion of αS2-casein (CN) 
variants A and B. Peptides that were unambiguously identified are represented by black continuous lines. 
Peptides with amino acid substitutions found only in αS2-CN A are shown with short dashed lines (……). 
Peptides detected solely in αS2-CN B are marked by large dashed lines ( _ _ _ _ ). The positions of the amino 
acid substitutions and IgE-binding epitopes are highlighted in bold. 
 
3.3.4. Duodenal digestion (phase 2) of αS2-casein 
MALDI-TOF-MS analysis of the duodenal digests from αS2-CN A and B showed the presence 
of 67 identical peptides with molecular masses from 400 to 2556 Da, covering most of the 
protein sequence. A precise assignment was possible for 54 of the 67 peptides (Fig. 4b). 
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Compared with phase 1 digestion, the increase in shorter fragments, especially in regions 20-
30, 89-110, 115-130, as well as 151-170, indicated further breakdown of both casein 
variants. Moreover, new peptides arose from the almost uncut areas 35-66 and 190-207. 
Thirteen fragments from phase 1 were also found in phase 2 and did not undergo further 
hydrolysis by trypsin and chymotrypsin. Due to the preferential cleavage by chymotrypsin at 
phenylalanine, the gastric peptide f4-21 of αs2-CN B
 was cut at position 8 during duodenal 
digestion and thus the resulting peptide f9-21 was specific for this variant (Table 3) 
(Kellermann, 2006; Sweeney & Walker, 1993). 
 
Table 3 
Identification of peptides with amino acid substitutions after gastric (phase 1) and duodenal (phase 2) digestion 
of αS2-casein variants A and B by MALDI-TOF-MS.  
Experimental mass 
 [M + H]
a
 
Theoretical mass 
 [M + H]
a
 
Position Sequence
b
 
αS2-casein 
variant 
Gastric digestion 
637.28 
738.34 
1108.55 
1824.77 
2143.98 
 
 
637.27 
738.32 
1108.51 
1824.81 
2159.92 
 
7-12 
8-14 
9-18 
5-20 
4-21 
 
7
VSSSEE
12
 
8
SSSEESI
14
 
(F)/
9
SSEESIISQE
18
 
5
EHVSSSEESIISQETY
20
 
4
MEHVFSSEESIISQETYK
21
 
 
A 
A 
B 
A 
B 
Duodenal digestion 
1500.71 
2615.27 
2631.20 
 
1500.71 
2615.23 
2631.25 
 
9-21 
1-22 
7-29 
 
(F)/
9
SSEESIISQETYK
21 
1
KNTMEHVFSSEESIISQETYKQ
22 
7
VSSSEESIISQETYKQEKNMAIN
29
 
 
B 
B  
A 
a 
Monoisotopic mass values.
 
b
 Bold letters represent the position of the amino acid substitution differentiating αS2-casein variants A and B. 
 
A replacement of the phosphorylated serine by a phenylalanine in variant B played a decisive 
role concerning the phosphoseryl cluster comprising the specific motif Ser(P)3-Glu2.  
Previously, it has been demonstrated that peptides carrying phosphorylated serine residues 
resist in vivo and in vitro gastro-duodenal digestion (Dupont et al., 2010b; Meisel et al., 
2003; Miquel et al., 2005). This is of significance as it has been assumed that the major 
phosphorylation sites act as important allergenic epitopes, because dephosphorylation of 
caseins led to a lower immunoreactivity (Bernard, Meisel, Creminon, & Wal, 2000). In this 
study, gastrointestinal digestion had no effect on the phosphoseryl clusters of αS1-CN B and 
C at position 64-70, since they were present in an intact form. In contrast, the main 
phosphoseryl clusters of αS2-CN A and B at positions 8-12 and 56-60 were particularly 
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resistant to gastrointestinal digestion. Two cleavage sites at positions 11 and 56 could be 
identified in both αS2-CN variants, with a further one at position 8 in αS2-CN B caused by the 
mutation (Fig. 4b). Consistent with these findings, Su, Qi, He, Yuan, and Zhang (2007) also 
showed that multi-phosphorylated αS1- and αS2-CN peptides were not stable against 
hydrolysis and did not survive pancreatic digestion. However, the role of the major 
phosphorylated sequences as crucial epitopes in caseins remains unclear, since epitope 
mapping studies were performed with synthetic peptides lacking a phosphorylated form 
(Busse et al., 2002; Cerecedo et al., 2008; Chatchatee et al., 2001; Lin et al., 2009).  
As indicated in Table 3, peptide f7-29, showing one oxidized methionine, occurred only in 
variant A and peptide f1-22 solely in variant B with slight variations in their masses. These 
two peptides contained 4, respectively, 5 missed theoretical cleavages of the pancreatic 
enzymes. The phosphoseryl cluster might also be responsible for this observation, as 
phosphorylation may change the structure of a protein so that its substrate properties can 
be impaired (Winter, Kugelstadt, Seidler, Kappes, & Lehmann, 2009). Furthermore, it has 
been reported that phosphorylations located close to peptide bonds, which are a target of a 
specific proteolytic enzyme, are able to inhibit such cleavage (Hynek, Zuzalkova, Sikac, & Kas, 
2002). Dupont et al. (2010b) also demonstrated that large fragments can resist digestion but, 
in contrast to this study, they identified no peptides in αS2-CN region 1-70 either in raw milk 
or in pasteurised and sterilised milk. The authors attributed this to the fact that αS2-CN 
contains two cysteine residues at positions 36 and 40 (Swaisgood, 2003), which probably 
generate heat-induced aggregates with whey proteins through the formation of disulphide 
bridges in whole milk, resulting in a protection of some larger parts of the protein against 
digestion (Dupont et al., 2010b). 
 
3.4. Comparison of identified peptides with IgE-binding epitopes 
Most food allergens are thought to sensitise an individual via the gastrointestinal tract (GIT). 
Therefore, these proteins need to survive the digestion in an immunologically active form to 
cross the gastrointestinal mucosa to interact with the immune system (Mills, Jenkins, 
Alcocer, & Shewry, 2004). Thus, digested protein fragments must be of sufficient size, being 
able to sensitise, elicit an allergic reaction, and react with IgE antibodies, which requires the 
presence of intact IgE-binding epitopes. It is generally assumed that peptides have to be 
approximately 3500 Da in size to possess an allergenic potential (FAO/WHO, 2001; Huby, 
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Dearman, & Kimber, 2000). However, a study of sensitising capacity of the digested main 
peanut allergen Ara h 1 demonstrated that peptide fragments smaller than 2000 Da can 
induce a significant antibody response (Bøgh et al., 2009). This can also be expected for the 
caseins because, despite their excellent digestibility, they act as potent allergens (Bernard et 
al., 1998; Docena et al., 1996). A comparison of the identified peptides in αS1- and αS2-CN 
after gastrointestinal digestion with the IgE-binding epitopes described in literature showed 
that peptides f106-120 and f120-145 in αS1-CN B and C correspond to the known epitopes 
f109-120, as well as f123-132 (Fig. 3b) (Chatchatee et al., 2001).  
For αS2-CN A and B, the epitopes f105-114 and f117-128 were found to resist digestion 
within peptides f104-119 and f116-128 (Fig. 4b) (Busse et al., 2002). This was also reported 
for the milk proteins β-CN and β-lactoglobulin (Dupont et al., 2010a; Picariello et al., 2010), 
as well as Ara h 1 (Bøgh et al., 2009), the epitopes of which are also able to survive the 
digestion process. 
Furthermore, it had been anticipated that the amino acid substitutions or deletions 
characterising the genetic milk protein variants could influence their IgE-binding epitope 
structure. Hence, it might be that milk produced from distinct genotypes could exhibit 
different allergenic properties (Ballabio et al., 2011; Caroli et al., 2009). The present study 
revealed that the amino acid substitutions affect the peptide pattern arising from the αS1- 
and αS2-CN variants, as modifications in their allergenic epitopes occurred. Peptides f174-193 
in αS1-CN B and f179-198 in αS1-CN C correspond to fragment f173-194, which has been 
reported as one of the major IgE-binding epitopes in αS1-CN B (Fig. 3b) (Chatchatee et al., 
2001). 
In αS2-CN, the variant specific peptides f7-29 (αS2-CN A) and f1-22 (αS2-CN B) are congruent 
with the known IgE-binding epitope f1-20 (Fig. 4b) (Cerecedo et al., 2008). Whether these 
modifications change the allergenicity of the different epitopes still remains unclear, 
because investigations are lacking. However, previous studies indicated that single or 
multiple amino acid substitutions within IgE-binding epitopes of some caseins resulted in an 
elimination or reduction of IgE-binding by pooled sera from cows’ milk-allergic patients 
(Cocco, Järvinen, Han, Beyer, & Sampson, 2007; Cocco, Järvinen, Sampson, & Beyer, 2003). 
Cocco et al. (2003) demonstrated that an exchange of the glutamic acid with alanine at 
position 192 in the IgE-binding epitope f179-192 of αS1-CN led to a slightly decreased binding 
to this epitope. In αS1-CN C, a glycine is located at position 192. Glycine and alanine have 
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similar features; both are small, neutral and uncharged amino acids. Taking into account the 
results of Cocco et al. (2003), it can be assumed that peptide f179-198 in αS1-CN C possesses 
a lower immunoreactivity than peptide f174-193 identified in the digests of αS1-CN B.  
For the different peptides detected in αS2-CN A (f7-29) and αS2-CN B (f1-22) modifications in 
their IgE-binding are conceivable. The missing phosphorylated serine residue in variant B, 
changing the sequence of the phosphoseryl cluster, may result in a diminished IgE-binding to 
this epitope, as described for dephosphorylated milk proteins (Bernard et al., 2000). The 
absence of binding to one of the main epitopes in αS1- and αS2-CN could induce a reduced 
allergenicity of the whole protein. However, further investigations are needed to confirm 
this. 
 
4. Conclusions  
The current study showed that in-vitro gastrointestinal digestion of αS1-CN and αS2-CN 
variants resulted in a wide range of peptides, which are long enough to contain IgE-binding 
epitopes. Due to the amino acid substitution characterising the genetic variants, some 
peptides, and in consequence epitopes, differ from each other. As the described epitopes 
refer to the reference proteins αS1-CN B and αS2-CN A and differences between the epitopes 
of the single variants could be demonstrated, further research is needed to examine the 
allergenic potential of these peptides. In this context, endangered breeds should be taken 
into consideration, because they play an important role concerning their preservation as 
gene reserves. Cattle breeds threatened by extinction can exhibit rare variants which are not 
present in the main breeds, as it was shown for αS1-CN F (Erhardt, 1993a). Such rare variants 
could possess a lower allergenic potential than the main variants and should therefore be 
investigated in further studies, as they could be useful for the production of milk with 
improved nutritional properties such as hypoallergenic qualities. Moreover, this emphasizes 
the importance of genetic polymorphisms of milk proteins not only in the field of animal 
breeding but also within the scope of human nutrition. 
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ABSTRACT 
Immunoglobulin E-mediated allergy to cow milk is a common allergy in industrialized 
countries, mainly affecting young children and infants. β-Casein (CN) and κ-CN belong to the 
major allergens in cow milk. Within these milk proteins, genetic polymorphisms occur, which 
are characterized by substitutions or deletions of AA, resulting in different variants for each 
protein. Until now, these variants have not been considered when discussing the allergenic 
potential of bovine milk. In this study, the focus was placed on the arising peptide pattern 
after in vitro gastrointestinal digestion of several β- and κ-CN variants to determine resistant 
fragments containing IgE-binding epitopes and to identify potential differences between 
these variants. β-Casein A1, A2, and B, as well as κ-CN A, B, and E, were separated and 
isolated from milk of cows homozygous for these variants and digested with an in vitro 
gastrointestinal digestion model. The resulting peptides were identified using mass 
spectrometry and compared with previously determined epitopes. Seven β-CN and 4 κ-CN 
peptides, common in all β- or κ-CN variants, remained of sufficient size to harbor IgE-binding 
epitopes. In addition, some peptides and, consequently, epitopes differ from each other due 
to the AA substitution occurring in the individual variants. The distinct peptides AA 108 to 
129 of β-CN A1 and A2, AA 103 to 123 of β-CN B, as well as AA 59 to 72, AA 59 to 80, and AA 
58 to 80 of all 3 β-CN variants correspond to the IgE-binding epitopes AA 107 to 120 and AA 
55 to 70, respectively. In κ-CN, the 2 variant-specific peptides AA 136 to 149 (κ-CN A, E) and 
AA 134 to 150 (κ-CN B) are congruent with the IgE-binding epitope AA 137 to 148. The 
present study shows that genetic polymorphisms affected the arising peptide pattern of the 
caseins and thus modifications in the IgE-binding epitopes occurred. As a consequence, the 
casein variants could show differences in their allergenicity. Studies investigating the 
allergenic potential of these different peptides are currently in progress. 
Key words: casein variants, allergenicity, in vitro gastrointestinal digestion, immunoglobulin 
E-binding epitope 
 
INTRODUCTION 
Milk from cows has been a valuable food source since domestication took place more than 
8,000 yr ago, especially in lactose-tolerant human societies (Beja-Pereira et al., 2003). On the 
other hand, cow milk is one of the major elicitors of food allergy, particularly in children, 
affecting around 2 to 3% of this population (Skripak et al., 2007). In adults, it is represented 
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with a prevalence of 0.1% (Osterballe et al., 2005). Cow milk allergy (CMA) is mostly 
mediated by milk protein IgE, which provokes allergic reactions at the skin, respiratory tract, 
and gastrointestinal tract (Huang and Kim, 2012). The 2 caseins β- and κ-CN are important 
cow milk allergens (Docena et al., 1996; Gaudin et al., 2008) and account for 40 and 10% of 
total milk protein, respectively (Farrell et al., 2004). β-Casein comprises 209 AA residues. It is 
a phosphoprotein including a cluster of phosphoseryl residues near the N terminus and it 
contains no cysteine. In contrast, κ-CN consists of 169 AA, and it is characterized by bound 
carbohydrates, the absence of phosphoseryl clusters, as well as 2 cysteines, which are able 
to form disulfide bonds (Farrell et al., 2004). Both caseins share a high proportion of proline 
residues, which contributes to the fact that they exhibit an open flexible structure with 
significant amounts of secondary structure but with no rigid tertiary structure (Swaisgood, 
1993; Farrell et al., 2004). Therefore, they are very susceptible to hydrolysis by all proteases 
(Astwood et al., 1996; Swaisgood, 2003). For β- and κ-CN, genetic polymorphisms are 
described as a consequence of either substitutions or deletions of AA within the polypeptide 
chain resulting in several protein variants (Erhardt, 1989, 1996; Caroli et al., 2009). Thus, a 
total of 12 β-CN variants (A1, A2, A3, B, C, D, E, F, G, H1, H2, and I) and 12 κ-CN variants (A, B, 
C, D, E, F1, F2, G1, G2, H, I, and J) were identified in the Bos genus, with important differences 
in occurrence and frequency of the variants among species and breeds (Farrell et al., 2004; 
Caroli et al., 2009).  
Within β-CN, the variants A1, A2, and B are widely distributed in all breeds, with β-CN A2 
showing the highest frequency. β-Casein A3, C, and I are rather common in Bos taurus. The 
other β-CN variants are rare and described in particular breeds only (Caroli et al., 2009).  
κ-Casein A is the most frequent variant in the bulk of breeds, followed by κ-CN B and H. κ-
Casein C and E are less common in Bos taurus, κ-CN G2 is specific for Bos grunniens, and the 
rest of the κ-CN variants occur infrequently in certain breeds only (Farrell et al., 2004; Caroli 
et al., 2009).  
Genetic polymorphisms of milk proteins are used in phylogenetic studies (Ibeagha-Awemu et 
al., 2004; Jann et al., 2004) and animal breeding, as they have a significant effect on milk 
production traits and cheesemaking properties (Martin et al., 2002; Heck et al., 2009). In 
addition, milk protein variants play a notable role in human nutrition because they improve 
the functional quality of milk and dairy products regarding bioactive peptides, which are 
considered as ingredients of functional foods. Thus, peptides derived from genetic variants 
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of several caseins exhibit differences in their antihypertensive, opioid, dipeptidyl peptidase-4 
inhibitory, and osteoblast mineralization activities (Jinsmaa and Yoshikawa, 1999; Weimann 
et al., 2009; Tulipano et al., 2010, 2011). Genetic polymorphisms may also influence the 
allergenicity of milk proteins. However, information about the allergenic potential of bovine 
milk protein variants is scarce. Modifications in the immunoreactivity of different caprine 
caseins could already be demonstrated in goat milk samples, where the genotypes αS1-CN 
0101 and 01F exhibited lower immunoreactions compared with the goat milk samples 
characterized by αS1-CN BB, BE, EE, and FF (Ballabio et al., 2011).  
It is generally accepted that most food allergens sensitize individuals through the 
gastrointestinal tract (Mills et al., 2004; Moreno, 2007). Therefore, several processes such as 
digestion, absorption, and mucosal immune responses take place before milk proteins 
induce an allergic reaction. The majority of milk allergenic patients showed a strong humoral 
and cellular response to β- and κ-CN, with high titers of IgE specific for these proteins (Shek 
et al., 2005). The allergenicity of these proteins is due to some small protein fragments 
containing IgE-binding epitopes, which are spread along the whole protein sequence, able to 
cross-link 2 IgE molecules, and thereby elicit an allergic reaction (Huang and Kim, 2012). 
Multiple IgE-binding epitopes in β- and κ-CN, ranging from 8 to 20 AA, have been identified 
by SPOT-membrane-based or microarray immunoassays with sera from CMA patients 
(Chatchatee et al., 2001; Cerecedo et al., 2008; Lin et al., 2009). Even though the caseins are 
labile proteins, recent studies reported that peptides resulting from in vitro gastrointestinal 
digestion of β-CN and β-LG still comprise IgE-binding epitopes and, therefore, may retain 
allergenic potential (Dupont et al., 2010a,b; Picariello et al., 2010). However, no previous 
study considered the influence of the genetic polymorphisms on the digestion of casein 
variants in association with their IgE-binding epitopes.  
Therefore, the aim of the present study was to detect resistant regions containing IgE-
binding epitopes and possible differences after a simulated gastrointestinal digestion of 
several bovine β- and κ-CN variants by using mass spectrometry. 
 
MATERIALS AND METHODS 
Chemicals, Enzymes, and Other Reagents  
Chemicals and reagents were purchased from standard suppliers: Servalyt pH 5.0 to 7.0, 
Coomassie Brilliant Blue R 250, diethylaminoethyl (DEAE) 52 Cellulose Servacel, and Protein 
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Test Mixture 6 for SDS-PAGE were obtained from Serva Electrophoresis GmbH (Heidelberg, 
Germany); Pharmalyte pH 2.5 to 5.0 and pH 4.2 to 4.9 carrier ampholytes were purchased 
from GE Healthcare Europe GmbH (Freiburg, Germany); sodium taurocholate (≥95% by thin-
layer chromatography), sodium glycodeoxycholate (≥97% by thin-layer chromatography), 
pepsin from porcine gastric mucosa (activity: 3,200–4,500 U/mg of protein using hemoglobin 
as substrate), trypsin from porcine pancreas (activity: 13,800 U/mg of protein using 
benzoylarginine ethyl ester as substrate), α-chymotrypsin from bovine pancreas (activity: 40 
U/mg of protein using benzoyltyrosine ethyl ether as substrate), and Bowman-Birk trypsin-
chymotrypsin inhibitor from soybean were acquired from Sigma-Aldrich Chemie GmbH 
(Steinheim, Germany); and 2.5-dihydroxy benzoic acid and methylene-diphosphonic acid for 
the matrix solution were obtained from Fluka (Neu-Ulm, Germany). All chemicals were of 
analytical reagent grade. 
 
Phenotyping of Milk Samples by Isoelectric Focusing  
Individual milk samples were collected from different bovine breeds derived from several 
associations and private dairy farms in Germany. Genetic variants of β- and κ-CN were 
determined by isoelectric focusing (IEF) on 0.3-mm thin polyacrylamide gels using carrier 
ampholytes according to Erhardt (1989). The gels (t = 5.01; C = 3.75; 7.09 M urea) contained 
0.644 mL of the following mixture of carrier ampholytes: 0.30% (wt/vol) Pharmalyte pH 2.5 
to 5.0, 1.10% (wt/vol) Pharmalyte pH 4.2 to 4.9, and 1.19% (wt/vol) Servalyt pH 5.0 to 7.0. 
After fixation in 20% (wt/vol) TCA and staining with a solution of 0.1% (w/v) Coomassie 
Brilliant Blue R 250, 45% (vol/vol) ethanol, and 10% acetic acid (vol/vol), β- and κ-CN variants 
were identified manually by using cow milk samples with known variants as reference 
samples. 
 
Preparation of Caseins from Milk 
Milk samples from cows with defined casein phenotypes (β-CN A1, A2, and B, and κ-CN A, B, 
and E) were skimmed by centrifugation at 1,620 × g for 10 min at 4°C. Preparation of whole 
casein was performed by acid precipitation. Briefly, skim milk samples were acidified with 
50% (vol/vol) acetic acid to pH 4.6 and centrifuged at 1,620 × g for 10 min. The casein 
precipitate was dissolved in distilled water with 1.0 M NaOH. Steps of precipitation and 
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washing were repeated 3 times. Whole casein was finally lyophilized and stored at −20°C 
until analysis. 
 
Purification of Caseins by Anion-Exchange Chromatography  
β-Casein and κ-CN variants were separated from the whole casein fraction by anion-
exchange chromatography according to a modified method of Andrews and Alichanidis 
(1983). The DEAE 52-cellulose resin was packed into a column (46.5 × 2.5 cm) to reach a 
column volume of 50 mL. Equilibration (EQ) took place with 0.01 M Tris/imidazole (pH 7.0), 
3.3 M urea, 0.01 M 2-β-mercaptoethanol, and 3.1 mM sodium azide (EQ buffer). An amount 
of 1.0 to 1.5 mg of lyophilized whole casein was dissolved in 30 to 40 mL of EQ buffer and 
applied onto the DEAE cellulose column. Buffers with different salt concentrations were 
prepared by mixing 1.0 M NaCl and EQ buffer. Caseins were eluted stepwise with 0.075, 
0.13, and 0.17 M NaCl buffer at a flow rate of 0.6 mL/min using a peristaltic pump (Ismatec 
Ip-4; Ismatec SA, Zürich, Switzerland). The absorbance of the column effluents were 
monitored at 280 nm (Uvicord SII detector; LKB, Bromma, Sweden) and fractions of 7 mL 
were collected. The main peak fractions of the resulting chromatogram, corresponding to 
the different purified caseins, were determined by IEF in the way described above, and then 
separately pooled and dialyzed 3 times against 5 L of distilled water for 24 h. After 
lyophilization, the purity and identity of pooled casein fractions were assessed by SDS-PAGE 
and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-
TOF-MS). Samples were frozen (−20°C) for storage until used. 
 
SDS-PAGE 
Sodium dodecyl sulfate PAGE was performed according to Laemmli (1970) with 1.5-mm thin 
polyacrylamide gels (16 × 14 cm) consisting of a 2.5% stacking gel and a 12% separating gel 
using the Dual Gel Electrophoresis System, Emperor Penguin (P9DS OWL; Thermo Fisher 
Scientific, Rochester, NY). Fifteen microliters of the sample preparations containing 11.5% 
(vol/vol) casein fraction, 0.069 M Tris-HCl (pH 6.8), 2.2% SDS, 11.1% glycerol, 5.5% 2-β-
mercaptoethanol, and traces of bromophenol blue were loaded onto each lane of the gel. 
The electrophoretic run was done in running buffer [25 mM Tris, 192 mM glycine, and 0.1% 
(wt/vol) SDS, pH 8.3] at 400 V. After fixation with 50% TCA, gels were stained with 0.1% 
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(wt/vol) Coomassie Brilliant Blue R 250. A molecular weight marker (Protein Test Mixture 6) 
was run with each gel. 
 
In Vitro Gastrointestinal Digestion of Casein Variants 
In vitro gastrointestinal digestion of β- and κ-CN variants (β-CN A1, A2, and B, and κ-CN A, B, 
and E) was performed in duplicate as described by Moreno et al. (2005). Each digestion was 
repeated twice and control incubations in the absence of proteases were done. 
 
In Vitro Gastric Digestion (Phase 1) 
β-Casein and κ-CN variants (10–15 mg/mL) were dissolved in simulated gastric fluid (SGF; 
0.15 M NaCl, pH 2.5), adjusted to pH 2.5 with 1.0 M HCl, and incubated at 37°C for 15 min. 
Then, a solution of 0.32% (wt/vol) porcine pepsin in SGF was added at an approximately 
physiological ratio of enzyme:casein (1:20, wt/wt), giving 165 U of pepsin/mg of protein. 
After incubation of the samples at 37°C for 60 min, the pH was raised to 7.5 to irreversibly 
inactivate pepsin by using 1.0 M NaOH and aliquots (40 μL) in triplicate were taken for 
MALDI-TOF-MS analysis. 
 
In Vitro Duodenal Digestion (Phase 2) 
Phase 2 digestion took place with the gastric digests of phase 1 as starting material. Before 
duodenal proteolysis, the pH of the digests was adjusted to 6.5 with 0.1 M NaOH. To 
simulate a duodenal environment, samples were mixed with a bile salt mixture containing 
equimolar quantities (0.125 M) of sodium taurocholate and sodium glycodeoxycholic acid, 
1.0 M CaCl2, and 0.25 M Bis-Tris (pH 6.5). Finally, solutions of 0.1% (wt/vol) trypsin and 0.4% 
(wt/vol) α-chymotrypsin in water were added at approximately physiological ratios of 
casein:trypsin:α-chymotrypsin = 1:400:100 (wt/wt/wt), respectively (1 mg:34.5 U:0.40 U). 
Duodenal digestion was performed for 60 min at 37°C and stopped by addition of a 2-fold 
excess of soybean Bowman-Birk trypsin-chymotrypsin inhibitor, calculated to inhibit trypsin 
and chymotrypsin in the digestion mix. At the end, aliquots (40 μL) in triplicate were 
removed for MALDI-TOF-MS analysis. 
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MALDI-TOF-MS 
Samples collected at the end of gastric (phase 1) and duodenal (phase 2) digestion, as well as 
isolated casein fractions from anion-exchange chromatography, were analyzed by MALDI-
TOF-MS to identify the peptides remaining after digestion. Prior to analysis, casein digests 
were desalted using ZipTip C18 columns (Millipore GmbH, Eschborn, Germany). After 
preparing the matrix solution by dissolving 2.5-dihydroxy benzoic acid and methylene-
diphosphonic acid at concentrations of 5 mg/mL in water, respectively, the samples were 
crystallized by the dried droplet method. The MALDI-TOF-MS analyses were carried out 
using an Ultraflex TOF/TOF I mass spectrometer (Bruker Daltonics, Bremen, Germany) 
equipped with a UV nitrogen laser (wavelength = 337 nm, 3-ns pulse width) to desorb/ionize 
the matrix/analyte material. Spectra were acquired in positive ion reflectron mode over the 
m/z range 400 to 4,000. Approximately 250 spectra were accumulated. External calibration 
was performed with a peptide standard mixture (Bruker Daltonics). 
 
Data Analysis 
The MALDI-TOF-MS data analysis took place with Compass 1.2 software (Bruker Daltonics). 
Based on the known sequences of the different caseins, the observed ions were assigned to 
the corresponding AA sequences by using the protein database Swiss-Prot and TrEMBL, as 
well as the tools FindPept and Peptide Mass (http://www.expasy.org). For identification of 
the peptides, the following search parameters were chosen: (a) peptide masses were 
indicated as monoisotopic and [M + H]+; (b) cysteines were treated with nothing and 
methionines oxidized; (c) the mass tolerance was set to 50 ppm with a maximum of 75 ppm; 
and (d) enzymes pepsin, trypsin, and chymotrypsin were selected. 
 
RESULTS 
Separation and Purification of β- and κ-CN Variants 
Figure 1 shows the separation pattern of different β- and κ-CN genotypes of bovine milk 
samples determined by IEF. The known genetic variants β-CN A1, A2, and B, as well as κ-CN A, 
B, and E could be demonstrated in homo- and heterozygous forms. After steps of 
precipitation and anion-exchange chromatography, the purity of β- and κ-CN variants was 
assessed by IEF (data not shown), SDS-PAGE, and MALDI-TOF-MS. From these analyses, it 
3. Genetic variants of bovine β- and κ-casein result in different immunoglobulin E-binding epitopes after in vitro 
gastrointestinal digestion 
 64 
was evident that some β- and κ-CN variants contained slight contaminations with other 
caseins. Nevertheless, in both casein fractions pure samples were obtained. 
 
 
Figure 1. Separation of bovine milk samples with different β- and κ-CN genotypes by isoelectric focusing. The 
positions of the major bands of the β-CN variants are indicated by an x and the main fractions of the κ-CN 
variants are marked by a dot. 
 
As summarized in Figure 2, the β-CN variants (lanes 1 to 5) occurred as one band at a relative 
molecular mass of around 28,000 Da, with exception of the samples β-CN A1 and A2 (lanes 1 
and 4), where a small second band was visible on the SDS-PAGE gel. This indicated 
contamination with κ-CN. Compared with the other β-CN variants, β-CN B (lane 5) had 
slightly faster electrophoretic mobility. The κ-CN variants (lanes 6 to 8) were located below 
β-CN with one main band at a relative molecular mass of around 26,000 Da. A further very 
light band was identifiable above κ-CN E (lane 6), supposing the presence of some 
contamination with β- or αS2-CN.  
To confirm these findings, the casein variants were additionally analyzed by MALDI-TOF-MS. 
For this purpose, the samples were digested with trypsin and their purity was determined on 
the basis of the intensity coverage (%) of the matched tryptic peptides. Three of 5 β-CN 
samples showed some contamination with κ- or αS2-CN. As already assumed by SDS-PAGE, 
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impurities with κ-CN were measurable in β-CN A1 and β-CN A2 (lanes 1 and 4, Figure 2). The 
intensity coverage of the matched κ-CN peptides in the samples were 15.1% for β-CN A1 and 
6.3% for β-CN A2. In contrast, β-CN A1 (lane 2, Figure 2) revealed small impurities of αS2-CN 
with a signal intensity of 5.9%, which was not visible with SDS-PAGE. The absence of 
contamination with other caseins could only be demonstrated in the samples β-CN A2 and β-
CN B (lanes 3 and 5, Figure 2). 
 
 
Figure 2. Sodium dodecyl sulfate PAGE analysis of different β- and κ-CN fractions obtained from anion- 
exchange chromatography. M= molecular weight marker. Lanes 1 and 2 = β-CN A
1
; lanes 3 and 4 = β-CN A
2
; 
lane 5 = β-CN B; lane 6 = κ-CN E; lane 7 = κ-CN A; lane 8 = κ-CN B. 
 
For κ-CN A and B (lanes 7 and 8, Figure 2), no impurities with other caseins were found. The 
existence of a contamination with αs2-CN casein could be detected in κ-CN E (lane 6, Figure 
2), which was already apparent in the SDS-PAGE gel. A signal intensity of 32% was measured 
for matched αs2-CN peptides. 
 
In Vitro Gastrointestinal Digestion of β- and κ-CN Variants 
The MALDI-TOF-MS analysis allowed the characterization of the comprising peptide pattern 
after gastric and duodenal digestion of the β- and κ-CN variants. In addition to the peptides 
detected together, variant specific peptides occurred in β-CN A1, A2, and B, as well as κ-CN A, 
B, and E. However, a total of 44 peptides (β-CN: 35 peptides; κ-CN: 9 peptides) could not be 
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unambiguously determined in both phases of the digestion, as for some masses, more than 
1 peptide was assigned during the FindPept database search. Thus, these peptides were not 
included in further evaluations. 
 
Gastric Digestion of β-CN (Phase 1) 
A total of 42 common peptides could be demonstrated for β-CN A1, A2, and B, with 
molecular masses ranging from 551 to 2,893 Da. Thirty peptides were exactly assignable 
(Figure 3a). Compared with the residual protein sequence, no peptides were identified in 
region AA 21 to 42. As shown in Table 1, peptide AA 113 to 121 was present in all 3 variants, 
as glutamic acid (E) is a preferential cleavage site for pepsin. Thus, the AA substitution at 
position 122, causing a replacement of a serine (S) in β-CN A1 and A2 by an arginine (R) in β-
CN B, has no negative effect on the cleavage of the enzyme. A further substitution 
distinguishes variant A1 and B (histidine) from A2 (proline) at position 67.  
 
Table 1. Identification of peptides with AA substitutions (bold letters) after gastric and duodenal digestion of β-
CN A
1
, A
2
, and B by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-
MS) 
Phase 
Experimental       
mass 
[M + H]
1
 
Theoretical      
mass 
[M + H]
1
 
Position Sequence 
β-CN        
variant 
Gastric 
digestion 
(phase1) 
1,109.55 1,109.55 113-121 
113
KYPVEPFTE
121
/(S) A
1
, A
2
 
1,109.56 1,109.55 113-121 
113
KYPVEPFTE
121
/(R)
 
B 
1,191.63 1,191.64 118-127 
118
PFTERQSLTL
127 
B 
 2,390.19 2,390.28 59-80 
59
VYPFPGPIPNSLPQNIPPLTQT
80 
A
2
 
 2,430.18 2,430.28 59-80 
59
VYPFPGPIHNSLPQNIPPLTQT
80 
A
1
, B 
Duodenal 
digestion 
(phase 2) 
1,100.57 1,100.57 59-68
2
 
59
VYPFPGPIPN
68 
A
2
 
1,140.57 1,140.58 59-68 
59
VYPFPGPIHN
68 
A
1
, B 
1,283.58 1,283.58 114-124
2
 
114
YPVEPFTESQS
124
 A
1
, A
2
 
 1,525.77 1,525.81 59-72
2
 
59
VYPFPGPIPNSLPQ
72 
A
2
 
 1,565.78 1,565.81 59-72 
59
VYPFPGPIHNSLPQ
72 
A
1
, B 
 1,865.93 1,865.93 110-125
2
 
110
PFPKYPVEPFTESQSL
125
 A
1
, A
2
 
 1,865.93 1,865.93 109-123 
109
MPFPKYPVEPFTERQ
123 
B 
 2,390.28 2,390.28 59-80 
59
VYPFPGPIPNSLPQNIPPLTQT
80 
A
2
 
 2,430.28 2,430.28 59-80 
59
VYPFPGPIHNSLPQNIPPLTQT
80 
A
1
, B 
 2,503.36 2,503.36 58-80
2
 
58
LVYPFPGPIPNSLPQNIPPLTQT
80 
A
2 
 2,543.36 2,543.37 58-80 
58
LVYPFPGPIHNSLPQNIPPLTQT
80 
A
1
, B 
 2,556.18 2,556.22 108-129 
108
EMPFPKYPVEPFTESQSLTLTD
129 
A
1
, A
2
 
 2,556.15 2,556.31 103-123 
103
APKHKEMPFPKYPVEPFTERQ
123 
B 
1
Monoisotopic mass values. 
2
Peptides also identified by Dupont et al. (2010a,b). 
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Therefore, peptide AA 59 to 80 was released from all 3 variants, with a mass shift of about 
40 Da resulting from the varying molecular weights of histidine (155.16 Da) and proline 
(115.13 Da). Nevertheless, peptide AA 118 to 127 was solely observed in digests of β-CN B. 
 
Duodenal Digestion of β-Casein (Phase 2) 
Duodenal digestion of β-CN A1, A2, and B gave rise to a significant number of 93 identical 
peptides with molecular masses from 414 to 3,039 Da, covering almost the whole protein 
sequence. Among these 93 peptides, 70 were unambiguously identified (Figure 3b). It is 
interesting to note that fragments with up to 3,039 Da could not be found after gastric 
digestion. According to this, it is likely that peptides larger than 3,500 Da appeared in the 
gastric phase, which were not detectable with MALDI-TOF-MS in this study. Duodenal 
digestion led to further degradation of the proteins and, hence, to the formation of a larger 
number of smaller fragments. Similar to the gastric phase, only a few enzyme cleavages 
occurred in area AA 21 to 42. Furthermore, 17 peptides resulting from gastric digestion were 
identified at the end of this phase and avoided the progressive hydrolysis by trypsin and 
chymotrypsin. In total, 13 peptides comprising the variant specific AA substitutions at 
positions 67 and 122 could be demonstrated in the digests of the β-CN variants (Table 1). 
Peptides AA 59 to 68, AA 59 to 72, AA 59 to 80, and AA 58 to 80 existed in all 3 variants, with 
a mass shift of about 40 Da between β-CN A1, B, and A2 and with peptide AA 59 to 80 
originating from gastric digestion. Peptid AA 114 to 124 was solely found in the digests of β-
CN A1 and A2. A corresponding peptide (AA 118 to 127) was already present in β-CN B after 
gastric digestion (Table 1). Probably, this peptide was further hydrolyzed to smaller 
fragments than AA 114 to 124 and was, therefore, not detectable in variant B during 
duodenal digestion. The peptides AA 109 to 123 in β-CN B, AA 110 to 125 in β-CN A1 and A2, 
as well as AA 103 to 123 in β-CN B and AA 108 to 129 in β-CN A1 and A2, occurred with 
identical masses but due to the mutation with modifications in their sequences. 
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Figure 3. Identification of peptides derived from gastric (a) and duodenal (b) digestion of β-CN A
1
, A
2
, and B by 
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS; continuous 
lines). Peptides with AA substitutions occurring in all β-CN variants are represented as small dashed lines (-----), 
peptides only present in β-CN B are indicated with dotted lines (……) and peptides detected solely in β-CN A
1 
and A
2
 are shown with large dashed lines (
_ _ _ _
). The positions of the amino acid substitutions and IgE-binding 
epitopes (Figure 3b) are highlighted in bold. 
3. Genetic variants of bovine β- and κ-casein result in different immunoglobulin E-binding epitopes after in vitro 
gastrointestinal digestion 
 69 
Gastric Digestion of κ-CN (Phase 1)  
With the gastric digestion of κ-CN A, B and E 66 congruent peptides with molecular masses 
ranging from 400 to 3,001 Da could be determined. As reported in Figure 4a, 64 of the 66 
peptides were clearly assignable. Peptides were observed in almost all regions of the 
protein, especially in area AA 40 to 66. However, the regions AA 1 to 17 and AA 130 to 169 
gave a low number of peptides. The AA substitutions at positions 136, 148, and 155 resulted 
in the formation of 8 different peptides in the individual variants (Table 2). Peptides AA 130 
to 137 and AA 125 to 137 originated from the digests of all κ-CN variants, with a mass shift of 
about 12 Da, which relies on the replacement of a threonine (T) by an isoleucine (I) at 
position 136 in variant B. This casein variant is characterized by a further substitution at 
position 148, where an aspartic acid (D) is located instead of an alanine (A) as compared with 
variant A and E. Thus, peptides AA 140 to 162 and AA 127 to 151 were only found in κ-CN B. 
These larger fragments contained some missed theoretical cleavage sites of pepsin, maybe 
caused by steric hindrance, limiting the access of pepsin to these areas. Additionally, a more 
degraded peptide (AA 135 to 145) was detected in κ-CN B but a similar peptide (AA 136 to 
149) occurred also in the samples of κ-CN A and E. κ-Casein E differs from κ-CN A and B by a 
glycine (G) instead of a serine (S) at position 155. Obviously, the mutation has no influence 
on the arising peptide pattern, as no peptides comprising the substitution appeared.  
 
Table 2. Identification of peptides with AA substitutions (bold letters) after gastric and duodenal digestion of κ-
CN A, B, and E by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) 
Phase 
Experimental       
mass  
[M + H]
1
 
Theoretical      
mass 
 [M + H]
1
 
Position Sequence 
κ-CN         
variant 
Gastric 
digestion 
(phase 1) 
833.38 833.39 130-137 
130
PTSTPTTE
137 
A, E 
845.44 845.43 130-137 
130
PTSTPTIE
137 
B 
1,120.52 1,120.57 135-145 
135
TIEAVESTVAT
145 
B 
1,290.60 1,290.61 125-137 
125
IASGEPTSTPTTE
137 
A, E 
 1,302.64 1,302.64 125-137 
125
IASGEPTSTPTIE
137 
B 
 1,451.74 1,451.68 136-149 
136
TEAVESTVATLEDS
149 
A, E 
 2,412.21 2,412.20 140-162 
140
ESTVATLEASPEVIESPPEINTV
162 
B 
 2,503.23 2,503.19 127-151 
127
SGEPTSTPTIEAVESTVATLEASPE
151 
B 
Duodenal 
digsestion 
(phase 2) 
1,290.60 1,290.61 125-137 
125
IASGEPTSTPTTE
137 
A, E 
1,302.64 1,302.64 125-137 
125
IASGEPTSTPTIE
137 
B 
1,451.74 1,451.68 136-149 
136
TEAVESTVATLEDS
149 
A, E 
1,714.81 1,714.87 134-150 
134
PTIEAVESTVATLEASP
150 
B 
1
Monoisotopic mass values. 
3. Genetic variants of bovine β- and κ-casein result in different immunoglobulin E-binding epitopes after in vitro 
gastrointestinal digestion 
 70 
However, glycine and serine seemed to be an unspecific substrate for pepsin because 
peptide AA 156 to 161 could be identified in all variants (Figure 3a). Presumably, this is due 
to the decreasing substrate specificity of pepsin at pH >2. 
 
Duodenal digestion of κ-CN (phase 2)  
The MALDI-TOF-MS analysis of the duodenal digests from κ-CN A, B, and E showed the 
presence of 69 common peptides with molecular masses between 402 and 3,123 Da, 
covering most of the whole protein sequence. A precise identification was made for 62 of 
the 69 peptides (Figure 3b). Although almost the same number of peptides existed after 
gastric and duodenal digestion, more fragments in the range from 402 to 1,000 Da were 
observed at the end of this phase, which indicated further degradation of the individual 
casein variants. In contrast, 29 peptides originating from gastric digestion survived the 
duodenal digestion unaltered and did not undergo progressed hydrolysis by the pancreatic 
enzymes. Comparable with gastric digestion, the C-terminal region AA 130 to 169 only 
generated a few peptides and was characterized by variant-specific enzyme cleavages, as the 
positions of the AA substitutions were located there (Table 2). Peptides AA 125 to 137 and 
AA 136 to 149 already arose after gastric digestion and, according to that, they were not 
further broken down, probably due to the missing typical trypsin and chymotrypsin cleavage 
sites. However, in the digests of κ-CN B, peptide AA 134 to 150, corresponding to peptide AA 
136 to 149 of κ-CN A and E, was found and presumably displays a degradation product of the 
gastric peptide AA 127 to 151 (Table 2). 
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Figure 4. Identification of peptides derived from gastric (a) and duodenal (b) digestion of κ-casein (CN) A, B, and 
E by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS; continuous 
lines). Peptides with AA substitutions occurring in all κ-CN variants are represented as small dashed lines (-----), 
peptides only present in κ-CN B are indicated with dotted lines (…….), and peptides detected solely in κ-CN A 
and E are shown with large dashed lines (
_ _ _ _
). The positions of the amino acid substitutions and IgE-binding 
epitopes (Figure 4b) are highlighted in bold. 
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DISCUSSION 
The aim of the present study was to investigate the occurrence and difference of fragments 
containing IgE-binding epitopes after in vitro gastrointestinal digestion of several β- and κ-CN 
variants. As reported for the caseins (Astwood et al., 1996; Fu et al., 2002; Dupont et al., 
2010a), all β- and κ-CN variants were rapidly broken down by pepsin during gastric digestion 
and no intact protein could be detected at the end of this phase. The addition of the 
pancreatic enzymes trypsin and chymotrypsin resulted in further degradation of the casein 
variants and gave a similar but more complex peptide mixture than in phase 1. This is 
consistent with the fact that β- and κ-CN share an open and flexible structure with no 
defined tertiary structure, which makes them very susceptible to all proteases, such as 
pepsin, trypsin, and chymotrypsin (Swaisgood, 1993, 2003). 
During duodenal digestion, β-CN A1, A2, and B were digested to 70 peptide fragments, and κ-
CN A, B, and E were digested to 69 peptide fragments of sizes <3,200 Da, with the longest 
peptides composed of 28 AA. Using a modified model of gastrointestinal digestion, Dupont 
et al. (2010a) also identified 70 peptides after duodenal digestion of β-CN A2, but in the 
range from 561 to 1,730 Da. Almost half of these peptides were consistent with the peptides 
found in the present study. Variations in the peptide pattern of both studies can be 
explained by using a modified form of digestion and a different MS technique in the study of 
Dupont et al. (2010a). In another study about digested raw, pasteurized, and sterilized milk, 
as well as yogurt, only a few peptides were detected for κ-CN, especially in area AA 106 to 
169 compared with the 69 peptides observed in the present study (Dupont et al., 2010b). 
However, this could be due to the fact that Dupont et al. (2010b) used whole milk as well as 
heated and processed dairy products instead of isolated κ-CN fractions applied here. The 
authors suspected that κ-CN from whole or heated milk probably generates heat-induced 
aggregates with whey proteins through the formation of disulfide bridges, which was already 
described by others (Lowe et al., 2004; Patel et al., 2006). This aggregation may be the 
reason for protection of κ-CN from digestion, which was not given in the present study. 
β-Casein contains serine-linked phosphate groups at positions 15, 17, 18, and 19, which are 
clustered and flanked by glutamate residues, whereas κ-CN possesses only 1 site of 
phosphorylation at position 149 but, on the other hand, some sites of glycosylation (121, 
131, 133, 135, 136, 142, and 165; Farrell et al., 2004). It has been shown that peptides 
carrying phosphorylated serine residues can resist in vivo and in vitro gastroduodenal 
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digestion (Meisel et al., 2003; Miquel et al., 2005). Conceivably, this may also apply to the 
glycosylated threonine residues as posttranslational modifications, explaining the low 
number of peptides found in area AA 125 to 169, which is in accordance to other studies, 
where peptide AA 106 to 169 particularly resisted digestion (Ledoux et al., 1999; Dupont et 
al., 2010b). In the present study, the phosphoseryl cluster of β-CN survived within peptide 
AA 15 to 19, although without the flanking glutamate residues. However, this peptide 
resulted from unspecific cleavage of chymotrypsin, which may elucidate why previous 
studies found the phosphoseryl cluster of β-CN in complete form after in vitro digestion 
(Dupont et al., 2010a,b; Picariello et al., 2010). This is of special interest, as 
dephosphorylation of β-CN led to a decreased recognition by IgE antibodies of human sera. 
Therefore, it has been assumed that the major phosphorylation sites act as important 
allergenic epitopes in the caseins (Bernard et al., 2000). Nevertheless, further investigations 
are needed as epitope mapping studies were performed with synthetic peptides lacking a 
phosphorylated form. 
Digested protein fragments must be of sufficient size, being able to sensitize, elicit an allergic 
reaction, and react with IgE antibodies, which requires the presence of intact IgE-binding 
epitopes. It is generally accepted that peptides have to be approximately 3,500 Da to 
possess allergenic potential (Huby et al., 2000; FAO/WHO, 2001). However, a study of 
sensitizing capacity of digested Ara h 1 has shown peptide fragments smaller than 2,000 Da 
inducing a significant antibody response (Bogh et al., 2009). This can also be expected for the 
caseins because, despite their excellent digestibility, they act as potent allergens (Docena et 
al., 1996; Gaudin et al., 2008). Given the fact that fragments up to 28 AA in length survived 
the gastrointestinal digestion of β- and κ-CN variants, a comparison of these peptides with 
the previously identified IgE-binding epitopes of β- and κ-CN was performed (Chatchatee et 
al., 2001; Cerecedo et al., 2008; Lin et al., 2009). The 7 β-CN peptides AA 44 to 60, AA 46 to 
58, AA 69 to 93, AA 78 to 93, AA 106 to 119, AA 144 to 163, and AA 164 to 185 exhibited the 
important IgEbinding epitopes AA 45 to 54, AA 83 to 92, AA 107 to 120, AA 149 to 164, and 
AA 167 to 184 (Figure 3b; Chatchatee et al., 2001). These findings are partially consistent 
with the results of Dupont et al. (2010a,b), which demonstrated solely fragments AA 81 to 
93 and AA 76 to 93, to be long enough to contain the epitope AA 83 to 92 after 
gastrointestinal digestion of β-CN. For κ-CN, the IgE-binding epitopes AA 21 to 44, AA 67 to 
78, AA 95 to 116, and AA 111 to 126 (Figure 4b) survived gastrointestinal digestion within 
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the 4 peptides AA 18 to 42, AA 65 to 81, AA 95 to 120, and AA 106 to 124 (Chatchatee et al., 
2001). In contrast, the κ-CN peptides identified by Dupont et al. (2010b) were too short to 
harbor entire IgE-binding epitopes. Such results were also obtained for other food allergens 
such as the easily digestible peanut allergen Ara h 1, some of whose epitopes were able to 
resist the digestion process (Eiwegger et al., 2006; Bogh et al., 2009, 2012). Furthermore, it 
has been shown that this allergen retains its allergenic potential when digested to smaller 
fragments. The authors attributed this to the peptides forming defined aggregates or to co-
immunization with mixtures of the peptides (Bogh et al., 2012). This could be equally 
probable for casein peptides and would imply an allergenic activity of shorter peptides 
containing no intact IgE-binding epitopes anymore. Among others, this may explain the high 
sensitization rate to the very well and rapidly digestible caseins. 
Although several studies have been done on the in vitro digestion of caseins, none has taken 
into account the genetic polymorphism of milk proteins until now. It had been anticipated 
that the genetic polymorphism, characterized by substitutions and deletions of AA, affect 
the IgE-binding epitope structure of the caseins and thus milk from cows with distinct 
genotypes might show different allergenic properties (Chessa et al., 2008; Caroli et al., 2009; 
Ballabio et al., 2011). 
The present study demonstrated an influence of the genetic polymorphism on the arising 
peptide pattern and the allergenic epitopes of β- and κ-CN variants. For β-CN A1, A2, and B, 
MALDI-TOF-MS analysis enabled the detection of 13 different peptides, which contained the 
variant specific AA substitution. Five of the 7 peptides identified for β-CN A2 were also found 
in the studies of Dupont et al. (2010a,b; Table 1). Gastrointestinal digestion of κ-CN A, B, and 
E showed the presence of 4 distinct peptides comprising the characterizing AA substitution. 
On the other hand, Dupont et al. (2010b) detected only the κ-CN peptides AA 138 to 146 and 
AA 139 to 146 in yogurt and sterilized and pasteurized milk but not in whole raw milk, which 
is presumably attributable to the variations in the conditions of both studies described 
above. 
In addition to these observations, peptides AA 108 to 129 of β-CN A1 and A2, AA 103 to 123 
of β-CN B, as well as AA 59 to 72, AA 59 to 80, and AA 58 to 80 of all 3 variants correspond to 
the IgE-binding epitopes AA 107 to 120 and AA 55 to 70 (Chatchatee et al., 2001). In κ-CN, 
the variant-specific peptides AA 136 to 149 (κ-CN A and E) and AA 134 to 150 (κ-CN B) are 
congruent with the IgE-binding epitope AA 137 to 148 (Chatchatee et al., 2001). It is quite 
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possible that these mutations have an effect on the immunoreactivity of the epitopes, as 
reported by previous studies (Cocco et al., 2003, 2007; Han et al., 2008). It has been shown 
that single or double AA substitutions within peptides representing the core epitopes of β- 
and κ-CN resulted in an elimination or reduction of IgE-binding by pooled sera from CMA 
patients. For epitope AA 55 to 70 of β-CN, IgE binding was eliminated by the substitution of 1 
AA, whereas exchanges at 2 positions were necessary in epitope AA 107 to 120 of β-CN 
(Cocco et al., 2007). This was also demonstrated for epitope AA 137 to 148 of κ-CN, which 
showed a loss of IgE binding after introduction of single-peptide mutations (Han et al., 2008). 
However, in all studies, only the small, neutral and uncharged AA alanine was used for the 
substitutions at the single positions in the distinct epitopes of β- and κ-CN. Nevertheless, the 
genetic variants are characterized by substitutions of different AA, which could give other 
immunoreactions than those observed by Cocco et al. (2003, 2007) and Han et al. (2008). 
Moreover, most AA, which induced a loss of IgE binding, were hydrophobic and located in 
the center of the epitope (Cocco et al., 2003, 2007; Han et al., 2008). According to this, the 
substitution of the hydrophobic proline by the hydrophilic histidine in peptides AA 59 to 72, 
AA 59 to 80, and AA 58 to 80 of β-CN A1 and B might give reduced immunoreactivity 
compared with β-CN A2. The exchange of a hydrophilic AA at position 122 in peptides AA 108 
to 129 of β-CN A1 and A2 as well as AA 103 to 123 of β-CN B occurs out of the core epitope 
AA 107 to 120. Due to the larger fragments and consequently differences in the sequences, 
modifications in the IgE binding to both peptides can be expected. In contrast to peptide AA 
136 to 149 of κ-CN A and E, a reduction in IgE binding might be conceivable for peptide AA 
134 to 150 of κ-CN B, where the hydrophilic threonine and aspartic acid at positions 136 and 
148 of variant A and E, respectively, are replaced by the hydrophobic isoleucine and the 
neutral alanine. Thus, investigations are needed to gain knowledge about the effect of the 
mutations on the allergenic potential of these epitopes and, as a consequence, of the whole 
protein. Moreover, a large reservoir of genetic variants exists within β- and κ-CN, as further 
AA substitutions than included in this study occur in both proteins. In this context, it would 
be of great importance to consider cattle breeds threatened by extinction because they can 
possess rare variants, such as κ-CN G, which are not represented in the main breeds. This 
variant was first discovered in the endangered breed Pinzgauer and could not be found in 
another population until now (Erhardt, 1996). Such rare genetic variations are of significant 
physiological relevance, as they may differ in their allergenic properties from the main 
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variants. However, several unknown factors exist in the protein chemistry as well as the 
immune response and regulation. Taken together with the high number of epitopes 
occurring in the caseins, hypoallergenic activity of genetic variants cannot be assumed in 
general. 
 
CONCLUSIONS 
It has been demonstrated that in vitro gastrointestinal digestion of several β- and κ-CN 
variants gave rise to a considerable number of peptides, some of which containing intact 
IgE-binding epitopes. As a consequence of the genetic polymorphism, differences between 
specific peptides and hence epitopes of the single variants could be identified, which may 
influence the allergenicity of these proteins. Thus, the next step will be to investigate the 
allergenic potential of these peptides in a future study by using protein microarray 
technology. The results of the present study showed that the genetic polymorphism needs 
to be taken into account when evaluating the allergenic potential of milk proteins. 
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ABSTRACT 
The allergenicity of the caseins (CN), one of the major allergens in cow milk, is well 
characterized and their immunoglobulin E (IgE)-binding epitopes have been identified. 
However, investigations about the allergenic potential of the genetic variants occurring in 
the caseins are lacking. Therefore, this study determined the influence of the genetic 
polymorphism on IgE binding to epitopes of bovine casein variants. Furthermore, differences 
in IgE binding between epitopes of goats and water buffaloes were analyzed. A set of 187 
peptides, covering the previously identified sequential IgE-binding epitopes of αS1-, αS2-, β-, 
and κ-CN variants from cows and the corresponding homologous peptides of water buffaloes 
and goats, were synthesized and tested by means of peptide microarray for IgE binding, 
using sera from 16 cow milk-sensitized individuals. Seven of the 16 sera samples showed 
positive signals on microarrays and were included in this study. In 5 αS1-CN variants (A, B, C, 
E, and I), the AA substitution or deletion affected the immunoreactivity of epitopes AA 4 to 
23, AA 17 to 36, AA 83 to 102, AA 173 to 192, and AA 175 to 194, as well as of the variant-
specific peptides AA 184 to 196, AA 187 to 199, AA 174 to 193, and AA 179 to 198, which 
were found to resist gastrointestinal digestion. Variation in IgE binding was further detected 
for peptides AA 103 to 123 and AA 108 to 129 of 3 β-CN variants (A1, A2, and B). The majority 
of sera showed IgE binding to αS1-CN peptides of cows and the homologous counterpart of 
goats and water buffaloes. However, αS1- and β-CN epitopes from goats and water buffaloes 
had lower immunoreactivity than those of cows, but, in some cases, higher or exclusive IgE 
binding was observed. The results of this study indicate that genetic variants of the caseins 
differ in their allergenicity. This might be useful in the search for a suitable protein source for 
cow milk-allergic patients. In addition, milk from water buffaloes and goats harbor an 
allergenic potential due to cross-reactivity of IgE antibodies with cow milk caseins and are, 
therefore, not an acceptable alternative in the nutrition of cow milk-allergic patients. 
Key words: casein variant, immunoglobulin E epitope, milk allergy, peptide microarray 
 
INTRODUCTION 
From a nutritional point of view, cow milk gains considerable attention, as it provides a wide 
range of essential nutrients, in particular proteins, fat, vitamins, and minerals. In contrast, 
cow milk belongs to the most common nutritive source of allergens during infancy and early 
childhood. Cow milk allergy (CMA) affects 2 to 3% of infants (Skripak et al., 2007) and 
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approximately 0.1% of adults (Osterballe et al., 2005) who are typically sensitized to several 
cow milk proteins (CMP). The majority of children with CMA achieve tolerance toward cow 
milk, although the age of clinical recovery has differed among various studies (Savilahti and 
Savilahti, 2013). Reports suggest that in most children, CMA resolves by 3 to 5 yr of age, but 
outgrowing CMA can develop even later (Skripak et al., 2007; Savilahti and Savilahti, 2013). 
Cow milk allergy is mostly mediated by milk protein-specific IgE antibodies that react with 
the allergenic epitopes on milk proteins. The 4 caseins αS1-, αS2-, β-, and κ-CN were 
confirmed to be the major allergens in cow milk, with αS1-CN found to be more allergenic 
than αS2-, β-, and κ-CN (Shek et al., 2005; Gaudin et al., 2008). By using SPOT-membrane- 
based or microarray immunoassays and sera from CMA patients, a large number of IgE-
binding epitopes 8 to 24 AA in length have been identified in the 4 caseins (Chatchatee et al., 
2001a,b; Busse et al., 2002, Cerecedo et al., 2008; Lin et al., 2009). Recent studies 
demonstrated that peptides resulting from in vitro gastrointestinal digestion of milk proteins 
still contain some of these IgE-binding epitopes (Dupont et al., 2010a,b; Lisson et al., 2013, 
2014). This might provide an explanation for the high sensitization rate to the caseins, even 
though they are very rapidly digestible proteins. 
Within the caseins, noticeable genetic variation has been identified, which is caused by 
substitutions or deletions of AA. So far, a total of 39 casein variants have been determined 
on the protein and DNA level, with important differences among species and breeds within 
the Bos genus (Caroli et al., 2009). 
To date, the only treatment for CMA is strict avoidance of CMP. This is very difficult, as milk 
proteins are used as additives or processing aids and, therefore, a large number of food 
products contain remaining amounts of CMP. Furthermore, infant formulas based on CMP 
still may provoke allergic reactions in selected patients, as residual allergenic activity has 
been reported in partially and extensively hydrolyzed formulas (Ragno et al., 1993; de 
Boissieu et al., 1997; Hoffman and Sampson, 1997). Moreover, CMP hydrolysates are 
disadvantaged by their bitter taste and the requirement of additional emulsifiers. Thus, the 
identification of a suitable protein source as well as the search for options to eliminate the 
allergenicity in milk products or infant formulas is of great importance. Genetic variants of 
milk proteins are not considered when discussing the allergenic potential of bovine milk. 
However, detection of CMP variants with reduced allergenicity may contribute to find 
adequate alternatives for allergic patients. Genetic polymorphisms of milk proteins are of 
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increasing interest in animal breeding because of their significant effect on milk production 
traits and on cheese-making properties (Martin et al., 2002; Heck et al., 2009). In addition, 
milk protein variants are also important in human nutrition, as they represent a reservoir of 
bioactive peptides (angiotensin I-converting enzyme inhibitory peptides, casomorphins, and 
caseinophosphopeptides), which affect the nutritional value of milk (Jinsmaa and Yoshikawa, 
1999; Weimann et al., 2009; Tulipano et al., 2010). 
On the basis of the allergenic epitopes previously identified, the present study investigated 
the influence of the genetic polymorphisms on the IgE-binding properties of epitopes from 
αS1-, αS2-, β-, and κ-CN variants. This study also aimed to determine if variant-specific casein 
peptides resisting in vitro gastrointestinal digestion still retain IgE-binding properties and 
differ in their allergenic potential. In addition, differences in IgE binding between epitopes of 
2 mammalian species (goats and water buffaloes) were analyzed because there has been an 
increasing focus on the use of proteins from non-bovine milk as a possible alternative to cow 
milk. 
 
MATERIALS AND METHODS 
Sera from Patients with CMA 
The screening was performed with sera from 16 patients (6 females, 8 males, and 2 
unknown; 8 mo to 52 yr old) who had a positive skin prick test reaction to cow milk or 
specific IgE antibodies to cow milk, or both. The sera were obtained from the University 
Hospitals Bonn and Marburg (Germany). The patients had milk-specific IgE antibodies 
ranging from 4.5 to >100 kUA/L (where UA = allergen-specific units), as measured with the 
ImmunoCAP System (Thermo Scientific, Freiburg, Germany). Only 7 (1 female, 5 males, and 1 
unknown; 8 mo to 35 yr old; IgE >100 kUA/L) of the 16 sera, which were characterized by an 
IgE titer ≥95.5 kUA/L, showed positive signals on microarray and were included in the 
current study. This study was approved by the local ethical review committees of the Justus-
Liebig-University Giesen and the University of Bonn, Germany. 
 
Synthesis and Printing of Casein Peptides  
To investigate the role of genetic polymorphism as well as interspecies differences on the 
epitope structure, a set of 187 peptides, 11 to 20 AA in length, covering the previously 
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determined sequential IgE-binding epitopes of αS1-, αS2-, β-, and κ-CN variants from cows and 
the corresponding homologous peptides of water buffaloes and goats as well as casein 
peptide variants, which were shown to resist gastrointestinal digestion (Lisson et al. 2013, 
2014), were synthesized as described below (Table 1). Moreover, 36 peptides were 
synthesized with a phosphorylated serine residue and 1 peptide with a phosphorylated 
threonine residue. A total of 9 of these 37 peptides were spotted on the microarray without 
the phosphorylation to study the influence of posttranslational modifications on the 
immunoreactivity of the epitopes (Table 1). All peptides were synthesized in a stepwise 
manner on a cellulose membrane by using the SPOT synthesis technology (Frank and 
Overwin, 1996; Wenschuh et al., 2000). The peptide library and 3 control spots (human IgG, 
mouse IgE, and human IgE) were spotted in triplicate on each glass slide using a microarray 
printing system (JPT Peptide Technologies GmbH, Berlin, Germany). This gave a general 
microarray layout with 3 identical subarrays. 
 
IgE-Binding Assays 
The determination of peptide antibody binding was performed by RepliTope analysis (JPT 
Peptide Technologies GmbH). The array slides were first incubated with blocking buffer 
(SmartBlock; Candor Bioscience GmbH, Wangen, Germany) for 60 min. Then, they were 
placed into a microarray processing station (Tecan HS4800; Tecan Group Ltd., Männedorf, 
Switzerland) and incubated with 200 μL of the patient’s serum, diluted 1:100 in diluent 
buffer [SuperBlock Tris-buffered saline (TBS); Pierce International, Rockford, IL], and with 
diluent buffer only as control for 2 h. Subsequently, the peptide microarray was washed 3 
times with 50 mM TBS buffer, including 0.1% Tween 20 (pH 7.2). Specific human IgE binding 
was detected by incubation with SureLight allophycocyanin-labeled secondary antihuman 
IgE (Abcam, Cambridge, UK) at a final concentration of 1 μg/mL in diluent buffer. Control 
incubation with secondary antibody only was performed in parallel. Afterward, 3 washing 
steps with 50 mM TBS buffer, including 0.1% Tween 20 (pH 7.2) were carried out, which 
were followed by a washing step with 3 mM saline-sodium citrate buffer (pH 7.0). Finally, 
peptide microarrays were dried using a nitrogen stream. 
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Table 1. The AA sequence of peptides spotted on the microarray 
No. Protein 
Position 
(AA no.) 
Sequence
1
 
Source of  
selected 
peptides
2
 
1 αs1-CN B cow 1-15 RPKHPIKHQGLPQEV 1 
2 αs1-CN goat 1-15 RPKHPINHRGLSPEV 1 
3 αs1-CN water buffalo 1-15 RPKQPIKHQGLPQGV 1 
4 αs1-CN B cow, water buffalo 17-36 NENLLRFFVAPFPEVFGKEK
3
 1 
5 αs1-CN A cow 4-23 HPIKHQGLPQPFPEVFGKEK 2 
6 αs1-CN goat 17-36 NENLLRFVVAPFPEVFRKEN 1 
7 αs1-CN B cow 34-48 KEKVNELSKDIGSES
3
 1 
8 αs1-CN goat 34-48 KENINELSKDIGSES 1 
9 αs1-CN water buffalo 34-48 KEKVNELSTDIGSES 1 
10 αs1-CN B cow, water buffalo 49-63 TEDQAMEDIKQMEAE
4
 1, 4 
11 αs1-CN D cow  49-63 TEDQ-pT-MEDIKQMEAE 2, 4 
12 αs1-CN E cow  49-63 TEDQAMEDIKKMEAE 2, 4 
13 αs1-CN H cow 45-59 GSESTEQMEAESISS 2 
14 αs1-CN goat 49-63 TEDQAMEDAKQMKAG 1, 4 
15 αs1-CN B cow 64-78 SISSSEEIVPNSVEQ
3
 1 
16 αs1-CN F cow  64-78 SILSSEEIVPNSVEQ 2 
17 αs1-CN goat 64-78 SSSSSEEIVPNSAEQ 1 
18 αs1-CN water buffalo 64-78 SISSSEEIVPISVEQ 1 
19 αs1-CN B cow, water buffalo, 
goat 
83-102 
 
KEDVPSERYLGYLEQLLRLK
3
  
 
1 
20 αs1-CN I cow 83-102 KDDVPSERYLGYLEQLLRLK 2 
21 αs1-CN B cow 106-120 VPQLEIVPN-pS-AEERL
3
 1, 4 
22 αs1-CN goat 106-120 VPQLEIVPK-pS-AEEQL 1, 4 
23 αs1-CN water buffalo 106-120 VPQLEIVPNLAEEQL 1, 4 
24 αs1-CN B cow, water buffalo 121-135 HSMKEGIHAQQKEPM
3
 1 
25 αs1-CN goat 121-135 HSMKEGNPAHQKQPM 1 
26 αs1-CN B cow 139-154 NQELAYFYPELFRQFY
3
 1 
27 αs1-CN water buffalo, goat 139-154 NQELAYFYPQLFRQFY 1 
28 αs1-CN B cow 159-174 YPSGAWYYVPLGTQYT
3
 1 
29 αs1-CN goat 159-174 YPSGAWYYLPLGTQYT 1 
30 αs1-CN water buffalo 159-174 YPSGAWYYVPLGTQYP 1 
31 αs1-CN B cow 173-192 YTDAPSFSDIPNPIGSENSE
3
 1 
32 αs1-CN C, E cow, goat 173-192 YTDAPSFSDIPNPIGSENSG 1, 2 
33 αs1-CN water buffalo 173-192 YPDAPSFSDIPNPIGSENSG 1 
34 αs1-CN B cow 175-194 DAPSFSDIPNPIGSENSEKT
3
 1 
35 αs1-CN C, E cow, goat 175-194 DAPSFSDIPNPIGSENSGKT 1, 2 
36 αs1-CN water buffalo 175-194 DAPSFSDIPNPIGSENSGKT 1 
37 αs1-CN B cow 184-196 NPIGSENSEKTTM
5
 3 
38 αs1-CN B cow 187-199 GSENSEKTTMPLW
5
 3 
39 αs1-CN C cow 187-199 GSENSGKTTMPLW
5
 3 
40 αs1-CN B cow 180-193 SDIPNPIGSENSEK
5
 3 
41 αs1-CN C cow 180-193 SDIPNPIGSENSGK
5
 3 
42 αs1-CN B cow 174-193 TDAPSFSDIPNPIGSENSEK
5
 3 
43 αs1-CN C cow 179-198 FSDIPNPIGSENSGKTTMPL
5
 3 
44 αs2-CN A cow 1-20 KNTMEHVSSSEESIISQETY
6
 1 
    Continued 
4. Immunoglobulin E epitope mapping by microarray immunoassay reveals differences in immune response to 
genetic variants of caseins from different ruminant species 
 88 
Table 1 (Continued). The AA sequence of peptides spotted on the microarray 
No. Protein 
Position 
(AA no.) 
Sequence
1
 
Source of  
selected 
peptides
2
 
45 αs2-CN B cow 1-20 KNTMEHVFSSEESIISQETY 2 
46 αs2-CN goat 1-20 KHKMEHVSSSEEPINIFQEI 1 
47 αs2-CN goat 2-21 HKMEHVSSSEEPINIFQEIY 1 
48 αs2-CN water buffalo 1-20 KHTMEHVSSSEESIISQETY 1 
49 αs2-CN A cow 13-32 SIISQETYKQEKNMAINPSK
6
 1 
50 αs2-CN A cow 14-33 IISQETYKQEKNMAINPSKE
6
 1 
51 αs2-CN C cow 13-32 SIISQETYKQEKNMAINPSK 2 
52 αs2-CN C cow 14-33 IISQETYKQEKNMAINPSKG 2 
53 αs2-CN A cow 31-45 -pS-KENLCSTFCKEVVR
7
 1 
54 αs2-CN C cow 31-45 -pS-KGNLCSTFCKEVVR 2 
55 αs2-CN A cow 42-56 EVVRNANEEEYSIG-pS-
7
 1,4 
56 αs2-CN C cow 42-56 EVVRNTNEEEYSIG-pS- 2, 4 
57 αs2-CN D cow 42-56 EVVRNANEEESAEVA 2, 4 
58 αs2-CN A cow 57-71 SSEESAEVATEEVKI 1 
59 αs2-CN D cow 48-62 NEEESAEVATEEVKI 2 
60 αs2-CN A cow 67-86 EEVKITVDDKHYQKALNEIN
4,6
 1 
61 αs2-CN A cow 83-100 NEINQFYQKFPQYLQYLY
7
 1 
62 αs2-CN A cow 93-108 PQYLQYLYQGPIVLNP
7
 1 
63 αs2-CN A cow 105-119 VLNPWDQVKRNAVPI
7
 1 
64 αs2-CN A cow 117-131 VPITPTLNREQLSTS
7
 1 
65 αs2-CN C cow 117-131 VPITPTLNREQLSIS 2 
66 αs2-CN A cow 130-144 TSEENSKKTVDMEST
6
 1 
67 αs2-CN C cow 130-144 ISEENSKKTVDMEST 2 
68 αs2-CN A cow 143-158 -pS-TEVFTKKTKLTEEEK
7
 1 
69 αs2-CN A cow 157-172 EKNRLNFLKKISQRYQ
7
 1 
70 αs2-CN A cow 165-184 KKISQRYQKFALPQYLKTVY
7
 1 
71 αs2-CN A cow 169-188 QRYQKFALPQYLKTVYQHQK
7
 1 
72 αs2-CN A cow 191-205 KPWIQPKTKVIPYVR
7
 1 
73 αs2-CN A cow 7-26 VSSSEESIISQETYKQEKNM
5
 3 
74 αs2-CN A cow 10-29 SEESIISQETYKQEKNMAIN
5
 3 
75 αs2-CN B cow 1-20 KNTMEHVFSSEESIISQETY
5
 3 
76 αs2-CN B cow 3-22 TMEHVFSSEESIISQETYKQ
5
 3 
77 αs2-CN B cow 9-21 SSEESIISQETYK
5
 3 
78 β-CN A
2 
cow, water buffalo 1-18 RELEELNVPGEIVESLSS
8
 1 
79 β-CN D cow 1-18 RELEELNVPGEIVESLSK 2 
80 β-CN goat 1-18 REQEELNVVGETVESLSS 1 
81 β-CN A
2 
cow 16-35 LSSSEESITRINKKIEKFQ-pS-
4
 1, 4 
52 β-CN A
2 
cow  18-37 SSEESITRINKKIEKFQ-pS-EE
4
 1, 4 
83 β-CN D cow  16-35 LSKSEESITRINKKIEKFQ-pS- 2, 4 
84 β-CN D cow 18-37 KSEESITRINKKIEKFQ-pS-EE 2, 4 
85 β-CN H
1
 cow 16-35 LSSSEESITCINKKIEKFQ-pS- 2, 4 
86 β-CN H
1
 cow  18-37 SSEESITCINKKIEKFQ-pS-EE 2, 4 
87 β-CN C cow  16-35 LSSSEESITRINKKIEKFQS 2, 4 
88 β-CN C cow 18-37 SSEESITRINKKIEKFQSEK 2, 4 
89 β-CN E cow 16-35 LSSSEESITRINKKIEKFQ-pS- 2, 4 
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Table 1 (Continued). The AA sequence of peptides spotted on the microarray  
No. Protein 
Position 
(AA no.) 
Sequence
1
 
Source of  
selected 
peptides
2
 
90 β-CN E cow  18-37 SSEESITRINKKIEKFQ-pS-KE 2, 4 
91 β-CN goat, water buffalo 16-35 LSSSEESITHINKKIEKFQ-pS- 1, 4 
92 β-CN goat, water buffalo 18-37 SSEESITHINKKIEKFQ-pS-EE 1, 4 
93 β-CN A
2 
cow, goat 34-50 Q-pS-EEQQQTEDELQDKIH
6
 1, 4 
94 β-CN C
 
cow 34-50 QSEKQQQTEDELQDKIH 2, 4 
95 β-CN E cow  34-50 Q-pS-KEQQQTEDELQDKIH 2, 4 
96 β-CN water buffalo  34-50 Q-pS-EEQQQMEDELQDKIH 1, 4 
97 β-CN A
2 
cow 42-56 EDELQDKIHPFAQTQ
8
 1 
98 β-CN A
2 
cow 55-72 TQSLVYPFPGPIPNSLPQ
8
 1 
99 β-CN A
1
, B, C, F, G
 
cow 55-72 TQSLVYPFPGPIHNSLPQ 2 
100 β-CN H
2
 cow  55-72 TQSLVYPFPGPIPNSLPE 2 
101 β-CN goat 55-72 AQSLVYPFTGPIPNSLPQ 1 
102 β-CN water buffalo 55-72 TQSLVYPFPGPIPKSLPQ 1 
103 β-CN A
2
, water buffalo 70-84 LPQNIPPLTQTPVVV 1 
104 β-CN H
2
 cow  70-84 LPENIPPLTQTPVVV 2 
105 β-CN goat 70-84 LPQNILPLTQTPVVV 1 
106 β-CN A
2 
cow 83-97 VVPPFLQPEVMGVSK
8
 1 
107 β-CN H
1
 cow 83-97 VVPPFIQPEVMGVSK 2 
108 β-CN H
2
, I cow 83-97 VVPPFLQPEVLGVSK 2 
109 β-CN goat 83-97 VVPPFLQPEIMGVPK 1 
110 β-CN water buffalo 83-97 VVPPFLQPEIMGVSK 1 
111 β-CN A
2 
cow, water buffalo 95-109 VSKVKEAMAPKHKEM 1 
112 β-CN A
3
 cow 95-109 VSKVKEAMAPKQKEM 2 
113 β-CN goat 95-109 VPKVKETMVPKHKEM 1 
114 β-CN A
2 
cow, goat, water buffalo 106-122 HKEMPFPKYPVEPFTES
8
 1 
115 β-CN A
3
 cow 106-122 QKEMPFPKYPVEPFTES 2 
116 β-CN B cow 106-122 HKEMPFPKYPVEPFTER 2 
117 β-CN A
2 
cow, water buffalo 121-135 ESQSLTLTDVENLHL
6
 1 
118 β-CN B cow 121-135 ERQSLTLTDVENLHL 2 
119 β-CN goat 121-135 ESQSLTLTDVEKLHL 1 
120 β-CN A
2 
cow 135-149 LPLPLLQSWMHQPHQ
8
 1 
121 β-CN G cow 135-149 LPLLLLQSWMHQPHQ 2 
122 β-CN water buffalo 135-149 LPLPLLQSWMHQPPQ 1 
123 β-CN goat  135-149 LPLPLVQSWMHQPPQ 1 
124 β-CN A
2 
cow, water buffalo 149-164 QPLPPTVMFPPQSVLS
8
 1 
125 β-CN B cow 149-164 QPLLPTVMFPPQSVLS 2 
126 β-CN goat 149-164 QPLSPTVMFPPQSVLS 1 
127 β-CN A
2 
cow, water buffalo 167-184 QSKVLPVPQKAVPYPQRD
8
 1 
128 β-CN goat 167-182 QPKVLPVPQKAVPQRD 1 
129 β-CN A
2 
cow, goat, 
water buffalo 
185-204 
 
MPIQAFLLYQEPVLGPVRGP
8
 
 
1 
130 β-CN A
2 
, A
1 
cow 114-124 YPVEPFTESQS
9
 3 
131 β-CN A
2 
cow 59-72 VYPFPGPIPNSLPQ
9
 3 
132 β-CN B
 
, A
1 
cow 59-72 VYPFPGPIHNSLPQ
9
 3 
133 β-CN A
2 
cow 59-78 VYPFPGPIPNSLPQNIPPLT
9
 3 
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Table 1 (Continued). The AA sequence of peptides spotted on the microarray 
No. Protein 
Position 
(AA no.) 
Sequence
1
 
Source of  
selected 
peptides
2
 
134 β-CN A2 cow 61-80 PFPGPIPNSLPQNIPPLTQT
9
 3 
135 β-CN B
 
, A
1 
cow 59-78 VYPFPGPIHNSLPQNIPPLT
9
 3 
136 β-CN B
 
, A
1 
cow 61-80 PFPGPIHNSLPQNIPPLTQT
9
 3 
137 β-CN A
2 
, A
1 
cow 110-125 PFPKYPVEPFTESQSL
9
 3 
138 β-CN B
 
cow 109-123 MPFPKYPVEPFTERQ
9
 3 
139 β-CN A
2 
, A
1 
cow 108-127 EMPFPKYPVEPFTESQSLTL
9
 3 
140 β-CN A
2 
, A
1 
cow 110-129 PFPKYPVEPFTESQSLTLTD
9
 3 
141 β-CN B
 
cow 103-122 APKHKEMPFPKYPVEPFTER
9
 3 
142 β-CN B
 
cow 104-123 PKHKEMPFPKYPVEPFTERQ
9
 3 
143 κ-CN A cow 1-15 QEQNQEQPIRCEKDE 1 
144 κ-CN F
2
 cow 1-15 QEQNQEQPIHCEKDE 2 
145 κ-CN A cow 9-26 IRCEKDERFFSDKIAKYI
8
 1 
146 κ-CN F
2
 cow 9-26 IHCEKDERFFSDKIAKYI 2 
147 κ-CN A cow 24-43 KYIPIQYVLSRYPSYGLNYY
8
 1 
148 κ-CN A cow 25-44 YIPIQYVLSRYPSYGLNYYQ
8
 1 
149 κ-CN A cow 34-53 RYPSYGLNYYQQKPVALINN
6
 1 
150 κ-CN A cow 49-68 ALINNQFLPYPYYAKPAAVR
8
 1 
151 κ-CN A cow 66-80 AVRSPAQILQWQVLS
8
 1 
152 κ-CN A cow 79-94 LSNTVPAKSCQAQPTT 1 
153 κ-CN A cow 95-114 MARHPHPHLSFMAIPPKKNQ
8
 1 
154 κ-CN A cow 97-116 RHPHPHLSFMAIPPKKNQDK
8
 1 
155 κ-CN G
1
 cow 95-114 MACHPHPHLSFMAIPPKKNQ 2 
156 κ-CN G
1
 cow 97-116 CHPHPHLSFMAIPPKKNQDK 2 
157 κ-CN C, D cow 95-114 MAHHPHPHLSFMAIPPKKNQ 2 
158 κ-CN C, D cow 97-116 HHPHPHLSFMAIPPKKNQDK 2 
159 κ-CN I cow 95-114 MARHPHPHLAFMAIPPKKNQ 2 
160 κ-CN I cow 97-116 RHPHPHLAFMAIPPKKNQDK 2 
161 κ-CN A cow 111-126 KKNQDKTEIPTINTIA
8
 1 
162 κ-CN A cow 125-139 IA-pS-GEPTSTPTTEAV 1 
163 κ-CN H cow 125-139 IA-pS-GEPTSTPITEAV 2 
164 κ-CN B, B
2
, C, F
2
, G
1
, J cow 125-139 IA-pS-GEPTSTPTIEAV 2 
165 κ-CN A cow 134-148 PTTEAVESTVATLED
8
 1 
166 κ-CN H cow 134-148 PITEAVESTVATLED 2 
167 κ-CN B, B
2
, C, F
2
, G
1
, J cow 134-148 PTIEAVESTVATLEA 2 
168 κ-CN G
2
 cow 134-148 PTTEAVESTVATLEA 2 
169 κ-CN F
1
 cow 134-148 PTTEAVESTVATLEV 2 
170 κ-CN A cow 146-160 LED-pS-PEVIESPPEIN 1 
171 κ-CN B, C, F
2
, G
1
, G
2
, J cow 146-160 LEA-pS-PEVIESPPEIN 2 
172 κ-CN F
1
 cow 146-160 LEV-pS-PEVIESPPEIN 2 
173 κ-CN B
2
 cow 146-160 LEA-pS-PEVTESPPEIN 2 
174 κ-CN E cow 146-160 LED-pS-PEVIEGPPEIN 2 
175 κ-CN J cow 146-160 LED-pS-PEVIERPPEIN 2 
176 κ-CN A cow 149-168 -pS-PEVIESPPEINTVQVTSTA
8
 1 
177 κ-CN B
2
 cow 149-168 -pS-PEVTESPPEINTVQVTSTA 2 
178 κ-CN E cow 149-168 -pS-PEVIEGPPEINTVQVTSTA 2 
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Table 1 (Continued). The AA sequence of peptides spotted on the microarray 
No. Protein 
Position 
(AA no.) 
Sequence
1
 
Source of  
selected 
peptides
2
 
179 κ-CN J cow 149-168 -pS-PEVIERPPEINTVQVTSTA 2 
180 κ-CN A, E cow 125-137 IASGEPTSTPTTE
9
 3 
181 κ-CN B
 
cow 125-137 IASGEPTSTPTIE
9
 3 
182 κ-CN A cow 146-157 LED-pS-PEVIESPP
9
 3 
183 κ-CN E cow 147-160 EDSPEVIEGPPEIN
9
 3 
184 κ-CN A cow 148-159 D-pS-PEVIESPPEI
9
 3 
185 κ-CN A, E cow 136-149 TEAVESTVATLED-pS-
9
 3, 4 
186 κ-CN A, E cow 136-149 TEAVESTVATLEDS
9
 3, 4 
187 κ-CN B
 
cow 134-150 PTIEAVESTVATLEASP
9
 3 
1
Peptides previously reported as IgE-binding epitopes are underlined. Phosphorylated peptides are indicated as 
-pS- or -pT-. 
2
1 = peptides described in cattle; 2 = bovine genetic variant; 3 = peptides resisting gastrointestinal digestion;     
4 = peptides with different phosphorylation levels.  
3
Chatchatee et al. (2001a). 
4
Lin et al. (2009). 
5
Lisson et al. (2014). 
6
Cerecedo et al. (2008). 
7
Busse et al. (2002).                             
8
Chatchatee et al. (2001b).  
9
Lisson et al. (2013). 
 
Signal Detection and Data Analysis 
The peptide microarrays were scanned with the GenePix Scanner 4300SL50 (Axon 
Instruments, Concord, ON, Canada). Images were saved electronically in tagged image file 
format (*.tif). Image analysis was performed using the spot-recognition software GenePix 
Pro 6.1 (Axon Instruments), which showed the signal intensity (light units) as single 
measurements for each peptide. Each spot feature was analyzed for total intensity and 
background intensity. For data tables and diagrams, the mean value of all 3 instances on the 
microarray was calculated. In case the standard deviation divided by the mean value was 
larger than 0.5, the mean of the 2 closest values was used instead. Negative controls were 
used to define background noise. The fluorescent intensity of each peptide was determined 
by subtracting the mean intensity of the corresponding peptide spots from control 
incubation without serum. Immunoglobulin E binding was considered positive if signal 
intensities were above the lower limit of detection, meaning that ratios of signal-to-
background noise intensities were greater than a minimum threshold of 1.5. 
 
4. Immunoglobulin E epitope mapping by microarray immunoassay reveals differences in immune response to 
genetic variants of caseins from different ruminant species 
 92 
RESULTS 
Identification of IgE-Binding Epitopes in Patient Sera Samples 
Among the sera samples tested in this study, IgE binding to at least 1 of the casein peptides 
occurred in all samples. A total of 46 casein peptides (27 αS1-CN peptides, 13 β-CN peptides, 
and 6 κ-CN peptides) were recognized by IgE antibodies from the different sera samples 
(Figure 1a, b, and c). All sera showed IgE binding to αS1-CN peptides. It was the most 
frequently detected milk allergen, whereas no significant IgE binding was found for αS2-CN 
peptides. The αS1-CN peptides AA 17 to 36, AA 139 to 154, AA 173 to 192, and AA 175 to 194 
of cows, goats, and water buffaloes reacted with IgE antibodies from at least 50% of the 
patient sera samples and, thus, represented the major IgE-binding epitopes (Figure 1a). The 
αS1-CN peptides AA 83 to 102, AA 159 to 174, AA 174 to 193, and AA 175 to 194 from cows 
were recognized by 3 of the 7 positive sera. The αS1-CN peptides AA 4 to 23 (cow), AA 83 to 
102 (goat and water buffalo), AA 179 to 198 (cow), and the β-CN peptide AA 16 to 35 (goat 
and water buffalo), as well as the κ-CN peptides AA 24 to 43 (cow) and AA 25 to 44 (cow) 
were identified in 2 sera samples (Figure 1a, b, and c). The other peptides of αS1-, β-, and κ-
CN, giving positive signals on the microarray, displayed only binding to individual sera, 
particularly to serum 4. 
Only in 1 serum was an influence observed of the posttranslational modification on the 
immunoreactivity of the epitopes for the αS1-CN peptide AA 106 to 120 of the water buffalo 
(Figure 3a). The IgE response to the peptide lacking the phosphorylated serine residue was 
86% higher than to the phosphorylated peptides of cows and goats. The other sera showed 
no variation in the immunoreactivity between the peptides carrying phosphorylated serine 
residues or not. 
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Figure 1. Immunoglobulin E binding pattern of cow milk-allergic patients to peptides of αS1-CN (a), β-CN (b), and 
κ-CN (c) from cows, goats, and water buffaloes. The bars indicate the percentage of sera showing IgE binding to 
peptides (represented by AA residues, number, and species). c = cow, g = goat, wb = water buffalo.  
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Identification of Variant-Specific Differences on the Epitope Structure  
The genetic variation affects the IgE-binding epitope structure of the caseins without 
inducing changes in IgE binding by the majority of sera (Table 2; Figure 2). Nevertheless, as 
indicated in Figure 2, some of the mutated epitopes led to abrogation or decreased or 
increased IgE binding in individual sera (≥15% of IgE binding remaining compared with the 
reference peptide). 
In 4 αS1-CN variants (A, C, E, and I), 1 deletion and 3 AA exchanges influenced the 
immunoreactivity of 5 epitopes (Figure 2a). Due to the deletion of AA 14 to 26 in αS1-CN A, 
epitope AA 4 to 23 differs in 10 AA from the reference epitope AA 17 to 36 in αS1-CN B. Thus, 
for peptide AA 4 to 23 of αS1-CN A, a loss of IgE binding could be observed in serum 5, a 
decrease in IgE binding in serum 2, and an increase in IgE binding in serum 4 compared with 
the reference peptide. Serum 6 reacted only with the peptide of αS1-CN A, but showed no IgE 
binding to the reference peptide.  
The AA substitutions characterizing epitopes AA 83 to 102 of αS1-CN I as well as AA 173 to 
192 and AA 175 to 194 of αS1-CN C and E resulted in a loss of IgE binding in serum 3 and 
increased IgE binding in sera 2, 3, 4, and 7. In contrast to peptides AA 173 to 192 and AA 175 
to 194 of αS1-CN C and E, IgE binding to the corresponding peptides of αS1-CN B was 
eliminated by the AA substitution occurring at position 192 (sera 2 and 6). In 3 sera, the AA 
exchanges had no significant effect on the immunoreactivity of epitopes AA 64 to 78 (serum 
4), AA 173 to 192 (sera 2 and 4), and AA 175 to 194 (sera 4 and 6). Both the mutated peptide 
as well as the reference peptide displayed similar IgE-binding intensities on the peptide 
microarray (Figure 2a). 
Five of the 7 peptides resulting from gastrointestinal digestion of αS1-CN B and C showed 
positive IgE binding on the microarray in 3 sera (Figure 2a). The AA substitution did not cause 
a change in the immunoreactivity of peptides AA 180 to 193 of αS1-CN B and C in serum 4. 
However, important differences in IgE binding were detected for peptides AA 187 to 199 and 
179 to 198 of αS1-CN C and the corresponding peptides of αS1-CN B because sera 4, 6, and 7 
revealed significantly higher or exclusive IgE binding to peptides of αS1-CN B. 
As indicated in Figure 2b, the highest signal intensity of the responses against the different 
β-CN peptides were almost 1500% lower (700 versus 11,000 arbitrary units) compared with 
the highest signals obtained for peptides of αS1-CN. Four AA exchanges occurring in epitopes 
AA 55 to 72 and AA 106 to 122 of 7 β-CN variants (A1, A3, B, C, F, G, and H2) only induced 
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positive IgE binding in serum 4 but without significant differences in the immunoreactivity 
between the mutated and the reference peptides.  
 
 
 
 
Continued 
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Figure 2. Differences in IgE binding between epitopes (represented by AA residues, number, and casein variant) 
of αs1-CN (a), β-CN (b), and κ-CN (c) variants from cows, using 7 sera with cow milk-specific IgE values >100 
kUA/L, where UA =  allergen-specific units. Differences in AA sequence between the reference peptides and the 
mutated peptides are underlined. The mean fluorescence intensity (arbitrary units, AU) of the 3 subarrays on 
the microarray for each peptide is presented.                  
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Table 2. Sera of cow milk-allergic patients reacting with peptides of αs1-, β-, and κ-CN variants and differences 
in IgE binding between variant-specific peptides and corresponding reference peptides
1
 
Patient 
serum
2
    
Age   
Milk IgE 
[kUA/L] 
Peptides 
(AA no.) 
Casein variant 
IgE binding compared with reference 
peptides  
αs1-CN B, β-CN A
2
, and κ-CN A 
2 35 y >100 4-23  αs1-CN A ↓
3
 
   17-36 αs1-CN B  
   83-102 αs1-CN B, I  ↑
4
 
   173-192 αs1-CN B, C, E No differences 
   175-194 αs1-CN C, E No reaction to reference peptide 
3 12 y >100 83-102 αs1-CN B, I ↑ 
   173-192 αs1-CN B No reaction to peptide of αs1-CN C, E 
4 24 y >100 4-23 αs1-CN A ↑ 
   17-36 αs1-CN B  
   64-78 αs1-CN B, F No differences 
   83-102 αs1-CN B, I ↑ 
   173-192 αs1-CN B, C, E No differences  
   175-194 αs1-CN B, C, E No differences 
   180-193 αs1-CN B, C, E No differences 
   184-196 αs1-CN B No corresponding peptide in αs1-CN C, E 
   187-199 αs1-CN B No reaction to peptide of αs1-CN C, E 
   179-198 
174-193 
αs1-CN C, E 
αs1-CN B 
Lower reaction compared with peptide 
174-193 of αs1-CN B 
   55-72 
 
β-CN A
2
, A
1
, B, C, F, G, 
H
2 
No differences 
 
   106-122 
 
β-CN A
2
, A
1
, B, C, F, G, 
H
2 
No differences 
 
   110-125 
109-123 
β-CN A
2
, A
1 
β-CN B
 
No differences between 110-125 of β-CN 
A
2
, A
1 
and 109-123 of β-CN B
 
   103-123 
 
β-CN B 
 
No reaction to corresponding peptide 
108-129 of αs1-CN A
2
, A
1
 
   9-26 κ-CN A, F
2
 No differences 
5 8 mo 95.5 17-36 αs1-CN B No reaction to peptide 4-23 of αs1-CN A 
6 10 y >100 4-23 
 
αs1-CN A 
 
No reaction to reference peptide 17-36 of 
αs1-CN B 
   173-192 
 
αs1-CN C, E 
 
No reaction to reference peptide 173-192 
of αs1-CN B 
   175-194 αs1-CN B, C, E No differences 
   174-193 αs1-CN B No reaction to corresponding peptide 
179-198 of αs1-CN C 
7 16 y >100 173-192 αs1-CN B, C, E ↑ 
   175-194 αs1-CN B, C, E ↑ 
   179-198 
174-193 
αs1-CN C, E 
αs1-CN B 
Lower reaction compared with peptide 
174-193 of αs1-CN B 
1
Reference proteins are shown in bold. 
2
Serum 1 (age unknown; >100 kUA/L, where UA = allergen-specific units) showed no reaction with any of the 
casein variant peptides.  
3
↓ = decreased binding. 
4
↑ = increased binding. 
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The peptides AA 110 to 125 and AA 108 to 129 of β-CN A1 and A2, as well as AA 109 to 123 
and AA 103 to 123 of β-CN B, which were found to resist gastrointestinal digestion of β-CN, 
reacted with IgE antibodies of serum 4 (Figure 2b). Significant variations in IgE binding could 
be demonstrated between peptides AA 103 to 122 and AA 104 to 123 of β-CN B, comprising 
the digested peptide AA 103 to 123, and peptides AA 108 to 127 and AA 110 to 129 of β-CN 
A1 and A2, representing the digested peptide AA 108 to 129, where peptides of variant A1 
and A2 were not recognized by the IgE antibodies of serum 4. 
Among the variant-specific κ-CN peptides, marked IgE binding was solely found for the κ-CN 
peptide AA 9 to 26 in serum 4. Nevertheless, the substitution of an arginine (R) by histidine 
(H) in position 10 of κ-CN F2 resulted in no significant change in immunoreactivity, as the 
remaining IgE binding was less than 15% compared with the reference peptide of κ-CN A 
(Figure 2c). 
 
Identification of Interspecies Differences on the Epitope Structure  
Due to the high degree of similarity in AA sequence between the known IgE-binding epitopes 
of caseins from cows and caseins from goats and water buffaloes, differences in their IgE-
binding potential were investigated. The majority of sera showed IgE binding to αS1-CN 
peptides of cows and the homologous counterpart of goats as well as water buffaloes. Some 
sera bound exclusively to peptides of cows, water buffaloes or goats. As illustrated in Figure 
3a, b, and c, only the immunoreactivities of αS1- and β-CN peptides were affected by the 
variation in the epitope sequences occurring in the different species. In most sera, a 
significant modification in IgE binding between epitopes of cows and the other species 
occurred if the peptides differed from each other in at least 2 AA. Nevertheless, in some 
epitopes, 1 AA was sufficient to cause differences in the immunoreactivities between the 
epitopes of the species. 
For several sera, marked diminished IgE binding (≥15% of IgE binding remaining compared 
with the reference peptides of cows) to αS1-CN peptides AA 17 to 36 (sera 4 and 5), AA 64 to 
78 (serum 4), AA 139 to 154 (sera 3 and 4) from goats as well as to αS1-CN peptides AA 139 
to 154 (sera 3 and 4) and AA 173 to 192 (serum 2) from water buffaloes was found (Figure 3a 
and b). In contrast, the αS1-CN peptides AA 139 to 154 (sera 1 and 2), AA 173 to 192 (serum 
7), and AA 175 to 194 (serum 7) of goats and water buffaloes were characterized by marked 
increased IgE binding compared with the peptides of cows. 
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Individual sera analyses recognized the cow αS1-CN peptides AA 34 to 48 (sera 2 and 3), AA 
121 to 135 (serum 5), AA 159 to 174 (sera 1, 3, and 4), and AA 173 to 192 (sera 2 and 3). 
However, they had no or less IgE binding to the homologous peptides of goats and water 
buffaloes. In contrast, 3 sera showed IgE binding solely to the αS1-CN peptides AA 17 to 36 
(serum 6), AA 173 to 192 (serum 6), AA 175 to 194 (serum 2), and AA 106 to 120 (serum 4) of 
goats or water buffaloes, or both, but not to the reference peptides of cows. In 3 sera, no 
significant differences in immunoreactivity were found between the αS1-CN peptides AA 17 
to 36 (serum 2), AA 173 to 192 (sera 2 and 4), and AA 175 to 194 (sera 4 and 6) of the 3 
species. 
For β-CN, significant IgE binding was seen for peptide AA 16 to 35 of goats and water 
buffaloes (sera 4 and 7), as indicated in Figure 3c. Additionally, serum 4 reacted with the β-
CN peptide AA 55 to 72 of cows and water buffaloes. However, no reaction against the 
homologous peptide of goats could be observed. On the other hand, significant IgE binding 
was only detected for peptide AA 135 to 149 (serum 4) of goats. 
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Figure 3. Differences in IgE binding between epitopes (represented by AA residues, number, and species) of αs1-
CN (a and b) and β-CN (c) from cows, goats, and water buffaloes, using 7 sera with cow milk-specific IgE values 
>100 kUA/L, where UA = allergen-specific units. Modifications in AA sequence between peptides of the 3 
species are underlined. The mean fluorescence intensity (arbitrary units, AU) of the 3 subarrays on the 
microarray for each peptide is presented. g = goat; wb = water buffalo.  
 
DISCUSSION 
Identification of IgE-Binding Epitopes in Patient Sera Samples 
In this study, each individual serum had a heterogeneous IgE recognition pattern in terms of 
diversity and intensity of epitope binding. This agrees with previous observations and might 
be associated with clinical features of CMA, such as the course or the severity of allergic 
reactions (Savilahti et al., 2010; Wang et al., 2010). Most sera were monosensitized toward 
αS1-CN, as IgE binding was mainly seen for αS1-CN peptides, which is consistent with the fact 
that αS1-CN has been described as the main allergen among the 4 caseins (Docena et al., 
1996; Gaudin et al., 2008, Schulmeister et al., 2009).  
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The strongest fluorescence intensities and binding to most of casein peptides were obtained 
with serum 4. Nevertheless, for most samples, weak signal intensities on the peptide 
microarray were observed, but showed significant higher signals compared with noise. 
Conceivably, this is caused by IgG antibodies, which compete with the binding of serum IgE 
to the specific epitope peptides. It has been demonstrated that IgE and IgG antibodies 
recognize the same or similar epitopes on the various CMP (Chatchatee et al., 2001a,b; 
Savilahti et al., 2010). Due to this fact, it also might be that additionally to serum 4, further 
sera would react with other αS2-, β-, or κ-CN peptides. Therefore, the possible competing 
interactions between IgE and IgG antibodies had to be considered in further analyses. 
 
Identification of Variant-Specific Differences on the Epitope Structure  
To date, the only treatment of CMA is strict avoidance of all CMP, including CMP-derived 
infant formulas and other dairy products. However, this carries the risk of inadequate 
nutrient intake, such as calcium or a negative calorie:protein ratio and AA composition 
(Fiocchi et al., 2010). Thus, the identification of a suitable protein source or safe cow milk 
substitutes is an important aim for pediatricians and nutritionists to ensure a balanced diet 
for CMA patients. Depending on the nature of the allergy and as a consequence of the 
specific sensitization pattern of an individual, the best alternative diet has to be defined for 
each patient (Restani et al., 2009; du Toit et al., 2010). In the present study, it was 
demonstrated that the genetic polymorphism has influence on the immunoreactivity of 
some casein epitopes and peptides resisting gastrointestinal digestion, although with 
significant differences between individual sera (Table 2). A marked heterogeneity in IgE 
binding was seen for the variant-specific epitopes AA 4 to 23 of αS1-CN A as well as AA 173 to 
192 and AA 175 to 194 of αS1-CN C and E because the deletions and substitutions resulted in 
abrogation or decreased or increased IgE binding in particular sera. This is of importance, as 
the corresponding epitopes AA 17 to 36 and AA 173 to 194 of the reference protein αS1-CN B 
were identified as immunodominant IgE-binding regions, not only in this study but also by 
Chatchatee et al. (2001a), because they were recognized with the highest IgE-binding 
intensities in the majority of patients. Therefore, abrogated or increased IgE binding to both 
epitopes in αS1-CN A, C, and E may change the allergenicity of the whole proteins in most 
patients. In contrast, epitope AA 83 to 102 of αS1-CN I showed almost identical IgE binding 
between individual sera. The AA substitution led to a significant increase in IgE binding in 3 
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of the 7 sera. This is quite surprising, as the substituted AA, glutamic acid (E), and aspartic 
acid (D) are both polar, acidic, and have the same hydrophobicity and, consequently, no 
change in the immunoreactivity between epitope AA 83 to 102 of αS1-CN I and B may be 
expected. However, in this epitope, the substitution is located at position 84 at the N 
terminus of the epitope, which confirms the observation of Cocco et al. (2003). They 
reported that substitutions of hydrophobic AA in the central portion of epitopes in αS1-CN 
were most likely to induce a loss of antibody binding, whereas a small increase in IgE binding 
was observed for some substitutions at the periphery of the epitope.  
For the majority of variant-specific peptides, no significant differences in IgE binding could 
be found compared with the corresponding reference peptides. This can be explained by the 
fact that the occurrence of only 1 AA substitution in these epitopes is not sufficient to alter 
their IgE-binding properties. In general, all sera showed variations in the IgE-binding 
intensities when peptides differed from each other by 2 AA. For example, with serum 4, 
more IgE binding was determined for peptides AA 173 to 192 > AA 175 to 194 > AA 174 to 
193 of αS1-CN B and for peptides AA 173 to 192 > AA 175 to 194 > AA 179 to 198 of αS1-CN C. 
This indicates that for αS1-CN, a minimum of 2 AA have to be changed to alter the 
immunoreactivity in the majority of epitopes, which is in agreement with the results of the 
mutational analysis of αS1-CN by Cocco et al. (2003). However, for the bulk of epitopes in β- 
and κ-CN, as well as in the peanut allergens Ara h1, Ara h2, and Ara h3, 1 AA substitution has 
been detected to be sufficient for inducing a significant modification in IgE binding (Burks et 
al., 1997; Stanley et al., 1997; Cocco et al., 2007; Han et al., 2008).  
Some of the αS1- and β-CN peptides, which were found to resist in vitro gastrointestinal 
digestion (Lisson et al., 2013, 2014), showed positive IgE binding on microarray 
immunoassay, suggesting that these digested low-molecular weight peptides retain an 
allergenic potential, as was also described for other food allergens (Bogh et al., 2009, 2012; 
Martos et al., 2012). In the current study, peptides 13 AA in length, such as AA 184 to 196 of 
αS1-CN B as well as AA 180 to 193 of αS1-CN B and C, displayed significant IgE binding on the 
peptide microarray, even if immunoreactivity was lower compared with the longer peptides 
(e.g., AA 173 to 192 or AA 175 to 194). It is generally thought that peptides have to be 
approximately 3,500 Da (30 AA residues) in length and must contain at least 2 IgE-binding 
epitopes to induce cross-linking of the IgE receptors for stimulating an immune response 
(Huby et al., 2000). Nevertheless, it has been reported that immunization with free peptides 
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as small as 6 to 14 AA long induced an acceptable antibody response (Atassi and Young, 
1985; Muller, 1999). This was also demonstrated for the peanut allergen Ara h1, where 
peptides of less than 2,000 Da were able to sensitize and elicit allergic reactions (Bogh et al., 
2009, 2012). Results of the present study suggest that this could also apply to casein 
peptides. Thus, they probably do not need to survive the digestion process as large 
fragments to react with the immune system, which might contribute to the high 
sensitization rate to the caseins and explain why caseins are such potent allergens despite 
their excellent digestibility. 
One limitation of the current study was the small number of tested sera, most of which 
reacted solely with αS1-CN. Among the 16 sera used in this study, 7 displayed positive IgE 
binding on the microarray and only 2 sera exhibited positive IgE binding to β- and κ-CN 
peptides. Thus, it is entirely possible that some epitopes of β- and κ-CN variants differ in 
their allergenic properties when tested with other sera. All sera had milk-specific IgE ≥95.5 
kUA/L, meaning that low or lacking signals on the microarray were due to confounding 
factors in the methods rather than the quality of the sera. To evaluate differences in 
immunoreactivity between the variant-specific epitopes, further investigations with a larger 
number of patient sera known to have IgE against both proteins are needed.  
In this study, decreased, abrogated, or even higher IgE binding to the immunodominant 
epitopes AA 17 to 36, AA 173 to 192, and AA 175 to 194 in αS1-CN A, C, or E was identified 
(Table 2). For example, serum 2 showed significant lower IgE binding to peptide AA 4 to 23 
of αS1-CN A than to peptide AA 17 to 36 of αS1-CN B, C, and E. Furthermore, peptide AA 175 
to 194 of variant A, sharing the same sequence with peptide of αS1-CN B, was no longer 
recognized from IgE antibodies of serum 2, whereas significant IgE binding was found to the 
corresponding peptide of αS1-CN C and E. As a consequence, it is likely that the decreased 
and abrogated IgE binding to these 2 immunodominant epitopes in αS1-CN A changed the 
allergenicity of the whole protein and, thus, milk from cows with genotypes αS1-CN AA might 
be characterized by a lower or, as was detected for sera 4 and 6, higher allergenicity. This 
could be also relevant for cows carrying the genotype αS1-CN CC and EE regarding the 
differences in IgE binding to epitopes AA 173 to 192 and AA 175 to 194. In the case of 
reduced allergenic potential, these protein variants might be suitable for the production of 
hypoallergenic milk or as a basis for infant formulas for a well-selected group of allergic 
patients monosensitized to αS1-CN. This does not necessarily mean that whole milk has to be 
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used, but rather individual milk protein fractions, which could be used for specific processed 
products. To achieve this aim, selection and breeding of particular cows with genotypes αS1-
CN AA, CC, or EE would be necessary. However, αS1-CN A is rather common, but occurs with 
low frequencies in Holstein-Friesian and German Red cows (Erhardt, 1993). In contrast, αS1-
CN C is very common in all main breeds, with higher frequencies such as 0.45 in Jerseys or 
0.2 in Pinzgauers and αS1-CN E has been reported only in Bos grunniens (Caroli et al., 2009). 
There is already a kind of milk with a specific genotype on the market. Since 2003, A2 milk, 
containing only the A2 variant of β-CN, has been marked in New Zealand and Australia 
because epidemiological evidence implies that A2 milk is better for human health than A1 
milk (A2 Corporation Ltd., Auckland, New Zealand), although the European Food Safety 
Authority could not establish a relationship between A1 milk and increased disease (EFSA, 
2009). Because of the fact that IgE antibodies from individual patients also displayed 
increased binding to several mutated epitopes in the current study makes it difficult to 
consider specific genetic variants as a safe protein source for all patients with CMA. 
 
Identification of Interspecies Differences on the Epitope Structure  
In the quest to identify alternative protein sources for patients with CMA, there has been an 
increasing focus on the use of proteins from other species. Nevertheless, clinical cross-
reactivity exists between milk from cows, sheep, goats, and water buffaloes (Järvinen and 
Chatchatee, 2009; Restani et al., 2009), which is due to the high degree of AA sequence 
homology between the proteins from cows and the other Bovidae (96.1% for buffaloes, 
91.1% for sheep, and 87.6% for goats; Restani et al., 2009). Most patients who are sensitized 
to cow milk do not tolerate goat or sheep milk (Bellioni- Businco et al., 1999; Carroccio et al., 
1999). In the present study, we found that several sera reacted with both cow peptides and 
the corresponding peptides of goats and water buffaloes, demonstrating cross-reactivity or 
co-sensitization. However, in the majority of sera, individual epitopes from goats and water 
buffaloes showed lower immunoreactivity compared with epitopes from cows, which 
suggests reduced allergenic activity of αS1-CN from goat. These findings are in agreement 
with the results of other studies (Spuergin et al., 1997; Bevilacqua et al., 2001; Lara-
Villoslada, et al., 2004; Sanz Ceballos et al., 2009; Hodgkinson et al., 2012). The lower 
allergenic potential of goat milk could be attributable, at least in part, to the high genetic 
polymorphism of αS1-CN that occurs also in goat milk proteins. In goat milk, genetic variants 
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of αS1-CN are characterized by high (3.5 g/L), medium (1.1 g/L), low (0.45 g/L), and null 
quantities of this protein (Ballabio et al., 2011). Several studies demonstrated that goat milk 
with low or null αS1-CN content has reduced allergenic potential. Ballabio et al. (2011) 
investigated the allergenic potency of goat milk with different αS1-CN genotypes. They 
detected lower immunoreactions to αS1-CN 0101 (null content of αS1-CN) and 01F (reduced 
content of αS1-CN) genotypes compared with goat milk samples containing αS1-CN BB, BE, EE, 
or FF. By using guinea pig models (Bevilacqua et al., 2001; Sanz Ceballos et al., 2009) and 
murine models (Lara-Villoslada et al., 2004; Hodgkinson et al., 2012), it could be also shown 
that milk from goats producing low levels of αS1-CN is potential less allergenic than milk from 
cows or goats containing higher levels of this protein. This may be one reason why some cow 
milk-allergic children are able to tolerate goat milk (Restani, 2004).  
Moreover, in the present study, individual sera IgE only recognized αS1-CN and β-CN peptides 
of goats or water buffaloes but not the corresponding cow milk peptides. This indicates 
higher allergenicity of both proteins from the nonbovine species and might explain the 
observation that some patients have a selective allergy to goat or sheep milk but not to cow 
milk, as has been reported by others (Alvarez and Lombardero, 2002; Bidat et al., 2003; Ah-
Leung et al., 2006; Mori et al., 2013).  
Interestingly, in serum 4, significant IgE binding was found to the αS1-CN peptide AA 106 to 
120 of water buffaloes. In comparison with the corresponding peptides of cows and goats, 
showing no IgE binding in any serum, this peptide lacks a phosphorylated serine at position 
115. Conflicting results exist about the role of phosphorylation in allergy. Cases et al. (2011) 
demonstrated that phosphorylation reduces the allergenicity of cow caseins in children with 
selective allergy to goat and sheep milk. In contrast, it has been assumed that the major 
phosphorylation sites act as important allergenic epitopes in the caseins, as 
dephosphorylation significantly diminish their allergenicity (Bernard et al., 2000), which is in 
concordance with the results of the present study. Twenty peptides were synthesized in 
phosphorylated and dephosphorylated form, but only 1 peptide (AA 106 to 120 of αS1-CN) 
revealed differences in immunoreactivity. The other peptides displayed no significant IgE 
binding on the microarray immunoassay. A possible explanation is that 17 of the 20 peptides 
were from αS2-, β-, and κ-CN and, therefore, not recognized by the IgE antibodies because 
most sera tested in this study were sensitized against αS1-CN. 
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CONCLUSIONS 
Genetic polymorphisms of caseins influence the allergenic potential of some 
immunodominant epitopes. Single AA substitutions or deletion resulted in a loss or decrease 
or increase in immunoreactivity in some αS1- and β-CN epitopes with the tested sera. The 
genetic polymorphism of caseins should be taken into account in the search for a suitable 
protein source for CMA patients. However, a heterogeneous pattern of IgE binding to the 
variant-specific peptides was found between the individual sera. Thus, further clinical studies 
with more patient sera are needed to verify their suitability for CMA patients. The results of 
the present study confirm that the milk of goats and water buffaloes harbor an allergenic 
potential due to cross-reactivity between the proteins and are, consequently, not an 
appropriate replacement for patients with CMA. Nevertheless, these species are also 
characterized by genetic polymorphisms that affect the allergenic properties of their IgE-
binding epitopes, as has been already shown for goat milk. 
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5. General discussion of the results 
5.1. In vitro gastrointestinal digestion analyses of casein variants 
The question what makes some dairy proteins allergens still remains open but abundance in 
the food supply, durability during food processing, and resistance to digestion in the 
gastrointestinal tract are thought to be important factors (Bredehorst & David, 2001). Thus, 
the physical behavior of allergens during gastrointestinal digestion is of especial relevance to 
assess their potential allergenicity (Astwood et al., 1996). Despite their physiological 
importance, the implementation of in vivo assays is hardly to achieve due to ethical reasons, 
technical constraints, costs, impracticability of large studies, and high inter-individual 
variability. Therefore, in vitro digestion systems mimicking the physiological process of 
gastrointestinal digestion are an alternative tool to investigate the digestibility of proteins 
(Wickham et al., 2009; Ménard et al., 2014). This work compared the digestibility of common 
αS1-, αS2, β-, and κ-CN variants using an in vitro digestion model according to Moreno et al. 
(2005a) that involve an gastric and subsequent duodenal stage with digestive enzymes in 
physiological concentrations, a good adaption of pH and enzyme/substrate ratio, as well as 
surfactants like bile salts (Moreno et al., 2005a; Moreno, 2007). Recently, it has been 
demonstrated that this model of in vitro digestion utilizing commercial non-human enzymes 
provides a good estimation of the gastrointestinal digestibility and potential allergenicity of 
proteins as marked similarities in the results obtained with an in vitro digestion system using 
human oral and gastrointestinal digestive fluids were found (Benedé et al., 2014). In 
accordance with previous studies (Astwood et al., 1996; Fu et al., 2002; Dupont et al., 
2010a,b), the caseins were rapidly digested and no intact proteins were detected at the end 
of gastric digestion by matrix assisted laser desorption ionisation-time of flight-mass 
spectrometry (MALDI-TOF-MS). After duodenal digestion, the greatest number of peptides 
was identified for β-CN A1, A2 and B with 93 fragments and molecular weights up to 3,039 Da. 
A lot of these peptides were either totally or partially coincident with fragments previously 
determined after gastroduodenal hydrolysis of β-CN using a similar model of in vitro 
digestion (Dupont et al., 2010a,b; Benedé et al., 2014). There are some studies describing 
the digestion of β-CN with physiologically relevant in vitro models (Mandalari et al., 2009a; 
Defernez et al., 2010; Dupont et al., 2010a; Picariello et al., 2010; Stanic et al., 2010; Benedé 
et al., 2014), whereas comparable studies investigating the in vitro digestion of isolated αS1-, 
αS2, and κ-CN fractions are lacking. The particular interest in β-CN might be explained by the 
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fact that it is known to be an important allergen binding IgE in more than 50% of CMA 
patients (Docena et al., 1996; Shek et al., 2005). Moreover, it is the most important 
precursor of peptides including a huge number of bioactive peptides with various activities 
(Boutrou et al., 2013). Furthermore, the discussion about the health implications of the 
bioactive peptide β-casomorphin-7 in milk containing the β-CN variant A1 may contribute to 
the focus on this protein (Bell et al., 2006; EFSA, 2009).  
At the end of duodenal digestion, 58 fragments with molecular weights up to 2,998 Da were 
determined for αS1-CN B and C, 67 fragments with up to 2,556 Da for αS2-CN A and B, as well 
as 69 fragments with up to 3,123 Da for κ-CN A, B, and E covering almost the entire protein 
sequences. Some of these αS1-, αS2-, and κ-CN peptides could also be found in a study dealing 
with the in vitro digestion of whole raw, pasteurized, and sterilized milk, as well as yoghurt 
(Dupont et al., 2010b). Nevertheless, existing differences in the αS1-, αS2-, and κ-CN peptide 
patterns between both studies are due to the fact that Dupont et al. (2010b) used whole and 
processed milk for digestion instead of purified casein fractions as analyzed in this work. The 
investigation of whole and processed milk has the advantage to take into account the 
influence of the dairy matrix, food processing, and potential interaction with other milk 
ingredients on the protein digestibility (Moreno, 2007). Thus, Dupont et al. (2010b) 
demonstrated that milk processing, and particularly heat treatment of milk, increases the 
resistance of caseins to digestion. The authors made the generation of heat-induced 
aggregates of αS2- and κ-CN with whey proteins through the formation of disulphide bridges 
responsible for this observation resulting in an increased protection of the caseins against 
digestion. Moreover, it has been shown that proteolysis of milk proteins can be affected as a 
result of interaction with food ingredients. Phosphatidylcholine (PC), which is both abundant 
in milk and secreted by the stomach itself, has a protective effect against digestion of α-La 
and β-LG (Moreno et al., 2005b; Mandalari et al., 2009b), whereas the presence of PC did 
not affect the digestibility of the caseins (Mandalari et al., 2009a; Defernez et al., 2010). The 
presence of polysaccharides such as gum arabic, pectins, or xylan has also been found to 
reduce the proteolysis of β-LG (Mouécoucou et al., 2004).  
However, for a basic screening and to estimate the protein persistence of food allergens, in 
vitro digestion assays are commonly performed with purified proteins (Moreno et al.,  
2005a,b; Eiwegger et al., 2006; Smole et al., 2008; Mandalari et al., 2009a; Dupont et al., 
2010a). Furthermore, the use of purified proteins allows a more detailed and easier 
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identification of the peptide profile by mass spectrometry due to the reduction of spectra 
complexity and suppression effects as well as the avoidance of overlapping isotopic 
distributions (Schmelzer et al., 2007). Protein digestion in the human gastrointestinal tract is 
a complex process and associated with large inter-individual differences in gastric and 
duodenal secretion and with intra-individual variations that are caused by the age and 
health status of a person as well as the type and amount of food consumed (Benedé et al., 
2014). Nevertheless, to perfectly reflect what happens with milk proteins during digestion, 
there is a need to develop effective in vitro digestion models that mirror the conditions and 
processes occurring actually in vivo and take into account the impact of the food matrix and 
food processing (Dupont et al., 2010a).  
Despite the significant enzymatic hydrolysis of the αS1-, αS2-, β-, and κ-CN variants during 
gastrointestinal digestion, peptides were of sufficient size to contain intact IgE-binding 
epitopes or at least substantial parts thereof. It could be demonstrated that 3 previously 
identified IgE-binding epitopes in αS1-CN (AA 109-120, AA 123-132, and AA 173-194), 3 in 
αS2-CN (AA 1-20, AA 105-114, and AA 117-128), 6 in β-CN (AA 45-54, AA 55-70, AA 83-92, AA 
107-120, AA 149-164, and AA 167-184), and 5 in κ-CN (AA 21-44, AA 67-78, AA 95-116, AA 
111-126, and AA 137-148) survived the in vitro gastrointestinal digestion. The exact lower 
size limit of peptides triggering an allergic response is not known but it has been assumed to 
be approximately 30 AA residues corresponding to a molecular weight of about 3,000 Da. 
Furthermore, these peptides must contain at least 2 IgE-binding epitopes, each of which 
with a minimum of 15 AA in length, to enable antibody binding and the induction of cross-
linking of IgE-receptors (Huby et al., 2000). This means that the allergen or fragments 
thereof have to be of sufficient size to retain IgE-binding and T-cell stimulating capacity in 
order to sensitize the mucosal immune system and to cause an allergic reaction (Breiteneder 
& Mills, 2005; Wickham et al., 2009). In the present work, peptides comprising IgE-binding 
epitopes of αS1-, αS2-, β-, and κ-CN variants and resisting gastrointestinal digestion range 
from 12 to 25 AA in length suggesting that these fragments are in theory too small to contain 
more than 1 IgE-binding epitope and are therefore incapable of causing mast cell 
degranulation. Nevertheless, immunization with free peptides that are 6 to 14 AA in length 
has been described to induce acceptable antibody responses (Atassi & Young, 1985). 
Corresponding results were obtained in a study on sensitizing capacity of the digested 
peanut allergen Ara h 1 showing that this protein retained both the sensitizing and eliciting 
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abilities when digested into small peptide fragments of less than 2,000 Da (Bøgh et al., 
2009). Aggregation of peptides to complexes of larger sizes is thought to be responsible for 
the sustained allergenic capacity of digestion products of allergens indicating that the size of 
the breakdown products is not a determining factor to mount an immune response (Bøgh et 
al., 2009, 2012). Similarly, this may also apply to casein peptides and would imply an 
allergenic activity of small fragments comprising only 1 or no intact IgE-binding epitope. 
Accordingly, this might be one explanation for the high allergenicity and sensitizations rate 
to the caseins despite their excellent digestibility. 
To our knowledge, the first digestion study with genetic casein variants was made within this 
work. The genetic polymorphisms have an influence on the arising peptide pattern of the 
αS1-, αS2-, β-, and κ-CN variants as common or different peptides between these variants 
could be identified. Thereby, the AA substitutions contribute to the formation of distinct 
peptides in several ways. Due to the AA exchange, specific cleavage sites for the enzymes 
disappear as it was seen for peptides AA 193-199 of αS1-CN B and AA 9-21 of αS2-CN B. These 
peptides could not be detected in the digests of αS1-CN C, respectively, αS2-CN A. 
Furthermore, the AA substitutions may change the recognition sequence of the enzymes or 
contribute to steric hindrance, which impedes the access for the proteases and result in 
different peptides between the variants. In consequence, the IgE-binding epitopes are also 
affected because they correspond to these peptides or are parts thereof. Thus, for αS1-CN B 
and C, 2 peptides (AA 174-193 of αS1-CN B and AA 179-198 of αS1-CN C) comprising the intact 
IgE-binding epitope AA 173-194 were found (Chatchatee et al., 2001a). In αS2-CN, peptide AA 
1-20 has been reported as a major IgE-binding epitope, which correspond to peptide AA 1-22 
of αS2-CN B and to a large portion of peptide AA 7-29 of αS2-CN A (Cerecedo et al., 2008). 
Peptides AA 59-72, AA 59-80, and AA 58-80 of β-CN A1, A2, and B, peptides AA 103-123 and 
AA 109-123 of β-CN B, as well as peptides AA 108-129 and AA 110-125 of β-CN A1 and A2 
contained the IgE-binding epitopes AA 55-70, respectively, AA 107-120 (Chatchatee et al., 
2001b). For κ-CN, the IgE-binding epitope AA 137-148 survived gastrointestinal digestion 
within peptides AA 136-149 of κ-CN A and E and peptide AA 134-150 of κ-CN B. It is 
interesting to note that identical or similar peptides were observed in regions AA 172-198 of 
αs1-CN as well as AA 57-80 and AA 106-125 of β-CN in an in vivo study on the hydrolysis of 
milk caseins in jejunal effluents collected from healthy human subjects (Boutrou et al., 
2013). Moreover, investigations about the in vitro digestibility of β-CN with simulated and 
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human oral and gastrointestinal fluids also demonstrated the presence of peptides AA 59-68, 
AA 59-72, AA 59-80, and AA 108-125 after digestion (Benedé et al., 2014). The similarities 
between the αS1- and β-CN peptides released by in vivo and in vitro digestion indicates that 
the in vitro model by Moreno et al. (2005a) used in this work provides an adequate 
estimation of the digestibility of the caseins as it was already assumed by Benedé et al. 
(2014). To assess the allergenic potential of the gastrointestinal digestion products of the 
αS1-, αS2-, β-, and κ-CN variants containing the specific AA substitutions, their IgE-binding 
properties were analyzed by microarray immunoassay with sera from CMA patients. The 
major immunoreactive fragments of αS1-CN were peptides AA 174-193 of αS1-CN B and AA 
179-198 of αS1-CN C in terms of frequency and intensity of IgE-binding, which is probably due 
to the fact that both peptides comprise the intact immunodominant epitope AA 173-194 
(Chatchatee et al., 2001a). However, also peptides AA 184-196, AA 187-199, and AA 180-193 
of αS1-CN B and C showed a significant IgE-binding albeit with lower intensities. This confirms 
an allergenic potential of small peptide fragments containing no full epitope anymore and 
agrees mainly with the results found after gastrointestinal digestion of other food allergens 
such as peanut, egg, or yellow mustard (Eiwegger et al., 2006; Bøgh et al., 2009; Martos et 
al., 2012; Sirvent et al., 2012). Thus, it can be supposed that these proteins do not need to 
survive the digestion process as large fragments to interact with the immune system, which 
implies that the correlation between resistance to digestion and allergenicity is not a 
generally parameter for the risk assessment of the allergenic potential of a protein (Bøgh et 
al., 2009, 2012). For the variant-specific gastrointestinal digestion products of β-CN, a 
significant IgE-binding was detected for peptides AA 110-125 of β-CN A1 and A2 as well as AA 
109-123 and AA 103-123 of β-CN B but not for peptides AA 59-68, AA 59-72, AA 59-80, and 
AA 58-80. The reverse was true in the study of Benedé et al. (2014), where peptide AA 57-68 
released from in vitro digestion of β-CN revealed the highest immunoreactivity, whereas 
peptides AA 106-119 and AA 108-125 of β-CN did not react with any of the sera. The 
discrepancies might arise from the sera employed in both studies as is was reported that 
individual sera display a great variability in the IgE epitope profiles (Cocco et al., 2007; Han et 
al., 2008; Savilahti et al., 2010). There was no IgE-binding to the digestion products of the 
αS2- and κ-CN variants, which can be explained by the observed monosensitization towards 
αS1-CN in most of the sera used in this study. 
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The variant-specific peptides of αS1-CN B and C, β-CN A
1, A2, and B, as well as κ-CN A, B, and E 
comprise not only IgE-binding epitopes but are also precursors of peptides, which exhibit a 
wide range of biological functions such as the antibacterial peptides AA 180-193 of αS1-CN 
and AA 138-158 of κ-CN, the β-casomorphins 4 to 11 that are a family of opioid peptides 
resulting from region AA 60-70 of β-CN with a length of 4-11 AA all starting with tyrosine 
residue in position 60, as well as the anticariogenic phosphopeptides AA 59-78 of αS1-CN and 
AA 7-24 of β-CN (Malkoski et al., 2001; Monaci et al., 2006; Kamiński et al., 2007; BIOPEP 
database, 2013). With exception of the β-casomorphins, these bioactive peptides refer to 
the reference proteins and not to their genetic variants. Thus, the genetic polymorphisms 
occurring within the antibacterial peptides AA 180-193 of αS1-CN C at position 192 and AA 
138-158 of κ-CN B, C, F1, F2, G1, G2, and J at position 148, respectively, of κ-CN B2 at position 
153 and of κ-CN E at position 155, as well as within the anticariogenic phosphopeptides AA 
59-78 of αS1-CN E and J at postiton 59, and AA 7-24 of β-CN D at position 18 change the 
sequence of these fragments, which might result in the release of peptides with other or 
modified activities. It has already been demonstrated that the AA substitutions or deletions 
characterizing the genetic variants influence the manner and activity of bioactive peptides. 
The opioid and immune suppressant β-casomorphin-7 (AA 60-66) was shown to be yielded 
only by successive gastrointestinal proteolytic digestion of β-CN A1, B, C, F, and G but not of 
the other β-CN variants because they possess a histidine instead of a proline at position 67, 
which determines the enzymatic cleavage of the peptide bond (Hartwig et al., 1997; Jinsmaa 
& Yoshikawa, 1999; Kamiński et al., 2007). It has been assumed that a high consumption of 
milk with β-CN A1 (B, C, F, and G) carrying the histidine at position 67 increases the risk of 
human heart disease, atherosclerosis, type 1 diabetes, and sudden infant death syndrome 
(Bell et al., 2006; Kamiński et al., 2007). In New Zealand and Australia, A2 milk containing 
only the A2 variant of β-CN is already available on the market (A2 Corporation, 2013), 
although the European Food Safety Authority (EFSA) could not establish a relationship 
between the dietary intake of β-casomorphin-7 and, in consequence, A1 milk and any of the 
indicated diseases (EFSA, 2009).  Furthermore, the genetic polymorphisms located within the 
peptides AA 148-150 of κ-CN B, C, and F1 and AA 96-99 of κ-CN C and G1 lead to the 
existence of 4 distinct angiotensin I converting enhyme (ACE)-inhibitory peptides, which 
display significant differences in their ACE-inhibitory properties (Weimann et al., 2009). 
Moreover, it has been demonstrated that the phosphopeptides AA 29-41 of β-CN C and AA 
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126-135 of αs2-CN C versus the peptides of the other β- and αs2-CN variants differentially 
affect the calcium deposition in the extracellular matrix (Tulipano et al., 2010).  
However, as described above, some of the bioactive peptides are parts of the IgE-binding 
epitopes and might therefore carry an allergenic potential. Their application in functional 
foods, nutraceutical products, and cosmetics is associated with an increased risk for allergic 
reactions triggered by the use of those products from CMA consumers (Monaci et al., 2006). 
As the appearance, the becoming, or the elimination of bioactive peptides is affected by the 
genetic polymorphisms, it can be suggested that the same could apply to the allergenic 
potential of the bioactive peptides. 
 
5.2. Influence of genetic polymorphisms on the allergenicity of milk protein 
variants 
Peptide microarray immunoassays have been shown to be very useful for epitope mapping 
of milk allergens measuring their IgE and IgG levels and classify them into major and minor 
allergens (Lin et al., 2009; Hochwallner et al., 2013). The identification of the 
immunodominant regions in milk proteins by IgE-epitope mapping is of great importance to 
obtain information about the relationship between allergen structure and immunoreactivity 
as well as the patient’s immune response and may provide an important tool for diagnosis, 
prognosis, and treatment of CMA (Lin et al., 2009; Savilahti et al., 2010; Wang et al., 2010). 
By the use of microarray immunoassays with synthetic peptides, representing the previously 
described IgE-binding epitopes of the caseins as well as their genetic variants, the αS1-CN 
peptides AA 17-36, AA 139-154, AA 173-192, and AA 175-194 were shown to be the most 
immunoreactive fragments in terms of frequency and IgE binding, which is in agreement to 
the results of the studies of Chatchatee et al. (2010a) and Lin et al. (2009). Five out of the 7 
sera appeared to be monosensitized towards αS1-CN as it was the most frequently 
recognized milk allergen, which was also described by others (Docena et al., 1996; Gaudin et 
al., 2008; Schulmeister et al., 2009). In the current study, further IgE-binding epitopes were 
recognized by individual sera. Data revealed IgE-binding to epitopes AA 34-48, AA 64-78, AA 
83-102, AA 121-135, AA 139-154, and AA 159-174 of αS1-CN, to epitopes AA 55-72 and AA 
106-122 of β-CN, as well as to epitopes AA 9-26, AA 24-44, AA 34-53, and AA 49-68 of κ-CN. 
In contrast, none of the sera reacted with any of the αS2-CN peptides. This is coincident with 
the results found by Matsumoto et al. (2009), where individual sera showed an IgE-binding 
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only to epitopes AA 67-82, AA 109-124, and AA 172-188 of αS1-CN, AA 1-16, AA 55-70, AA 
106-121, AA 130-145, and AA 148-163 of β-CN, as well as AA 25-40, AA 52-67, AA 67-82, AA 
136-151, and AA 154-169 of κ-CN, some of which were also identified in the present study. 
Nevertheless, Cong et al. (2013) reported deviant findings with respect to the major IgE-
binding regions on αS1-CN that were located at AA 6-20, AA 11-25, AA 126-140, and AA 
171-185. It is important to note that the IgE recognition patterns and binding affinities for 
casein-derived peptides are different in the serum for each individual patient and, thus, the 
results depend heavily on patient selection (Cocco et al., 2007; Matsumoto et al., 2009; 
Savilahti et al., 2010; Wang et al., 2010).                                                    
The present study demonstrated that the genetic polymorphisms characterizing the milk 
protein variants affect the IgE-binding epitope structure and, in consequence, influence the 
allergenicity of milk protein variants. Previous studies showed that single or multiple AA 
substitutions within IgE-binding epitopes of αS1-, β-, and κ-CN, as well as β-LG result in a loss 
or reduced binding of milk-specific IgE antibodies by pooled or individual sera from CMA 
patients (Cocco et al. 2003, 2007; Han et al., 2008). In accordance to Cocco et al. (2003, 
2007), single AA substitutions or deletions occurring within IgE-binding epitopes or 
gastrointestinal digestion products of αS1- and β-CN variants led to a loss or reduced or 
increased IgE-binding in individual sera. Differences in IgE-binding were found between 
epitopes AA 17-36, AA 4-23, AA 83-102, AA 173-192, AA 175-194, AA 187-199, AA 174-193, 
and AA 178-198 of the αS1-CN variants A, B, C, E, and I. Modifications in IgE-binding to 
epitopes of β-CN variants could only be determined for the gastrointestinal digestion 
products AA 103-123 of β-CN B and AA 108-129 of β-CN A1 and A2 that differ in 12 AA from 
each other. Epitopes AA 55-72 of β-CN A1, B, C, E, G, H2, and AA 106-122 of β-CN A3 and B, as 
well as the eptiope AA 9-26 of κ-CN F2 showed no change in IgE-binding compared to the 
reference proteins β-CN A2 and κ-CN A, respectively. This agrees with the results of Cocco et 
al. (2007) as they reported that single AA substitutions were inadequate to eliminate IgE-
binding to epitopes AA 57-70 and AA 107-120 of β-CN, as well as AA 11-24 of κ-CN by using 
individual sera from CMA patients. In the studies of Cocco et al. (2003, 2007) and Han et al. 
(2008), substitutions of AAs were most likely to eliminate IgE-binding if they were 
hydrophobic and located in the central portion of the epitope, a finding which could only be 
partially confirmed within the present study. However, although an IgE-binding to epitope 
AA 55-72 was observed in all β-CN variants, peptides AA 59-68, AA 59-72, AA 59-80, and AA 
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58-80, which correspond to products of gastrointestinal digestion of β-CN A1, A2, and B, were 
not recognized by the IgE antibodies of any sera indicating that differences of 4 AA were 
critical for IgE-binding. One limitation of this study was the small number of tested sera and, 
hence, for a better assessment of the allergenicity of milk protein variants, a larger group of 
patients shall be investigated in the following by the means of peptide microarray 
immunoassay. Nevertheless, as described by others (Cocco et al., 2003, 2007; Han et al., 
2008; Savilahti et al., 2010; Wang et al., 2010), all sera displayed a great heterogeneity in IgE-
binding and, thus, it strongly depended on the tested serum whether the casein variants had 
a higher or a lower allergenic potential than the corresponding reference proteins. This is of 
importance in regard to a conceivable use of milk protein variants with a lower allergenicity 
for patients with CMA. αS1-CN A seemed to be characterized by a reduced allergenicity in 2 
sera showing a lacking or decreased IgE-binding to the immunodominant epitopes AA 17-36, 
respectively, AA 4-23, AA 173-192, and AA 175-194, whereas αS1-CN C and E tended to have 
a higher allergenic potential than the reference protein in most sera utilized in this study. 
However, the reverse case could be observed for 2 other sera and, in consequence, the 
determination of the individual reactivity profiles of allergic subjects to milk protein variants 
is necessary to assess their potential tolerability for these patients. The routine application 
of microarray technology will allow this purpose within a single assay that requires only tiny 
amounts of patients’ sera (Hochwallner et al., 2013). 
Allele frequencies of αS1-CN A are generally low but this variant occurs in common (Holstein 
Friesian or German Red) and not in rare or special breeds (Erhardt, 1993). αS1-CN C is very 
common and appears with high frequencies in all main breeds, whereas αS1-CN E seems to 
be specific for Bos grunniens (Caroli et al., 2009). Thus, selection and breeding of cows with 
the particular genotype αS1-CN AA or CC could be practicable. Milk from such cows might be 
suitable for the production of hypoallergenic milk or infant formulas for a well-selected 
group of allergic patients’ monosensitized against αS1-CN. In addition, the exclusive use of 
individual milk protein fractions for specific processed products could also be considered as 
milk proteins are applied as food additives or adjuvants due to their technical functions 
ranging from thickening, gelation, stabilization, emulsification, and film forming 
functionalities to tenderization (coffee, beef, bread, and sausages etc.) (Monaci et al., 2006). 
Before selecting and breeding of animals suitable for the generation of hypoallergenic milk 
and products thereof, further investigations with large patient groups followed by clinical 
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studies utilizing SPT and oral challenges are necessary to verify the reactivity to milk with 
particular genotypes in allergic individuals.  
In the context of the identification of an adequate and alternative protein source for 
patients with CMA, milk from other species has become the focus of increasing interest. 
Nevertheless, cross-reactivity between milk proteins from cow, sheep, goat, and water 
buffalo has been described because of the high degree of AA sequence homology between 
the proteins from cow and the other Bovidae (96.1% for water buffalo, 91.1% for sheep, and 
87.6% for goat) (Järvinen & Chatchatee, 2009; Restani et al., 2009). Thus, most of the 
patients with CMA cannot tolerate goat´s or sheep milk and probably buffalo milk, although, 
no clinical study has been published on the tolerance to buffalo milk in patients with CMA 
until now (Bellioni-Businco et al., 1999; Carroccio et al., 1999).  
In the present study, we demonstrated that the majority of sera reacted both with αS1- and 
β-CN peptides of cow as well as the corresponding peptides of goat and water buffalo 
indicating cross-reactivity. In some sera, the immunoreactivity to most αs1-CN peptides of 
goat and water buffalo was lower than to those of cow. Accordingly, Spuergin et al. (1997) 
investigating the cross-reactivity of α-CN among different species showed that the IgE-
response to caseins from goat and sheep was weaker than that to cow. Generally, goat milk 
is the subject of intense discussion regarding a less allergenic potential than cow milk, which 
is due to the high degree of genetic polymorphisms among goats resulting in different αS1-
CN variants that are characterized by high (3.5 g/L), medium (1.1 g/L), low (0.45 g/L), and 
null contents of this protein (Caroli et al., 2006). Several studies using guinea pig models 
(Bevilacqua et al., 2001) or murine models (Lara-Villoslada et al., 2004; Hodgkinson et al., 
2012) have reported that goat milk with lower αS1-CN level has reduced allergenic effects 
compared with milk from goat or cow containing higher levels of this protein. Furthermore, 
Ballabio et al. (2011) performed SPT and in vitro testing with sera from CMA patients to 
compare the reactivity of milk from goats with different αS1-CN genotypes and found less 
immunoreaction to 2 goat milk samples characterized by null or low αS1-CN content. Due to 
this fact, it is likely that milk from goat with αS1-CN null alleles will be tolerated from 
patient’s monosensitized against this protein and may explain why some subjects with CMA 
can consume goat milk and derivates (Ellis et al., 1991; Restani et al., 2002, 2009). However, 
Ballabio et al. (2011) also observed an increased immunoreactivity against milk homozygous 
for the null allele. In the current study, 2 sera showed an exclusive IgE-binding to the 
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immunodominant αS1-CN epitopes AA 17-36, AA 173-192, and AA 175-194 of goat and water 
buffalo but not to the corresponding peptides of cow suggesting a higher allergenic potential 
of this protein in the non bovine species. In this context, several cases of a selective allergy 
to goat and sheep milk but not to cow milk have been described in children and adults 
(Alvarez & Lombardero, 2002; La Muñoz Martín et al., 2004; Ah-Leung et al., 2006; Cases et 
al., 2011; Mori et al., 2013). Combined, these data propose that in general goat milk is not an 
adequate replacement for patients with CMA but it might be suitable in some cases and, 
thus, the individual tolerability of goat milk with a particular genotype has to be ascertained 
individually. Interestingly, Bernard et al. (2012) examined the structural determinants that 
account for the absence of cross-reactivity between the highly homologous β-CN of cow and 
goat in patients allergic to goat milk but tolerant to cow milk and found domain AA 49-79 of 
β-CN from goat of decisive importance. The authors assumed that the 3 AA substitutions, 
which differentiate peptide AA 49-79 of goat from that of cow, are the reason for the lack of 
cross-reactivity between these highly homologous allergens. In addition to the results of the 
present study, the findings of Bernard et al. (2012) confirm that the AA substitutions and 
deletions have an influence on the allergenicity of milk proteins not only in cows but also in 
the other Bovidae such as goat and sheep. Moreover, a genetic variability could also be 
identified within αS1-CN of camel milk (Shuiep et al., 2013) and, recently, for the first time 
within κ-CN of camel milk (Pauciullo et al., 2013). The constantly growing number of genetic 
variants in cow and in the other species necessitates their consideration in the field of 
human nutrition. On basis of in vitro (Restani et al., 1999, 2002) and in vivo studies (Shabo et 
al., 2005; Ehlayel et al., 2011a), there is some evidence that camel milk might be a promising 
protein source for patients with CMA as the homology with proteins from cow is only 60%, 
which corresponds to the lowest level of similarity among the species. Additionally, β-LG, 
one of the most dominant milk allergen, is not present in camel milk (Restani et al., 2009; 
Hinz et al., 2012). Further studies on the allergenicity of camel milk are needed as cross-
reactivity with cow milk could be observed in 25% of CMA patients, which also tested 
positive by SPT to camel milk (Katz et al., 2008).  
 
5.3. Concluding remarks and future approaches 
With the present study, it could be demonstrated that the genetic polymorphisms influence 
the allergenicity of milk protein variants. To confirm the observation of an higher or lower 
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allergenic potential of some αS1- and β-CN variants made in this study and to clarify whether 
the immunoreactivity of epitopes in the αS2- and κ-CN variants as well as the α-LA and β-LG 
variants are affected by the genetic polymorphisms, a larger group of patients with CMA 
should be tested in the following. Furthermore, the corresponding peptides of all milk 
proteins together with the genetic variants from goat, sheep, water buffalo, and camel 
should be included in these investigations to identify potential cross-reactivity as well as 
differences in the allergenicity between the peptides of cow and the other species. However, 
the IgE recognition pattern for casein-derived peptides varies in the serum of each patient. 
Therefore, the determination of the individual reactivity profile for patients with CMA is 
necessary to assess the possible tolerability of milk protein variants from cow as well as from 
other species. The characterization of the patients IgE reactivity not only to peptides of the 
genetic variants but also to the whole proteins inclusive the identification of cross-
reactivity’s with other proteins would be reasonable and able by the routine application of 
protein microarray technology. Currently, there is already a commercial protein microarray 
chip available (ImmunoCAP ISAC-CRD 103, Phadia, Uppsala, Sweden). The ImmunoCAP ISAC 
Allergen Chip is a miniaturized immunoassay platform that allows the measurement of 
specific IgE antibodies to 103 allergenic components using only 20 μL of patient sera, which 
is of particular importance in case of the diagnosis of allergy in infants and children. Purified 
natural or recombinant major and minor allergen components of the most significant food 
and inhalation allergens are located on the chip. They include also whole casein, α-LA, β-LG, 
bovine serum albumin, and lactoferrin but do not represent the genetic variants of milk 
proteins from cow and the other species. Thus, the development of a custom-made protein 
array containing all the actually known milk protein variants of cow as well as of goat, sheep, 
water buffalo, and camel will be required for a first assessment of the individual tolerability 
of milk with a particular genotype. 
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6. Summary 
Within the screening of milk samples from different bovine breeds, the known genetic casein 
variants αS1-CN B and C, αS2-CN A, B, and D, β-CN A
1, A2, and B, as well as κ-CN A, B, and E 
were confirmed and used for in vitro gastrointestinal digestion analyses. The results showed 
that, despite the significant enzymatic hydrolysis of the αS1-, αS2-, β-, and κ-CN variants 
during gastrointestinal digestion, peptides were of sufficient size to contain intact IgE-
binding epitopes or at least substantial parts thereof. Three previously identified IgE-binding 
epitopes in αS1-CN (AA 109-120, AA 123-132, and AA 173-194), 3 in αS2-CN (AA 1-20, AA 105-
114, and AA 117-128), 6 in β-CN (AA 45-54, AA 55-70, AA 83-92, AA 107-120, AA 149-164, 
and AA 167-184), and 5 in κ-CN (AA 21-44, AA 67-78, AA 95-116, AA 111-126, and AA 137-
148) survived the in vitro gastrointestinal digestion. Furthermore, it could be demonstrated 
that the genetic polymorphisms have an influence on the arising peptide pattern as different 
peptides between the αS1-, αS2-, β-, and κ-CN variants were found. In αS1-CN B and C, the 2 
peptides AA 174-193 of αS1-CN B and AA 179-198 of αS1-CN C comprising the intact IgE-
binding epitope AA 173-194 were determined. In αS2-CN B, peptide AA 1-22 and in αS2-CN A, 
peptide AA 7-29 could be detected both corresponding to the major IgE-binding epitope AA 
1-20 or parts thereof. Peptides AA 59-72, AA 59-80, and AA 58-80 of β-CN A1, A2, and B, as 
well as peptides AA 103-123 and AA 109-123 of β-CN B, and AA 108-129 and AA 110-125 of 
β-CN A1 and A2 contained the IgE-binding epitopes AA 55-70, respectively, AA 107-120. For κ-
CN, the IgE-binding epitope AA 137-148 survived gastrointestinal digestion within peptides 
AA 136-149 of κ-CN A and E and peptide AA 134-150 of κ-CN B. Microarray immunoassays 
with sera from patients (n = 7) with CMA indicated an allergenic activity of some of these 
digested casein fragments. This might be one explanation for the high allergenicity and 
sensitizations rate to the caseins despite their excellent digestibility. Major immunoreactivity 
was identified for peptides AA 174-193 of αS1-CN B and AA 179-198 of αS1-CN C but also for 
the smaller peptides AA 184-196, AA 187-199, and AA 180-193 occurring in both αS1-CN 
variants. Significant IgE-binding was further detected to the gastrointestinal digestions 
products AA 110-125 of β-CN A1 and A2 as well as AA 109-123 and AA 103-123 of β-CN B. 
None of the sera used in the present study reacted with any of the digestion products of the 
αS2- and κ-CN variants.  
This study confirmed an influence of the genetic polymorphisms on the IgE-binding 
properties of epitopes from αS1-, αS2-, β-, and κ-CN variants of cow and revealed differences 
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in IgE-binding to corresponding epitopes of goat and water buffalo. Single AA substitutions 
or deletions existing within IgE-binding epitopes AA 17-36, AA 4-23, AA 83-102, AA 173-192, 
and AA 175-194 of the αS1-CN variants A, B, C, E, and I or gastrointestinal digestion products 
AA 187-199, AA 174-193, and AA 178-198 of αS1-CN B and C, as well as AA 108-129 and AA 
103-123 of β-CN A1 and A2, respectively, B led to a loss or reduced or increased IgE-binding 
with a marked heterogeneity in individual sera. The modifications in the immunoreactivity 
mainly affected the immunodominat epitopes and, in consequence, it can be accepted that 
the allergenicity of the whole proteins are altered.  
The majority of sera showed IgE-binding to αS1-CN peptides of cow but also to the 
homologous counterparts of goat and water buffalo indicating cross-reactivity, which is due 
to the high degree of AA sequence homology between the milk proteins from cow and the 
other Bovidae. However, individual sera exhibited a lower, higher, or exclusive 
immunoreactivity to epitopes of αS1- and β-CN from goat and water buffalo.  
The results of our investigations support the suggestion that genetic variants differ in their 
allergenic properties and might therefore provide a new approach for the identification of an 
alternative and suitable protein source for CMA patients. Furthermore, milk of goat and 
water buffalo cannot be recommended in general as substitution for cow milk in the 
nutrition of CMA patients. Nevertheless, the milk proteins of these species are also 
characterized by genetic polymorphisms, whose effects on IgE-binding and allergenicity have 
to be defined. 
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7. Zusammenfassung 
Im Rahmen des Screenings von Milchproben verschiedener Rinderrassen wurden die 
bekannten Kaseinvarianten αS1-CN B und C, αS2-CN A, B und D, β-CN A
1, A2 und B, sowie κ-CN 
A, B und E bestätigt und für in vitro gastrointestinale Verdaustudien herangezogen. Die 
Ergebnisse zeigten, dass die Peptide, trotz der umfassenden enzymatischen Hydrolyse der 
αS1-, αS2-, β- und κ-CN-Varianten während des gastrointestinalen Verdaus, noch groß genug 
waren, um intakte IgE-bindende Epitope oder signifikante Teile davon zu enthalten. So 
überstanden 3 bereits identifizierte IgE-bindende Epitope des αS1-CN (AA 109-120, AA 123-
132 und AA 173-194), 3 des αS2-CN (AA 1-20, AA 105-114 und AA 117-128), 6 des β-CN (AA 
45-54, AA 55-70, AA 83-92, AA 107-120, AA 149-164 und AA 167-184) und 5 des κ-CN (AA 21-
44, AA 67-78, AA 95-116, AA 111-126 und AA 137-148) den gastrointestinalen Verdau 
unverändert. Zudem konnte nachgewiesen werden, dass der genetische Polymorphismus 
einen Einfluss auf das entstehende Peptidmuster besitzt, da unterschiedliche Peptide 
zwischen den αS1-, αS2-, β- und κ-CN-Varianten detektiert wurden. In den αS1-CN-Varianten B 
und C wurden die 2 Peptide AA 174-193 (αS1-CN B) und AA 179-198 (αS1-CN C) gefunden, die 
das intakte IgE-bindende Epitop AA 173-194 umfassen. Im αS2-CN B konnte Peptid AA 1-22 
und im αS2-CN A Peptid AA 7-29 bestimmt werden, die beide dem IgE-bindenden 
Hauptepitop AA 1-20 oder Teilen davon entsprechen. Die Peptide AA 59-72, AA 59-80 und 
AA 58-80 der 3 β-CN-Varianten A1, A2 und B sowie die Peptide AA 103-123 und AA 109-123 
des β-CN B und AA 108-129 und AA 110-125 des β-CN A1 und A2 enthalten die IgE-bindenden 
Epitope AA 55-70 bzw. AA 107-120. Bei dem κ-CN überstand das IgE-bindende Epitop AA 
137-148 den gastrointestinalen Verdau als Bestandteil von Peptid AA 136-149 des κ-CN A 
und E und von Peptid AA 134-150 des κ-CN B. Mittels Microarray Immunoassay und Seren 
von Patienten (n= 7) mit CMA konnte bei einigen dieser verdauten Kaseinfragmente eine 
allergene Aktivität bestätigt werden, was eine Erklärung für die hohe Allergenität und 
Sensibilisierungsrate gegenüber den Kaseinen trotz ihrer exzellenten Verdaulichkeit sein 
könnte. 
Die Peptide AA 174-193 des αS1-CN B und AA 179-198 des αS1-CN C wiesen die stärkste 
Immunreaktivität auf, aber auch für die kleineren Peptide AA 184-196, AA 187-199 und AA 
180-193 beider αS1-CN-Varianten konnte eine deutliche IgE-Bindung festgestellt werden. Des 
Weiteren wurde eine signifikante IgE-Bindung an die gastrointestinalen Verdauprodukte AA 
110-125 des β-CN A1 und A2 sowie AA 109-123 und AA 103-123 des β-CN B identifiziert. 
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Keines der verwendeten Seren reagierte mit einem der Verdauprodukte der αS2- und κ-CN-
Varianten.  
Die Ergebnisse der Microarray Immunoassays bestätigten einen Einfluss des genetischen 
Polymorphismus auf die IgE-bindenden Eigenschaften der Epitope der αS1-, αS2-, β- und κ-CN-
Varianten beim Rind und wiesen zudem Unterschiede in der IgE-Bindung zu den 
entsprechenden Epitopen von Ziege und Wasserbüffel auf. Einzelne 
Aminosäuresubstitutionen oder -deletionen, die innerhalb der IgE-bindenden Epitope AA 17-
36, AA 4-23, AA 83-102, AA 173-192 und AA 175-194 der αS1-CN-Varianten A, B, C, E und I 
oder der gastrointestinalen Verdauprodukte AA 187-199, AA 174-193 und AA 178-198 des 
αs1-CN B und C sowie AA 108-129 und AA 103-123 des β-CN A
1, A2, bzw. B auftraten, führten 
zu einem Verlust oder einer Abnahme oder einer Zunahme der IgE-Bindung mit deutlichen 
Heterogenitäten zwischen den einzelnen Seren. Die Veränderungen in der Immunreaktivität 
betrafen hauptsächlich die immunodominanten Epitope und folglich sind Auswirkungen auf 
die Allergenität des gesamten Proteins anzunehmen. 
Die Mehrheit der Seren zeigte eine IgE-Bindung an die Peptide des αS1-CN vom Rind, aber 
auch an die homologen Gegenstücke von Ziege und Wasserbüffel, was auf eine 
Kreuzreaktion hinweist, die durch den hohen Grad der Homologie in der Aminosäuresequenz 
zwischen den Milchproteinen des Rindes und der anderen Bovidae bedingt ist. Allerdings 
wiesen einzelne Seren eine niedrigere, höhere oder ausschließliche IgE-Bindung an die 
Epitope des αS1- und β-CN von Ziege und Wasserbüffel auf. 
Aus den Ergebnissen dieser Untersuchungen wird deutlich, dass sich die genetischen 
Varianten in ihren allergenen Eigenschaften unterscheiden. Sie bieten daher einen neuen 
Ansatz für die Identifikation einer geeigneten Proteinquelle für Patienten mit 
Kuhmilchallergie. Zudem kann die Milch von Ziege oder Wasserbüffel generell nicht als ein 
Ersatz für Kuhmilch in der Ernährung von kuhmilchallergischen Patienten empfohlen 
werden. Allerdings sind auch die Milchproteinvarianten dieser Tierarten durch genetische 
Polymorphismen charakterisiert, deren Effekte auf die IgE-Bindung und Allergenität der 
Proteine noch bestimmt werden müssen. 
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